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Summary 
Although adipose tissue plays important physiological roles, the increase in adiposity 
with aging is a common feature in several pathologies, including some forms of 
osteoporosis. Ion channels and ghrelin signalling have been shown to be involved in 
regulating many cell processes such as proliferation, differentiation and apoptosis, 
particularly in bone. This thesis investigated the roles of ghrelin and ion channels in the 
adipogenic differentiation of 7F2 preosteoblastic cells. The amount of Oil Red O stain 
increased by 135%, and the mRNA expression of two adipocytic markers, PPARγ (5.46 
± 0.22; p = 0.024) and C/EBPα (25.3 ± 0.21; p = 0.0048), was higher in 7F2 cells 
cultured with adipogenic medium compared with basal medium, indicating that 7F2 
cells differentiated into adipocytes. 7F2 cells also expressed previously unreported 
variant isoforms of ghrelin at the mRNA level; these variants isoforms were much more 
abundant than native ghrelin. 7F2 cells also express the other key genes from ghrelin 
signalling, i.e. Ghsr and Mboat4, suggesting that ghrelin or its variant isoforms may have 
autocrine/paracrine effects in these cells. Ghrelin mRNA expression was higher in 7F2 
cells treated with basal medium + 200 nM ghrelin (144.84 ± 0.58) and adipogenic 
medium + 200 nM ghrelin (123.07 ± 0.33) compared with cells cultured with basal 
medium alone (p = 0.01), and adipogenic medium alone (0.79 ± 0.40; p = 0.0089), 
respectively. Treatment with 20 nM and 200 nM ghrelin had no significant effect on 
lipid content and on osteoblastic and adipocytic markers mRNA levels (p > 0.05). On 
the contrary, cell numbers were lower in 7F2 cells cultured with the voltage-gated K+ 
channel blocker tetraethylammonium, and lipid droplets inside 7F2 cell-derived 
adipocytes were smaller compared with cells cultured with adipogenic medium alone, 
suggesting that voltage-gated K+ channels are involved in regulating cell proliferation 
and adipogenic differentiation. 7F2 cells and 7F2 cell-derived adipocytes expressed the 
KATP channel subunits Kcnj8 and Sur2B, and the BK channel subunits Kcnma1 and 
Kcnmb2. 12 types of functional ion channels were detected in electrophysiology 
experiments but could not be identified. In conclusion, ghrelin treatment did not inhibit 
adipogenic differentiation in 7F2 cells, but 7F2 cells expressed previously unreported 
variant isoforms of ghrelin and ion channels which may play important roles in 
regulating osteoblast functions and adipogenic differentiation. Future work is required 
to confirm the presence of ghrelin variants at the protein level, and to study the roles of 
these variants and ionic mechanisms in bone metabolism. A better understanding of 
the mechanisms underlying pathological adipogenesis in bone may provide interesting 
therapeutic targets for disorders such as osteoporosis.   
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SUR Sulphonylurea receptor 
TEA Tetraethylammonium 
TGF Transforming growth factor 
TMD Transmembrane domain 
TRPV Transient receptor potential, vanilloid-type 
V Voltage 
VDCC Voltage-dependent calcium channel 
VRAC Volume-regulated anion channel 
VSD Voltage-sensor domain 
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1.1. Outline 
While adipose tissue plays an essential role in many physiological processes, pre-
terminal differentiation or trans-differentiation of mature mesenchymal cell 
phenotypes into adipocytes within different tissues is proposed to be a common feature 
of certain pathologies, including osteoporosis, cancer or age-associated immune 
senescence. Adipose tissue is an important regulator of bone metabolism via the 
secretion of factors that can regulate bone homeostasis by direct and indirect 
mechanisms (Ali et al., 2013). Bone is a multifunctional, dynamic tissue that is 
constantly remodelled; bone homeostasis is a result of the balance between two 
processes: bone resorption and bone formation. Both these processes depend on the 
proliferation, differentiation and functions (resorption/mineralisation) of specialised 
bone cells, osteoclasts and osteoblasts. Any interference with any of these key 
physiological processes can result in unbalanced bone resorption or formation, leading 
to bone disorders. Bone marrow contains adipose tissue, which participates in 
regulating bone homeostasis, but is also associated with several bone disorders, such as 
osteoporosis. Osteoporosis is one of the most common bone disorders, affecting over 3 
million people in the United Kingdom; the economic cost of fragility fractures was 
estimated at £3,497 million in 2010 (Svedbom et al., 2013). Osteoporosis is associated 
with decreased osteoblast formation and activity, and increased adipogenesis. There 
are several risk factors for osteoporosis, such as long-term glucocorticoid therapy 
(Briot and Roux, 2015). Various treatments are already available, but they are not 
adapted for every patient, so it is necessary to develop new treatments. Prevention is 
also an important aspect of osteoporosis management, and understanding the 
mechanisms of the pathology can help with that. There are many factors regulating 
bone homeostasis; in particular, hormones from energy metabolism, such as ghrelin, 
play a central role. Ghrelin, which was first discovered in 1999 for its actions in 
stimulating growth hormone (GH) release and appetite (Kojima et al., 1999; Wren et al., 
2000), plays many roles in peripheral tissues, including bone and adipose tissues, 
regulating osteoblast and adipocyte proliferation and differentiation (Delhanty et al., 
2014a; Müller et al., 2015). Although mice deficient in ghrelin (Ghrl–/–) or ghrelin 
receptor (Ghsr–/–) have unaltered bone mineral density (BMD) (Sun et al., 2003, 2004), 
their bone microarchitecture is modified: Ghsr–/– mice have lower trabecular bone 
mass, while Ghrl–/– mice have lower cortical bone mass (Delhanty et al., 2014b; a). The 
role of ion channels in bone homeostasis is now well established; numerous ion 
channels are expressed in mesenchymal stem cells (MSCs), osteoblast precursors and 
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osteoblasts. A large number of studies have demonstrated that ion channels, and 
particularly potassium (K+) channels, regulate cell proliferation, differentiation and 
functions in bone MSCs (Tao et al., 2008), osteoblasts (Henney, 2008; Henney et al., 
2009; Li, 2012), osteoclasts (Yeon et al., 2015) and adipocytes (Zhang et al., 2012). 
Mutations in ion channels can be involved in some pathologies called channelopathies, 
including in bone; for example, mutations in the chloride transporter ClC-7 are 
associated with osteopetrosis, and this channel may be a therapeutic target against 
osteoporosis (Zhao et al., 2009; Schulz et al., 2010). Finally, K+ channels are also 
involved in mediating ghrelin signalling (Dezaki et al., 2007). The work presented in 
this thesis focuses on the role of ghrelin and ionic mechanisms in the adipogenic 
transdifferentiation of murine 7F2 cells as a model for the adipogenesis of osteoblast 
precursors. 
1.2. Bone 
Bone is a multifunctional organ, playing important mechanical and metabolic roles. 
Bone is a dynamic tissue; it is constantly renewed through a process called remodelling, 
which involves bone resorption by specialised cells called osteoclasts, followed by new 
bone formation by osteoblasts. In addition to osteoblasts and osteoclasts, bone also 
contains various other cells, including haematopoietic stem cells, MSCs, osteocytes, 
lining cells, and adipocytes (Contador et al., 2015); these cells communicate with and 
influence each other (Datta et al., 2008). Osteoblasts and adipocytes originate from the 
same precursors, the MSCs.  
1.2.1. Functions of bone 
Bone plays several important mechanical roles: as a skeleton it is essential for 
locomotion, providing structure and support for the body and enabling mobility. It also 
provides protection for important organs such as the brain, protected by the skull, and 
the heart, protected by the ribcage. Bone is composed of two types of bone tissues: 
cortical bone and trabecular bone. Cortical bone is compact and forms the outside part 
of bones. Trabecular bone forms the internal part of bones, is less dense than cortical 
bone, and frequently contains myeloid tissue, where haematopoiesis occurs (Porter and 
Calvi, 2008).  
Bone also plays important metabolic roles. Bone functions as a mineral store and is a 
vital player of the calcium-phosphate homeostasis, storing these two minerals and 
releasing them in the circulation during the process of bone resorption. Bone stores 
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lipids via the bone marrow adipocytes. There are multiple regulatory links between 
bone and energy metabolism: bone metabolism is both a target and a regulator of 
energy metabolism via direct and indirect mechanisms, hormones acting systemically 
and/or cytokines acting locally. Osteoblasts, via secreted undercarboxylated 
osteocalcin, increase pancreatic β-cell proliferation, insulin secretion, and insulin 
sensitivity (Hauschka et al., 1989; Lee et al., 2007; Ferron et al., 2008; Brennan-
Speranza and Conigrave, 2015). Osteoblasts also possess insulin receptors, and insulin 
signalling is necessary for osteoblasts, directly stimulating cell proliferation, 
differentiation and survival (Ferron et al., 2010; Fulzele et al., 2010; Clemens and 
Karsenty, 2011; Pramojanee et al., 2014). Bone marrow adipocytes, via adipokines such 
as leptin and adiponectin, also participate in the regulation of energy metabolism 
(Karsenty, 2006; Cawthorn et al., 2014). Another energy metabolism-regulating 
hormone, ghrelin, influences bone homeostasis via direct and indirect mechanisms (see 
section 1.4.2.1). 
1.2.2. Bone remodelling 
Bone remodelling allows for repairing microdamage, healing fractures, and regulating 
calcium-phosphorus homeostasis. Bone remodelling involves bone resorption by 
osteoclasts followed by new bone formation by osteoblasts (see figure 1.1); these two 
processes are tightly coupled and balanced (Delhanty et al., 2014a). Bone remodelling 
is achieved by the cooperative and sequential work of several bone cell types, including 
osteoblasts, osteocytes, bone lining cells and osteoclasts, which are organised in 
specialised units called bone multicellular units (BMUs) (Zhou et al., 2010). Osteoblast 
and osteoclast differentiation and functions are regulated by multiple factors including 
cytokines acting locally, hormones acting systemically, neurotransmitters, and 
mechanical stimuli (Harada and Rodan, 2003; Teitelbaum and Ross, 2003; Hu et al., 
2017). 
Osteoblasts play a central role in forming and maintaining skeletal architecture: they 
are responsible for bone formation through the secretion of the organic components of 
bone matrix in the form of a complex mixture of bone matrix proteins, also called 
osteoid; they also regulate the differentiation and function of osteoclasts. Osteoblasts 
are located on bone surfaces, usually in a single layer (Marks and Odgren, 2002; 
Mackie, 2003).  
Osteoblasts are derived from MSCs, also called skeletal stem cells (SSCs) or bone 
marrow stromal cells (BMSCs), which can be found in the bone marrow stroma and 
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periosteum (Harada and Rodan, 2003). MSCs are capable of differentiating into 
multiple lineages, including osteoblasts and adipocytes. The osteogenic differentiation 
of MSCs and osteoblasts are tightly regulated by a number of transcription factors, 
growth factors and hormones (Aubin and Triffitt, n.d.; Wang et al., 2016; van de Peppel 
et al., 2017), such as parathyroid hormone (PTH), oestrogens, transforming growth 
factor-β (TGF-β), bone morphogenetic proteins (BMPs), insulin, and ghrelin (Lee et al., 
2000; Gimble, 2011; Delhanty et al., 2014a; Pramojanee et al., 2014). Some of these 
factors, such as TGF-β and BMPs, are secreted by osteoblasts and sequestered in bone 
matrix; they are released during osteoclastic resorption (Mackie, 2003).  
Between 60 and 80% of osteoblasts recruited to a resorption pit die by apoptosis 
within 200 days (Jilka et al., 1999, 2007; Manolagas and Parfitt, 2010); some of the 
osteoblasts become quiescent bone-lining cells, which cover inactive, non-remodelling 
bone surfaces and communicate with each other via gap junctions. They are 
responsible for immediate release of calcium from the bone and most likely participate 
in bone remodelling (Miller et al., 1989). Bone lining cells prevent the direct interaction 
between osteoclasts and bone matrix on non-remodelling bone surfaces, where bone 
resorption should not occur (Florencio-Silva et al., 2015). Bone lining cells also 
constitute a major source of osteoblasts in adults (Matic et al., 2016); they can be 
induced to proliferate and differentiate into osteogenic cells, and participate in bone 
remodelling.  
The remaining osteoblasts become surrounded with bone and differentiate into 
osteocytes, which progressively stop secreting osteoid. Osteocytes represent 
approximately 90% of the cells in bone (Manolagas and Parfitt, 2010). They are not 
isolated cells; they are located in lacunae and form a network throughout mineralised 
bone matrix, communicating with each other via gap junctions and canaliculi 
throughout bone. Osteocytes can also communicate with osteoblasts on the bone 
surface (Marks and Odgren, 2002; Mackie, 2003), participating in regulation of bone 
remodelling (Komori, 2013). They participate in mechanosensation and paracrine 
signalling to regulate bone remodelling in response to mechanical strain and fatigue 
damage (Marotti, 2000; Zhao et al., 2002; Han et al., 2004), in particular via K+ channels 
(Gu et al., 2001a).  
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Figure 1.1: Cellular activities supporting bone remodelling 
Bone is resorbed by osteoclasts, which result from the fusion of several mononuclear precursors 
originating from haematopoietic stem cells. Osteoclasts are large, multinucleated cells that form 
resorption pits in the bone matrix by secreting acids and enzymes that degrade the bone (Blair 
et al., 2005; Lampiasi et al., 2016). After resorbing bone, osteoclasts undergo apoptosis. Then, 
osteoblasts, which originate from MSCs, produce new osteoid matrix and promote 
mineralisation. 60-80% of the osteoblasts recruited to a resorption pit die by apoptosis (Jilka et 
al., 1999, 2007; Manolagas and Parfitt, 2010); others become small, quiescent lining cells; and 
the remaining osteoblasts become surrounded with bone and differentiate into osteocytes. 
Adapted from (Lian et al., 2012).  
 
In healthy adults, bone resorption and bone formation are well-balanced; however, 
with aging and other risk factors such as glucocorticoid therapy, these two processes 
become unbalanced, leading to bone loss and increasing the risk of developing 
osteoporosis (see section 1.3.1). 
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1.2.3. Bone marrow adipose tissue 
In addition to bone resorbing and bone forming cells, bone contains adipocytes. Like 
osteoblasts, adipocytes originate from MSCs. Bone marrow adipogenesis is both a 
physiological and pathological process; it occurs throughout the entire life of all 
mammals (Rosen et al., 2009; Hardouin et al., 2016). Around the time of birth, bone 
cavities mainly contain active haematopoietic cells in the marrow; but in adults, human 
bone marrow adipose tissue (BMAT) represents between 50% and 70% of total bone 
marrow volume and 5% of total body fat mass (Hardouin et al., 2016). Bone marrow 
adipogenesis accelerates during aging, especially after menopause for women. 
Similarly, in rodents, BMAT is present in adults (Lecka-Czernik, 2012; Wang et al., 
2013) and increases with aging (Pittenger et al., 1999; Sadie-Van Gijsen et al., 2013).  
Adipose tissue functions as an energy store and a secretory organ; adipocytes can 
secrete various adipokines such as leptin and adiponectin, but also free fatty acids and 
inflammatory cytokines (Hardouin et al., 2016). These molecules participate in the 
regulation of energy metabolism and inflammation (Hardouin et al., 2016). Until 
recently, the functions of BMAT were unknown; it has been the focus of several studies 
in the recent years. In humans, BMAT has often been considered as a “filling” tissue, 
filling the void left by bone during aging (Rosen et al., 2009). However, bone marrow 
adipocytes are now known to play an important role in fat-bone interactions, by 
secreting paracrine and autocrine factors (Rosen et al., 2009; Cawthorn et al., 2014; 
Suchacki et al., 2016) that may interfere with haematopoiesis and bone remodelling 
(Corre et al., 2004). Bone is both a target and a regulator of energy metabolism; leptin 
and adiponectin can modulate bone mass via direct and indirect mechanisms (Justesen 
et al., 2001; Verma et al., 2002). BMAT seems to be an important factor of bone 
alterations (Hardouin et al., 2016), and increased BMAT is associated with BMD loss in 
aging, menopause, and with several chronic conditions, including diabetes, anorexia 
nervosa and osteoporosis (Cawthorn et al., 2014; Hardouin et al., 2016). The secretory 
role of adipocytes in regulation of haematopoiesis may also be involved in the 
pathophysiology of myeloma (Reagan et al., 2015) and bone metastases (Hardaway et 
al., 2014; Morris and Edwards, 2016). 
In mice, the functions of BMAT are less clear. Some studies indicate that marrow 
adipocytes may be metabolically inert (Duque, 2007), suggesting that MSCs may 
differentiate into adipocytes “by default”, because they cannot differentiate into other 
cell types, in particular osteoblasts; this suggests that in mice, BMAT functions as a 
“filling” tissue. However, other studies demonstrate that on the contrary, bone marrow 
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adipocytes are metabolically active and can induce differentiation of more MSCs into 
adipocytes (Lecka-Czernik et al., 2002), preventing them to differentiate into other cell 
types, especially osteoblasts. This is supported by studies that have demonstrated that 
the adipogenic transcription factor PPARγ can inhibit osteoblastic differentiation (see 
section 1.3.2). Also, in mice under caloric restriction, BMAT significantly contributes to 
serum adiponectin levels (Cawthorn et al., 2014). 
1.2.4. Mesenchymal stem cells 
1.2.4.1. Definition 
MSCs are a group of fibroblast-like stem cells located in the non-hematopoietic 
compartment of the bone marrow. These cells have the potential to replace or restore 
the function of damaged tissues; they can differentiate into various lineages and can 
incorporate into a variety of tissues, including bone, cartilage, muscle and lung (Deng et 
al., 2007; Kassem et al., 2008). Under appropriate conditions in vitro, MSCs can 
differentiate into various mesoderm cell types, including osteoblasts, adipocytes, 
chondrocytes, hepatocytes, cardiomyocytes, and neuronal cells (Pittenger et al., 1999; 
Bianco et al., 2001; Abdallah et al., 2005; Deng et al., 2007), making MSCs a promising 
cell source for tissue engineering and regenerative medicine.  
1.2.4.2. Osteogenesis and adipogenesis 
Osteogenesis and adipogenesis are both tightly regulated processes, controlled by 
lineage-specific transcription factors that can induce MSC differentiation. MSC 
differentiation is also controlled by a variety of growth factors, hormones, extracellular 
matrix components and mechanical stimuli (Steward and Kelly, 2015; Wang et al., 
2016). Genetic and “micro-environmental” approaches have been used to identify 
several osteogenic and adipogenic transcription factors and signalling pathways.  
1.2.4.2.1. Osteogenic differentiation of BMSCs 
Osteogenesis is a tightly regulated process that is characterised by a sequence of 
events: the commitment of osteoprogenitors cells, differentiation into pre-osteoblasts 
and differentiation into mature osteoblasts whose function is to synthesise bone matrix 
that becomes progressively mineralised. These steps are controlled by several 
transcription factors such as runt-related transcription factor 2 (Runx2, also named 
Osf2/Cbfa1) (Marie, 2008). Other transcription factors, such as Osterix, β-catenin and 
ATF4, act downstream of Runx2 and play an important role in osteoblastogenesis. 
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Runx2 is the major transcription factor controlling osteoblast commitment and 
differentiation; it is both necessary and sufficient for MSC differentiation into 
osteoblasts (Marie, 2008). Runx2 activates gene expression by binding to the Runx 
consensus sequence (PuACCPuCA), also named osteoblast specific element 2 (OSE2), in 
the promoters of osteoblast-specific genes such as osteocalcin, type I collagen, 
osteopontin, and bone sialoprotein (Marie, 2008). Overexpression of Runx2 in non-
osteoblastic cells (such as observed in MC3T3-E1 calvarial cells) or in adipose-tissue-
derived MSCs (as in AD-MSCs) stimulates osteoblastic differentiation, increasing the 
expression of osteocalcin, bone sialoprotein and type I collagen; overexpression of 
Runx2 also promotes mineralisation (Ducy et al., 1997; Otto et al., 1997; Zhang et al., 
2006). On the contrary, deletion of Runx2 inhibits the differentiation of MSCs into 
osteoblasts (Ducy et al., 1997; Komori et al., 1997). Komori et al. (1997) have shown 
that homozygous Runx2 mutant mice die just after birth, and completely lack mature 
osteoblasts and mineralised bone. Osterix is another important osteogenic 
transcription factor specifically expressed by osteoblasts in all developing bones, 
required for osteoblast differentiation and bone formation (Nakashima et al., 2002; 
Zhou et al., 2010). In Osx null mice, mesenchymal cells cannot differentiate into mature 
osteoblasts and cannot deposit bone matrix, even though Runx2 is expressed. 
Interestingly, Runx2 null mice do not express Osterix, indicating that this transcription 
factor acts downstream of Runx2 (Nakashima et al., 2002).  
1.2.4.2.2. Adipogenic differentiation of BMSCs 
Like osteogenesis, adipogenesis is a tightly regulated process, occurring in multiple 
steps. BMSCs first have to commit to the adipogenic cell lineage by differentiating into 
preadipocytes, then terminally differentiate into mature, functional adipocytes. In mice, 
there is an additional step, the clonal expansion of preadipocytes which divide once or 
twice (Rosen and MacDougald, 2006), followed by withdrawal from cell cycle and 
terminal differentiation (Ali et al., 2013). In humans, preadipocytes do not divide 
before terminal differentiation (Rosen and MacDougald, 2006).  
Adipogenesis is regulated by multiple transcription factors in sequential activation; the 
CCAAT/enhancer-binding proteins C/EBPβ, C/EBPδ and C/EBPα and peroxisome 
proliferator-activated receptor γ (PPARγ) play a central role in adipogenic 
differentiation. At the first stage of adipogenesis, extracellular signals induce the 
expression of C/EBPβ and C/EBPδ in preadipocytes. These two transcription factors 
then promote the expression of PPARγ and C/EBPα, which are considered to be the 
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master transcriptional regulators of adipogenesis. PPARγ and C/EBPα form a positive 
feedback loop, increasing and maintaining their expression, and promoting terminal 
differentiation by activating genes that are required for the withdrawal of adipocytes 
from the cell cycle, and for the function and maintenance of mature adipocytes 
(Gregoire, 2001; Ali et al., 2013). 
There is a complex relationship between bone and adipose tissue; adipocytes secrete 
various molecules that regulate bone metabolism and skeletal homeostasis. Various 
bone disorders are associated with altered bone formation, including osteoporosis, 
Paget’s disease of bone and osteoarthritis. The differentiation of the osteoblast 
precursors, the BMSCs, is also often altered in various bone disorders, particularly 
osteoporosis (Bianco et al., 2008); increased adipogenic differentiation of BMSCs at the 
expense of osteoblastogenesis has been associated with osteoporosis (Gao et al., 2014; 
Greco et al., 2015).  
1.3. Osteoporosis 
1.3.1. Definition of osteoporosis 
Osteoporosis is a major public health problem; it is a common metabolic bone disease 
characterised by excessive bone resorption and increased bone fragility that result 
from increased osteoclastogenesis and increased marrow adipogenesis at the expense 
of osteoblastogenesis (Bethel et al., 2013). Fragility fractures represent the main 
clinical consequence of osteoporosis and are associated with pain, suffering, disability 
and can even lead to death for the affected patients due to complications. This silent 
disease has no symptom until fragility fracture occurs. Osteoporosis affects one in three 
women and one in five men after 50 years of age; more than 3 million people in the 
United Kingdom are estimated to have osteoporosis. There are more than 500,000 
fractures every year associated with osteoporosis (National Osteoporosis Society, 
2018). In 2010, a study estimated that approximately 536,000 fragility fractures 
occurred in the UK, and the economic cost of incident and previous fragility fractures 
was estimated at £ 3,497 million for the same year. Up to 20% of patients with 
osteoporosis die after hip fractures, and 40% can no longer live independently 
(Manolagas, 2000). As the population ages, it was estimated that in 2025, there will be 
approximately 682,000 fragility fractures, and the cost will represent £ 5,465 million 
(Svedbom et al., 2013). There are several subtypes of osteoporosis (Clunie and Keen, 
2014; Morimoto et al., 2017) (see table 1.1). 
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Subtype  Causes  
Primary 
osteoporosis 
Type I (postmenopausal 
osteoporosis)  
Loss of oestrogen, increased bone 
resorption  
Type II (senile 
osteoporosis)  
Unbalanced bone remodelling  
Secondary  
osteoporosis  
Other conditions (hormonal 
imbalance, hyperparathyroidism, 
diabetes mellitus), iatrogenic 
(glucocorticoid therapy), idiopathic  
Table 1.1: Subtypes of osteoporosis 
Type II osteoporosis generally occurs after the age of 70 and affects women twice as frequently 
as men (Marchigiano, 1997; Bartl and Bartl, 2017). 
 
Osteoblasts, osteoclasts and bone marrow adipocytes are directly involved in the 
pathophysiology of osteoporosis. The differentiation and functions of these cells is 
affected by several factors, such as aging, sex, or glucocorticoid therapy. Age and female 
sex increase the risk of developing both obesity and types I and II osteoporosis; several 
epidemiologic and clinical studies have shown that a high level of fat mass might be a 
risk factor for osteoporosis and fragility factures (Zhao et al., 2008; Kim et al., 2010; 
Compston et al., 2014; Greco et al., 2015). Aging is associated with decreased osteoblast 
numbers and activity, increased osteoclast differentiation and increased bone marrow 
adiposity in humans (Hardouin et al., 2016) and rodents (Pittenger et al., 1999; Sadie-
Van Gijsen et al., 2013). MSCs differentiation has been shown to be age-dependent. 
Many in vitro, in vivo and clinical studies have shown that bone marrow adipocytes can 
directly modulate osteoblastogenesis and osteoclastogenesis through the release of 
paracrine factors (Hardouin et al., 2016), especially the two adipokines leptin and 
adiponectin, which can modulate bone mass through direct and indirect mechanisms 
(Gimble, 2011; Kawai et al., 2012; Naot and Cornish, 2014). In female patients, the 
expression levels of the adipogenic marker PPARγ increase with aging, while the 
expression levels of the osteogenic marker Runx2 decrease. However, this effect is not 
observed in male patients (Jiang et al., 2008). 
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Glucocorticoid-induced osteoporosis is the most common form of secondary 
osteoporosis (Briot and Roux, 2015). Glucocorticoids, which are corticosteroid drugs 
that are widely used to treat diseases such as rheumatoid arthritis, lupus 
erythematosus, asthma and lung disorders (Schatz and Hamilos, 1995; Goldstein et al., 
1999; Toogood, 2004), are associated with rapid bone loss and increased risk of 
fractures (Briot and Roux, 2015). This is due to several factors: the underlying 
inflammation treated by glucocorticoids plays a role in bone fragility (Staa et al., 2006; 
Roux, 2011; Briot and Roux, 2015); glucocorticoids inhibit bone formation and 
accelerate bone resorption, leading to bone loss and decreased BMD rapidly after the 
beginning of therapy; and bone quality is also altered, making the bones more fragile. 
Some 10% of bone mass can be lost in the first year of glucocorticoid therapy 
(Morimoto et al., 2017). 
1.3.2. Osteoporosis: obesity of the bone? 
As osteoblasts and adipocytes originate from the same MSC precursors, it has been 
hypothesized that an unbalanced adipogenesis at the expense of osteoblastogenesis 
could be involved in the pathophysiology of bone disorders, especially osteoporosis 
(Greco et al., 2015). This theory is known as the “fat theory” for osteoporosis and is 
supported by experimental and clinical studies. Increased bone marrow adipogenesis is 
associated with several types of osteoporosis, particularly the forms associated with 
aging, menopause, or glucocorticoid treatment (Moerman et al., 2004; Hardouin et al., 
2016). 
MSCs derived from osteoporotic patients differentiate preferentially into adipocytes, 
instead of osteoblasts (Nuttall and Gimble, 2004; Rosen and Bouxsein, 2006; Rodriguez 
et al., 2008). Similarly in mice with glucocorticoid-induced osteoporosis, BMSCs 
preferentially differentiate into adipocytes; this may be due to alterations of epigenetic 
markers in the promoter of regulatory genes such as PPARγ (Zych et al., 2013; Zhang et 
al., 2015).  
MSC differentiation is regulated by a variety of factors in the cell microenvironment, 
leading to the activation of signalling cascades that generally converge on two key 
transcription factors: PPARγ for adipogenesis and Runx2 for osteoblastogenesis. Many 
studies have demonstrated that factors that induce adipogenesis inhibit 
osteoblastogenesis (Beresford et al., 1992; Dorheim et al., 1993; Muruganandan et al., 
2009) and vice versa (Gimble et al., 1995; Hong et al., 2005). Also, some signalling 
pathways are involved in regulation of both differentiation lineages, including Wnt 
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signalling (Hofmann, 2000; Willert et al., 2003; Leclerc et al., 2008; Piters et al., 2008; 
Colaianni, 2014; Jing et al., 2015; Yuan et al., 2015), chemerin/CMKLR1 signalling 
(Muruganandan et al., 2010, 2011), ERK1/2 signalling (Li et al., 2016a) and Akt1 
(Kawamura et al., 2007). Typically, increased expression of one of the key regulators of 
adipogenesis and osteoblastogenesis, PPARγ and Runx2, is accompanied by a 
decreased expression of the other (James, 2013). Furthermore, studies in animal 
models have shown that upregulated PPARγ activity led to bone loss and increased 
marrow adiposity (Rzonca et al., 2004; Sottile et al., 2004). On the contrary, 
downregulated PPARγ activity led to bone mass elevation; ex vivo culture of MSCs 
derived from the bones of PPARγ+/- mice shows a decrease of the number of adipocytes 
and an increase of the number of osteoblasts (Akune et al., 2004; Cock et al., 2004). Liu 
et al. (2010) co-cultured primary fat cells or differentiated adipocytes with osteoblastic 
cells, and observed a decrease in two osteoblastic markers, Runx2 expression and 
alkaline phosphatase (ALP) activity. This was accompanied by an increase in two 
adipocytic markers, PPARγ expression and adiponectin secretion. These results suggest 
that adipocytes can modulate osteoblast functions through the release of secretory 
products such as adiponectin, and that PPARγ plays a key role in this process (Liu et al., 
2010). This is consistent with the fact that high circulating levels of adiponectin are 
associated with low BMD, and that treatment of bone MSCs with adiponectin inhibits 
osteogenesis in favour of adipogenesis (Abbott et al., 2015). 
Increased marrow adiposity is also associated with accelerated bone resorption. Some 
studies have shown that adipocytes may play a role in promoting osteoclast formation 
(Benayahu et al., 1994; Kelly et al., 1998, p.2; Sakaguchi et al., 2000). This may be 
mediated, at least in part, by RANKL. RANKL expression is induced during 
adipogenesis, through the action of the adipogenic transcription factors C/EBPβ and/or 
C/EBPδ. The number of RANKL-positive preadipocytes increases in bone marrow with 
aging, suggesting that increased marrow adipogenesis could influence 
osteoclastogenesis, accelerating bone resorption, and thus contributing to osteoporosis 
(Takeshita et al., 2014). 
Inter-conversion of osteoblasts into adipocytes has been demonstrated in vitro and 
may occur in vivo. Single cell MSC-derived clones can be induced to differentiate into 
adipocytes, then de-differentiate and re-differentiate into osteoblasts in vitro (Kim et 
al., 2004). Mature adipocytes can be induced to transdifferentiate into osteoblastic cells 
under appropriate culture conditions (Justesen et al., 2004) and inversely, mature 
osteoblasts can be induced to transdifferentiate into adipocytes (Nuttall et al., 1998). 
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7F2 cells, which were isolated p53-/- mouse bone marrow taken from the femur, are 
preosteoblast cells that can be induced to transdifferentiate into adipocytes (Thompson 
et al., 1998). There is a correlation between the osteoadipogenic trandifferentiation of 
bone marrow cells and some bone metabolism diseases (Boskey and Coleman, 2010). 
However, the fat theory for osteoporosis remains controversial. For example, the in vivo 
origin of bone-producing osteoblasts is not fully defined (Matic et al., 2016); quiescent 
lining cells may be an important source of osteoblasts in adults. In addition, some 
histomorphometric studies demonstrate that bone mass and adipose tissue mass in the 
bone marrow can change in the same direction, suggesting that bone formation and 
adipocyte formation may be regulated independently (Tornvig et al., 2001).  
1.3.1. Treatments for osteoporosis 
The current treatments include both pharmacological and non-pharmacological 
management; the latter include weight-bearing and muscle-strengthening exercises, as 
well as dietary and lifestyle changes to reduce risk factors (Henney, 2008; An et al., 
2016; Wang et al., 2016) (see table 1.2). Exposure to sunlight is the main source of 
vitamin D, but supplementation may be necessary (Holick, 2009; Tella and Gallagher, 
2014). Calcium supplementation is also often needed, as aging is associated with a 
negative calcium balance (Tella and Gallagher, 2014). Various pharmacological 
treatments are available. However, there is still need for new therapies, as these 
treatments can be costly, take a long time to be effective, and have adverse secondary 
effects. Biphosphonates for example may suppress bone turnover and lead to 
osteonecrosis of the mandible (Wang et al., 2016). Also, HRT is not generally used 
because of its adverse effects, which include increased risks of breast cancer, strokes, 
and cardiovascular disease (National Osteoporosis Society, 2018). As osteoporosis 
results from imbalanced bone remodelling and is associated with increased marrow 
adipogenesis, new treatments that increase the number of osteoblasts and decrease the 
number of adipocytes may provide a cure for osteoporosis (Wang et al., 2016). Getting 
a better understanding of pathological adipogenesis in bone marrow will help develop 
new treatments in the long term.  
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Medication  Effect  
Biphosphonates (Briot and Roux, 2015)  Inhibit resorption  
Teriparatide (Roux, 2010)  
Stimulates osteoblast proliferation and 
mineralisation  
Denusomab (Roux, 2010)  Targets RANKL, inhibits resorption  
Hormone Replacement Therapy (HRT) 
(Rossouw et al., 2002)  
Compensates loss of oestrogen, inhibits 
resorption  
Selective estrogen receptor modulators 
(SERMs): raloxifene (Yogui et al., 2018; 
Zhang et al., 2018) 
Mimicks estrogen actions, inhibits 
resorption 
Table 1.2: Various types of therapies against osteoporosis 
The available treatments mainly target the symptoms and complications of osteoporosis, 
promoting bone formation and mineralisation, and inhibiting bone resorption. 
1.4. Ghrelin 
1.4.1. Ghrelin signalling: an overview 
1.4.1.1. Ghrelin 
Ghrelin is a 28 amino-acid peptide hormone mainly secreted in the stomach, by the 
oxyntic glands of the gastric fundus (Kojima et al., 1999). Ghrelin was discovered in 
1999 as the endogenous ligand for growth hormone secretagogue receptor (GHSR) 1a 
and it stimulates GH release from the anterior pituitary gland (Müller et al., 2015). 
Ghrelin also regulates food intake, body weight, adiposity, and glucose metabolism, 
acting as a “hunger” hormone, signalling glucose metabolism status to the central 
nervous system (CNS) to adjust food intake and energy expenditure. Ghrelin secretion 
is influenced by the metabolic status (figure 1.2), and is regulated by many factors, 
including nutrients and other peptide hormones such as insulin and leptin (Delporte, 
2013; Müller et al., 2015; Sato et al., 2015). Ghrelin needs to be modified 
postranslationally to bind and activate the GHSR1a receptor; it is acylated by ghrelin O-
acyltransferase (GOAT). Ghrelin, the GHSR and GOAT are highly conserved in 
vertebrates (Kojima and Kangawa, 2005; Gutierrez et al., 2008). Ghrelin also plays 
direct roles in peripheral organs, including bone and adipose tissue. 
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Figure 1.2: Parameters that influence circulating levels of ghrelin 
Levels of circulating ghrelin depend on secretion, ddegradatin rates and clearance rates. Ghrelin 
is secreted mainly by X/A-like cells in the stomach; secretion is regulated by energy state. Once 
released in the bloodstream, acylated ghrelin can be converted into unacylated ghrelin by 
esterases, and ghrelin can also be degreaded by proteases. Following infusion, acylated ghrelin 
has a mean half-life of 9-11 minutes, whereas total ghrelin (acylated and unacylated) has a mean 
half-life of 35 minutes (Delporte, 2013). In mice, transport of both human and mouse ghrelin has 
been shown to be bidirectional; unacylated ghrelin transport rate is higher than that of acylated 
ghrelin (Banks et al., 2002; Rhea et al., 2018).      
1.4.1.2. Growth Hormone Secretagogue Receptor (GHSR) 
The discovery of the ghrelin receptor began with studies of growth hormone 
secretagogues (GHSs), which are small synthetic peptide and nonpeptide compounds 
that can stimulate the release of GH from the pituitary (Kojima et al., 1999; Davenport 
et al., 2005; Kaiya et al., 2013). Some of these GHSs also stimulate appetite in mammals 
(Kaiya et al., 2013). In 1996, GHSs were found to bind a G-protein coupled receptor 
(GPCR) that was named the growth hormone secretagogue receptor (GHSR) (Howard 
et al., 1996); it has been found in both human and swine pituitary and hypothalamus. 
The GHSR is a rhodopsin-like GPCR with seven transmembrane domains, belonging to 
Family A (Davenport et al., 2005). It is well conserved among vertebrates, including 
mammals, birds, and fish (Kojima and Kangawa, 2005).  
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The Ghsr gene contains two exons and one intron (McKee et al., 1997; Petersenn et al., 
2001); the first exon encodes transmembrane domains 1 to 5, and the second exon 
encodes transmembrane domains 6 and 7 (Kojima and Kangawa, 2005). The promoter 
region of the gene contains no typical TATA, GC or CAAT boxes, but contains putative 
binding sites for several transcription factors, including part of an oestrogen response 
element (Iguchi et al., 1999). Consistent with this, several studies have shown that 
GHSR gene expression can be upregulated by thyroid hormones (Kamegai et al., 2001; 
Petersenn et al., 2001) and oestrogens (Petersenn et al., 2001). GHSR gene expression 
is also regulated by glucocorticoids: it was demonstrated to be inhibited by 10-7 M 
hydrocortisone in rat pituitary cells (Petersenn et al., 2001), but stimulated by 
dexamethasone in pituitary gland of rats treated with 200 µg dexamethasone per day 
for 8 days (Tamura et al., 2000).  
In humans, swine and rats, there are two known mRNA isoforms for this receptor, 
GHSR1a and GHSR1b. Translation of the GHSR1a isoform produces the biologically 
active receptor that can be activated by acylated ghrelin; it arises from regular splicing 
of the gene, which removes the intron. GHSR1a consists of 366 amino acids in humans 
(Petersenn et al., 2001) and of 364 amino acids in rats (McKee et al., 1997) and mice; 
the third transmembrane domain is reportedly involved in ligand-binding (Smith et al., 
1999).  
GHSR1b arises from alternative splicing in humans and swine; it contains the first exon 
and retains the intron, causing a single base translation frameshift and introducing a 
stop codon within the intron. This gives rise to a C-terminally truncated protein (Kaiya 
et al., 2013). The corresponding protein consists of 289 amino acids (Petersenn et al., 
2001), and contains only the first five transmembrane domains plus a unique 24 amino 
acid “tail” encoded by the intron (Jeffery et al., 2003). GHSR1b is pharmacologically 
inactive as no binding of the synthetic GHSs or ghrelin has been demonstrated. 
However, it may function to attenuate the activity of GHSR1a by heterodimerising with 
it (Callaghan and Furness, 2014). Although the main site of ghrelin synthesis is the 
stomach, the GHSR mRNA has been identified in a variety of tissues, including the 
stomach, heart, lung, pancreas, intestine, kidney, adipose tissues (Kojima et al., 1999; 
Tschöp et al., 2000, p.2000; Gualillo et al., 2001; Shuto et al., 2001), the hypothalamus, 
the pituitary (Guan et al., 1997), and in the brainstem (Bailey et al., 2000). Some studies 
did not detect GHSR mRNA in bone marrow (Guan et al., 1997), but other indicates that 
GHSR1a is expressed both at the mRNA and the protein level in rat adipocytes, and that 
its expression increases with age (Choi et al., 2003; Kim et al., 2005).  
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1.4.1.3. Ghrelin-O-acyltransferase (GOAT) 
In the circulation, ghrelin is present in two forms: acylated ghrelin (also named 
octanoylated ghrelin or acyl-ghrelin), and unacylated ghrelin (also named desacyl-
ghrelin) (figure 1.3). Only a small proportion of circulating ghrelin is acylated; the 
majority of circulating ghrelin unacylated (Hosoda et al., 2000a; Delhanty et al., 2012). 
Acylated ghrelin is rapidly deacylated in the serum by circulating esterases, without 
proteolysis (De Vriese et al., 2004).  
Ghrelin is the only known protein modified with an O-linked octanoyl side group, which 
is an 8-carbon fatty acid side chain; this modification occurs on its third serine residue 
which is conserved in all mammals (Kojima and Kangawa, 2005). This modification is 
critical for the role of ghrelin in regulating GH release, food intake, and lipid 
metabolism (Li et al., 2016b): acylated ghrelin at nanomolar concentrations can bind 
and activate the GHSR1a, while it takes a much higher concentration of unacylated 
ghrelin to activate this receptor. As circulating levels of acylated ghrelin and unacylated 
ghrelin are comprised between 0.1 and 0.5 nmol/L, the concentration of unacylated 
ghrelin is too low to activate GHSR1a (Callaghan and Furness, 2014). Although 
unacylated ghrelin cannot bind and activate the GHSR1a in physiological circulating 
concentrations, it does have biological activities in multiple tissues such as adipose 
tissue, bone, skeletal muscles, heart, and pancreatic tissues; but the receptor(s) 
involved in these activities have not yet been identified (Callaghan and Furness, 2014). 
For example, unacylated ghrelin, as well as acylated ghrelin, can stimulate lipid 
accumulation in rat and human visceral adipocytes and rat bone marrow adipocytes 
(Thompson et al., 2004; Kos et al., 2009; Rodríguez et al., 2009) 
The enzyme responsible for acylation of ghrelin was identified by two separate 
research groups in 2008 (Gutierrez et al., 2008; Yang et al., 2008). Yang et al. (2008) 
identified 16 membrane-bound O-acyltransferase (MBOAT) proteins encoded by 11 
genes in mice; endocrine cell lines were co-transfected with ghrelin and various 
MBOAT constructs. Only one member of the MBOAT family was capable of 
octanoylating ghrelin (Yang et al., 2008); it was termed ghrelin O-acyltransferase 
(GOAT). In the same year, Gutierrez et al. (2008) identified GOAT in humans using 
gene-silencing experiments in human medullary thyroid carcinoma cells (TT cells), 
which have been shown to produce acyl ghrelin (Kanamoto et al., 2011). Candidate 
genes were selected depending on several criteria: similarity to known acyltransferase 
sequences, existence of human homologues, and unknown gene function. 12 candidate 
genes were selected, most of which were orphan MBOATs. These candidate genes were 
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individually silenced by siRNA; silencing of one candidate, MBOAT4, using five distinct 
siRNAs, greatly reduced octanoyl ghrelin synthesis, while the knock down of the other 
candidate genes had no effect on the amount of octanoyl ghrelin. To confirm that 
MBOAT4 encoded the enzyme that acylates ghrelin, Gutierrez et al. cotransfected 
human embryonic kidney (HEK-293) cells with both the ghrelin gene and MBOAT4; 
72h after transfection, the media from HEK-293 contained acyl ghrelin. Genetic 
disruption of the GOAT gene in mice led to a complete absence of acylated ghrelin in the 
circulation, further confirming that acylation of ghrelin is mediated by GOAT (Gutierrez 
et al., 2008).  
The predicted catalytic residues of mouse GOAT are asparagines-307 and histidine-
338; when either of these residues is substituted with alanine, GOAT is unable to 
acylate ghrelin (Yang et al., 2008). GOAT is conserved across vertebrate species; an 
amino-acid sequence comparison shows a ~90%-similarity between human, mouse 
and rat GOAT; and a ~60%-similarity between mammalian and zebrafish amino acid 
sequences (Gutierrez et al., 2008). When GOAT cDNA from mouse, rat or zebrafish is 
co-transfected with human ghrelin in HEK-293 cells, ghrelin is acylated (Gutierrez et al., 
2008). This is consistent with the fact that acylation of ghrelin is critical for its function, 
and with the fact that the ghrelin sequence, and more particularly the active core that 
contains the serine 3 residue, is very well conserved in mammals, birds, and fish 
(Kojima and Kangawa, 2005; Yang et al., 2008). Also, GOAT was found to be mainly 
expressed in the stomach, which is also the main source of ghrelin, as well as in 
peripheral tissues, such as breast, adipose tissue, lungs, muscles, kidneys, or pancreas 
(Lim et al., 2011; Delhanty et al., 2012). Thus, although a small proportion of circulating 
ghrelin is acylated, local concentrations of acylated ghrelin could be higher due to local 
acylation by GOAT. 
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Figure 1.3: Posttranslational modifications of ghrelin 
Ghrelin is mainly synthesised in the stomach, as preproghrelin. Preproghrelin is then processed 
to give rise to ghrelin and obestatin. Adapted from (Romero et al., 2010).  
1.4.2. Ghrelin is much more than a ‘hunger hormone’ 
There is growing evidence that ghrelin plays a more complicated role than just 
regulating GH release and energy metabolism (figure 1.4). The ghrelin receptor GHSR is 
expressed in a variety of peripheral tissues and organs, including the stomach, heart, 
lung, pancreas, intestine, kidney, adipose tissues (Kojima et al., 1999; Tschöp et al., 
2000; Gualillo et al., 2001; Shuto et al., 2001), bone marrow adipose tissue (Choi et al., 
2003),  the arcuate nucleus (Arc) and ventromedial nucleus of the hypothalamus, in the 
pituitary (Guan et al., 1997) and in the brainstem (Bailey et al., 2000).  It is also 
expressed by osteoblasts, both in primary cells and in cell lines, in human, mouse and 
rat (Fukushima et al., 2005; Kim et al., 2005; Maccarinelli et al., 2005). As the stomach 
is the main source of circulating ghrelin, the wide tissue expression of its receptor 
suggests that ghrelin produced in and secreted from the stomach may have a variety of 
functions in addition to regulating GH secretion and food intake, through endocrine, 
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autocrine and/or paracrine signalling. Ghrelin is also expressed in a variety of tissues, 
including bone (Nikolopoulos et al., 2010), and the ghrelin transcript can undergo 
alternative splicing; a number of isoforms have been identified in humans and mice 
(see Chapter 4). The expression pattern of ghrelin and existence of various ghrelin 
isoforms further suggest a role for ghrelin in processes other than GH release and 
energy metabolism. Consistent with this, ghrelin has been shown to play a role in many 
processes such as inflammation, cell proliferation, differentiation and apoptosis (Kim et 
al., 2005; Maccarinelli et al., 2005; Liang et al., 2012), particularly in bone.  
 
Figure 1.4: Main physiological activities of ghrelin 
Ghrelin has a variety of functions in addition to stimulating growth hormone secretion and 
regulating energy metabolism. Adapted from (Delporte, 2013). 
1.4.2.1. Ghrelin and bone 
Several hormones from energy metabolism regulate bone homeostasis, including 
leptin, orexin, insulin, insulin-like growth factor 1 (IGF-1), adiponectin and ghrelin 
(Evans et al., 2011; Delhanty et al., 2014a; Wee and Baldock, 2014; Pizzorno, 2016b; a; 
Yue et al., 2016). A large number of in vitro studies have shown that nanomolar 
concentrations of ghrelin stimulated proliferation and differentiation of both primary 
osteoblastic cells and osteoblastic cell lines across different species, including rats and 
humans (Fukushima et al., 2005; Kim et al., 2005; Maccarinelli et al., 2005; Isabelle et 
al., 2013). Ghrelin also inhibits apoptosis in osteoblastic cells (Kim et al., 2005). Costa et 
al. (2011) showed that ghrelin had a strong mitogenic effect on human osteoblasts, but 
that effect was weaker in rat osteoblasts. Both ghrelin and its receptor GHSR1a have 
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been detected in rat osteoblasts (Fukushima et al., 2005), suggesting that ghrelin has 
autocrine/paracrine effects in bone. The effects of ghrelin on osteoblasts appear to be 
mediated by GHSR1a (Kim et al., 2005; Maccarinelli et al., 2005; Isabelle et al., 2013), 
accompanied by increased ALP activity, increased matrix mineralisation, and increased 
expression of osteoblast-specific genes, such as osteocalcin. Costa et al., 2011 also 
showed that ghrelin increased osteoclastic bone resorption in rats, but did not alter 
osteoclast differentiation.  
Ghrelin may also have biological effects in BMSCs. Ghrelin has been shown to stimulate 
BMSC proliferation in rats (Abdanipour et al., 2018) and rabbits (Ye and Jiang, 2015). 
However, the effects of ghrelin on MSC lineage allocation are unclear. In murine embryo 
sarcoma cells (C3H10T1/2 cells) cultured with osteogenic differentiation medium, 
ghrelin downregulated ALP activity and osteoblast-specific gene expression, suggesting 
that ghrelin inhibited early osteogenic differentiation (Kim et al., 2009). In C3H10T1/2 
cells cultured with growth medium, ghrelin treatment increased PPARγ and C/EBPα 
protein expression and suppressed Runx2 protein expression, suggesting that ghrelin 
may stimulate adipogenesis. However, when these cells were cultured with adipogenic 
medium, ghrelin did not promote adipogenic differentiation, as there was no increase 
in adipogenic gene expression and lipid content (Kim et al., 2009). On the contrary, 
another study has demonstrated that ghrelin promoted osteoblastogenesis in rabbit 
MSCs (Ye and Jiang, 2015).  
In vivo, ghrelin is also known to modulate osteoblast differentiation and function, both 
directly and indirectly via paracrine and endocrine mechanisms (Nikolopoulos et al., 
2010). Some of the effects of ghrelin may be associated with increased food intake, 
through the regulation of the GH-insulin-like growth factor (IGF) axis (Kim et al., 2005), 
increased GH secretion and increased body weight stimulating bone formation due to 
the additional load. Ghrelin also has GH-independent effects on bone homeostasis, as 
chronic central administration of ghrelin increases bone mass through a mechanism 
independent of appetite regulation (Choi et al., 2013), and intraperitoneal infusion of 
ghrelin increases BMD in GH-deficient rats (Fukushima et al., 2005). Ghrelin also 
improves the repair of calvarial bone defects in rats, promoting the expression of 
osteoblastic markers such as ALP, osteocalcin, and type I collagen (Deng et al., 2008; 
Nikolopoulos et al., 2010). 
Ghrelin signalling not only regulates osteoblast proliferation and differentiation; it is 
also necessary for normal bone formation (Ma et al., 2015). GHSR-null mice exhibit a 
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low bone mass phenotype, with reduced bone formation; this phenotype is attenuated 
by restoring the expression of GHSR in osteoblasts. Ghrelin directly stimulates 
osteoblast differentiation via phosphorylation of cAMP response element-binding 
protein (CREB) and the expression of Runx2 (Ma et al., 2015). In GHSR- and leptin-
deficient mice, ghrelin has dual effects on osteoclastogenesis, inhibiting osteoclast 
progenitors directly but stimulating osteoclastogenesis via a systemic/central pathway; 
with aging, the osteoclastogenic effect of ghrelin is attenuated, revealing a protective 
effect of ghrelin on bone (van der Velde et al., 2012). Another hormone, orexin, has 
been shown to regulate bone homeostasis in mice by peripheral mechanisms via orexin 
receptor 1 (OX1R) and ghrelin: OX1R-deficient mice exhibit high bone mass associated 
with a differentiation shift from marrow adipocytes to osteoblasts and with higher 
ghrelin expression in bone (Wei et al., 2014).  
These studies indicate that ghrelin is an important regulator of bone homeostasis and 
bone marrow function, via direct and indirect mechanisms, and acting on various cell 
types including BMSCs, osteoblasts and osteoclasts. 
1.4.2.2. Ghrelin and adipogenesis 
Ghrelin has been shown to affect adiposity through centrally and peripherally mediated 
signalling mechanisms (Müller et al., 2015). Most in vivo studies show a stimulatory 
effect of ghrelin on adiposity. Pharmacological or genetic manipulation of ghrelin 
signalling affects adiposity and body weight: central and peripheral administration of 
ghrelin increases body weight and fat mass; intravenous and intra-bone marrow 
infusion of both acylated and desacyl ghrelin increase bone marrow adiposity, although 
these effects may be mediated by a receptor other than GHSR1a (Thompson et al., 
2004). In addition, suppression of arcuate GHSR expression induces a reduction in fat 
pad weight (Shuto et al., 2002); mice lacking ghrelin or ghrelin receptors accumulate 
less fat mass than wild-type mice when on a high-fat diet (Wortley et al., 2005; Zigman 
et al., 2005). On the contrary, other studies reported that ablation of GHSR had no effect 
on body weight and fat mass in male mice fed with standard chow diet (Sun et al., 2004; 
Zigman et al., 2005) or in mice fed with a high fructose corn syrup (Ma et al., 2013), but 
seemed to prevent age-associated obesity and insulin resistance by regulating fat 
metabolism in white and brown adipose tissues (Ma et al., 2013; Müller et al., 2015). 
Ghrelin also stimulates the expression of enzymes involved in fatty acid storage and 
downregulates genes controlling the rate-limiting step in fat oxidation; these effects are 
mediated by the sympathetic nervous system and some of them are independent of 
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food intake (Theander-Carrillo et al., 2006). Ghrelin also acts centrally to promote 
hepatic lipid storage (Sangiao-Alvarellos et al., 2009), inducing hepatic steatosis and 
increasing lipid droplet number and triacylglycerol content in a GHSR1a-dependent 
way (Davies et al., 2009). However, the effect of peripheral ghrelin on adiposity is not 
uniform, suggesting tissue- and fat deposit-specific actions of ghrelin (Wells, 2009).   
In vitro, the effects of ghrelin on adipogenesis are less clear. Some studies have shown 
that ghrelin directly stimulated the differentiation of rat preadipocytes, increasing the 
expression of PPARγ and inhibiting lipolysis (Choi et al., 2003). Another in vitro study 
showed that ghrelin gene products positively regulated adipogenesis (Giovambattista 
et al., 2007). In contrast, other studies have shown that overexpression of ghrelin 
inhibited adipogenesis. Zhang et al. (2004) established a 3T3-L1 preadipocyte cell line 
overexpressing ghrelin, and observed that ghrelin significantly attenuated adipocyte 
differentiation, decreasing PPARγ expression and stimulating cell proliferation. In the 
thymus, ghrelin and ghrelin receptor expression decrease during aging, and genetic 
ablation of ghrelin and its receptor leads to loss of thymic epithelial cells, while 
stimulating adipogenesis (Youm et al., 2009). Acylated ghrelin increases thymic size 
and cellularity, reflecting an inhibition of adipose/fibrous differentiation while 
rejuvenating the epithelial/stromal microenvironment, leading to the expansion of the 
T-cell content (Dixit et al., 2007). This indicates a reversal of age-dependent fatty 
involution (loss of epithelial function and T-cell production) that is associated with 
immune senescence (Taub et al., 2010). 
While ghrelin increases adiposity when infused in the bone marrow, it is not known 
which cell type is affected; ghrelin may promote the adipogenic differentiation of 
BMSCs, or the maturation of cells that are already committed to the adipogenic lineage. 
Alternatively, ghrelin may induce the trans-differentiation of cells that were already 
committed to the osteoblastic lineage.  
1.5. Ion channels 
Ion channels are transmembrane proteins that allow the principal cellular ions (sodium 
(Na+), potassium (K+), calcium (Ca2+) and chloride (Cl-)) to move through the plasma 
membrane at different rates by diffusing down their concentration gradients. There are 
a large number of ion channel subtypes in all cells, and they are involved in regulating 
important cell processes such as proliferation and differentiation, particularly in 
osteoblasts and adipocytes. Ion channels play important roles in bone metabolism and 
may be involved in the mechanisms of pathological adipogenesis.  
Chapter 1 – Introduction  
 
25 
 
1.5.1. Potassium channels and membrane potential 
Potassium (K+) channels in the cytoplasmic membrane are the most diverse class of ion 
channels, with over 80 genes identified. They are present in almost all cells, including 
both excitable and non-excitable cells, in a large number of tissues (Wang et al., 2008). 
K+ channels can be classified into 5 subcategories by function and structure: voltage-
gated K+ channels (KV), Ca2+- and Na+-activated K+ channels (KCa and KNa), inward-
rectifier K+ channels (KIR),  and 2-pore domain K+ channels (K2P) (figure 1.5).  
 
Figure 1.5: K+ channels subfamilies 
KV channels are widely expressed in the nervous system and other tissues, including non-
excitable cells, and may also regulate cell proliferation, cell migration and cell volume in a wide 
range of cell types.  They display a large diversity as KV channel subunits can form homomeric 
and heteromeric channels within each of the KV1, KV2, KV3, KV4 and KV7 subfamilies. The K2P 
channels open across the physiological voltage-range and are regulated by chemical and 
physical factors, including neurotransmitters, post-translation modifications, second 
messengers, temperature and mechanical stretch. Some K2P subunits can form heterodimers 
across subfamilies, further increasing the diversity of K+ channels. Finally, the inward rectifiers 
have diverse physiological functions depending on their type and their location; similarly to 
voltage-gated K+ channels, KIR pore-forming subunits can form heteromeric channels within 
subfamilies, and are expressed in a wide variety of tissues (Hibino et al., 2010; Alexander et al., 
2011a, 2017). 
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Membrane potential and ion channels are involved in transmitting signals via action 
potential in excitable cells such as neurons or myocytes, but they also play important 
roles non-excitable cells, regulating important processes such as cell proliferation, 
apoptosis, differentiation, migration, secretion and metabolism (Blackiston et al., 2009; 
Capiod, 2011; Adams and Levin, 2013; Levin, 2013; Resende et al., 2013). 
1.5.2. Ion channels and bone 
Sundelacruz et al. published two papers highlighting the role of membrane potential in 
the control of proliferation and differentiation of MSCs (Sundelacruz et al., 2008, 2009). 
Working with human MSCs cultured in adipogenic or osteogenic differentiation media, 
they showed that MSC differentiation was inhibited by membrane depolarisation via 
high extracellular [K+] or ouabain treatment, which blocks the Na/K-ATPase 
transporter. On the contrary, MSC osteogenic differentiation was stimulated by 
membrane hyperpolarisation (Sundelacruz et al., 2008). Hyperpolarisation occurred 
during both osteogenic and adipogenic differentiation; ion flux and changes in 
membrane potential have been associated with the control of proliferation and 
differentiation in various cell types (Binggeli and Weinstein, 1986; Levin, 2007). 
Proliferative and relatively immature cells tend to have depolarised membrane 
potentials, while terminally differentiated cells tend to have strongly hyperpolarised 
membrane potentials.  
In bone, membrane potential and ion channels are involved in the regulation of 
proliferation and differentiation in various cell types, from BMSCs to differentiated cells 
such as osteoblasts, osteoclasts, and adipocytes, in various species, including humans, 
mice and rats.  
There is good evidence that ion channels are involved in regulating the osteogenic and 
adipogenic differentiation of MSCs, including experiments with electrical stimulation 
and electromagnetic fields, and the numerous electrophysiological studies with MSCs 
from human, mice and rats, derived from bone or other tissues. Studies have shown 
that the electrical stimulation of adipose-derived MSCs enhanced osteogenic 
differentiation (Pelto et al., 2013; Björninen et al., 2014; Zhang et al., 2016); this effect 
appeared to be mediated by voltage-gated channels as it was reduced with blockers of 
voltage-gated sodium, potassium and chloride channels, and completely nullified with a 
voltage-gated calcium channel blocker (Zhang et al., 2016). Mechanical cues also 
regulate key processes in MSCs, including proliferation and differentiation, via ion 
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channels (Rawlinson et al., 1996; Steward and Kelly, 2015; Chubinskiy-Nadezhdin et al., 
2017). 
Osteoblasts, osteoblast-like cells and MSCs express a variety of ion channels which 
function in cooperation and regulate many aspects of osteoblast function, including 
proliferation, differentiation and mineralisation.  
1.5.2.1. Potassium channels and osteoblasts 
Osteoblasts, osteoblast-like cells and MSCs express an array of K+ channels, including 
voltage-gated K+ channels of the S4 family with six transmembrane domains (Li et al., 
2005, 2006), inward rectifier (Yellowley et al., 1998), ATP-sensitive K+ channels 
(Moreau et al., 1997; Henney, 2008), a two-pore domain K+ channel (Hughes et al., 
2006), and Ca2+-activated K+ channels of small-, intermediate- and large-conductance 
(Moreau et al., 1997; Li et al., 2005, 2006; Deng et al., 2007; Henney, 2008; Hirukawa et 
al., 2008; Henney et al., 2009; Zhang et al., 2014). A number of studies have 
demonstrated that K+ channels play a central role in the regulation of cell processes 
including proliferation, differentiation, mineralisation and secretion. The expression 
pattern of some of these K+ channels may be species-specific; for example, the 
intermediate-conductance Ca2+-activated channel is highly expressed in mouse and rat 
BMSCs (Deng et al., 2007; Tao et al., 2007), but not in human BMSCs (Heubach et al., 
2004; Li et al., 2005). Also, the expression pattern may change with cell differentiation 
and maturation; in smooth muscle cells, cells that are at the proliferative stage express 
intermediate-conductance Ca2+-activated K+ channels, but when they become mature 
smooth muscle cells, these channels are replaced by large conductance channels 
(Köhler et al., 2003; Tharp et al., 2006). Finally, K+ channel expression and activity also 
vary with cell cycle progression (Deng et al., 2007). 
The human ether-à-go-go (hEag1 or Kv10.1) and the large-conductance calcium-
activated (BK channel or KCa1.1) potassium channels putatively regulate the 
proliferation, the adipogenic and osteogenic differentiation of human BMSCs, and 
osteoblast functions (Zhang et al., 2014). Pharmacological inhibition of either of these 
channels, or knockdown with specific shRNA, leads to reduced cell proliferation, 
decreasing the expression of the cell cycle regulatory proteins cyclin D1 and cyclin E 
and reducing the phosphorylation of ERK1/2 and Akt. Adipogenic differentiation of 
human BMSCs cultured with adipogenic medium is also reduced, as shown by the 
observed decrease in lipid accumulation and decreased PPARγ expression. Inhibition of 
hEag1 or BK channels also decreases osteogenic differentiation of hBMSCs cultured 
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with osteogenic medium, with reduced in vitro mineralisation and osteocalcin 
expression (Zhang et al., 2014).  
The BK channel is also densely expressed in several human osteoblastic cells, including 
primary human osteoblasts and MG63 and SaOS-2 human osteoblast-like cell lines 
(Henney, 2008; Henney et al., 2009; Li, 2012). These studies demonstrated that the BK 
channel is involved in regulation of proliferation and mineralisation. MG63 cells also 
express several KATP subunits: the pore-forming subunits Kir6.1 and Kir6.2, and the 
regulatory subunits SUR1 and SUR2B; pinacidil, which is a KATP channel opener, causes 
a significant increase in cell number (Henney, 2008). Both BK channel and KATP 
channels has been shown to also regulate osteocalcin secretion by MG63 cells (Moreau 
et al., 1997). 
In osteocytes, K+ channels and voltage-dependent calcium channels (VDCCs) were 
shown to be involved in paracrine signalling and mechanotransduction (Gu et al., 
2001b; a). In osteoblasts, Ca2+-activated K+ channels regulate cell volume (Weskamp 
2000) and resting membrane potential: KCa channel activation triggers membrane 
hyperpolarisation, balancing the depolarisation associated with [Ca2+]i increases. The 
K+ channels hence function as feedback regulators of [Ca2+]i (Moreau et al, 1996; 
Ravesloot et al, 1990; Yellowley et al, 1998). In particular, TREK-1, may be involved in 
the mechanotransduction in osteoblasts, controlling bone remodelling (Hughes et al., 
2006). TREK-1 is a member of the two-pore domain potassium channel family (K2P); it 
is sensitive to membrane stretch, lysophospholipids, free fatty acids, temperature, 
intracellular pH, and anaesthetics. TREK-1, TREK2c and TRAAK expression was 
detected in human derived osteoblasts and MG63 cells; these three channels 
collectively form the lipid and mechanosensitive subfamily of mammalian K2P channels 
(Patel and Honoré, 2002). Treatment with a TREK-1 blocker upregulated bone cell 
proliferation (Hughes et al., 2006).  
In mouse MSCs, intermediate-conductance Ca2+-activated K+ (IKCa or KCa3.1) and 
volume-sensitive Cl- (Clcn3) channels have been shown to regulate cell proliferation 
(Tao et al., 2008); blocking or silencing these channels reduced cell proliferation of 
mouse MSCs by 20-30%, decreasing the expression of cyclin D1 and cyclin E. The large-
conductance Ca2+-activated K+ channel (BK channel) regulates MC3T3-E1 preosteoblast 
cell proliferation; BK channel knock-out significantly reduces cell number (Hei et al., 
2016).   
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Rat MSCs express several functional potassium channels, either alone or in 
combination: two delayed rectifier channels (Kv1.2 and Kv2.1), the BK channel 
(KCa1.1), an intermediate-conductance Ca2+-activated K+ channel (KCa3.1) and two 
transient K+ channels (Kv1.4 and Kv4.3) (Li et al., 2006; Deng et al., 2007; Wang et al., 
2008). The expression of these potassium channels, in particular voltage-gated (Kv1.2 
and Kv2.1) and calcium-activated potassium channels (KCa1.1 and KCa3.1), changed 
during cell cycle progression and played an important role in regulating this process. 
Membrane potential was shown to hyperpolarise during cell cycle progression, and this 
was associated with increased cell size. IKDR decreased and IKCa increased during 
progress from G1 to S phase. This was associated with decreased expression levels of 
Kv1.2 and Kv2.1, and increased expression level of KCa3.1 during the cell cycle 
progression (Deng et al., 2007). Pharmacological blockade of the voltage-gated 
channels (Kv) and Ca2+-activated channels inhibited proliferation of cultured MSCs by 
arresting cell-cycle progression (Deng et al., 2007; Wang et al., 2008), and 
downregulation of Kv1.2, Kv2.1 and KCa3.1 with specific RNAi also inhibited cell 
proliferation (Deng et al., 2007). Another study showed that the BK channel regulate 
rat osteoblast proliferation, differentiation and functions, using ROS17/2.8 osteoblasts: 
BK channel knockout significantly decreased cell number, the expression of 
osteoblastic markers Runx2, osteocalcin and osteopontin), and the ability to mineralise 
(Hei et al., 2016). 
1.5.2.2. Potassium channels and adipocytes 
K+ channels also regulate proliferation and adipogenic differentiation in MSCs and 
preadipocytes. Voltage-gated K+ channels regulate the adipogenic differentiation of 
human BMSCs; blocking KV currents with tetraethylammonium (TEA) significantly 
reduces lipid droplet formation and the expression of the adipogenic marker aP2. You et 
al. (2013) showed that blocking Kv2.1 suppresses adipogenesis. The 3T3-L1 mouse 
preadipocytes have been shown to express the Ca2+-activated intermediate 
conductance K+ channel (KCa3.1), an inwardly rectifying potassium (Kir2.1) and the 
volume-sensitive chloride channel  (Clcn3); KCa3.1 and Clcn3 participate in regulating 
cell proliferation (Zhang et al., 2012). Finally, KATP channels also regulate proliferation 
and differentiation in rat preadipocytes (Wang et al., 2007). 
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1.6. Hypothesis, aims and experimental strategies 
The principle hypothesis of this thesis is 1) that ghrelin can inhibit adipogenic 
transdifferentiation in 7F2 cells, and 2) that potassium channels are involved in 
mediating ghrelin signalling in this process.  
The overarching aim of this thesis was to provide a better understanding of the 
mechanisms underlying pathological adipogenesis in bone. In order to do this, this 
study investigated the effects of ghrelin on the adipogenic differentiation of osteoblast-
like cells, and the role of potassium channels in that process. Indeed, recently, ghrelin 
has been shown to play an important role in regulating bone metabolism and adiposity, 
particularly in a context of pathological adipogenesis. It is also well established that ion 
channels, and particularly K+ channels, are also involved in regulating bone 
metabolism. Pathological adipogenesis is a common feature of several pathologies, 
including some forms of osteoporosis. Osteoporosis represents a major health problem, 
due to its high financial costs, its consequences on quality of life (reduced mobility, 
isolation) and the increased death risk due to serious fractures and associated 
complications. While various treatments are available, they are not recommended for 
every patient, and new treatments are still needed. Investigating the effects of ghrelin 
on the adipogenic trans-differentiation of 7F2 cells osteoblast-like cells, and the role of 
ionic mechanisms, particularly K+ channel, in this process, will provide a better 
understanding of pathological adipogenesis mechanisms in bone, which underlies 
several forms of osteoporosis, particularly glucocorticoid-induced osteoporosis. This 
research may, in the long term, lead to the development of drugs that will help prevent 
osteoporosis by targeting ghrelin signalling and ionic mechanisms. Numerous studies 
have shown that ghrelin stimulates osteoblastogenesis and adipogenesis; what about 
the effects of ghrelin on cells that are already committed to osteoblast lineage, but that 
can be induced into adipocytes, such as 7F2 cells? What are the roles of K+ channels in 
this process? 
To answer these questions, the key objectives of this thesis were: 
1) to optimise the protocol to differentiate 7F2 cells into adipocytes, to trigger efficient 
differentiation while still leaving room to observe a possible stimulatory effect of 
ghrelin; 2) to investigate the expression of key genes from ghrelin signalling (Ghrl, Ghsr 
and Mboat4) in 7F2 osteoblastic cells and adipocytes and to test the effects of ghrelin 
on these; 3) to test the effects of ghrelin and potassium channel ligands on 7F2 cell 
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adipogenic differentiation; 4) to investigate and compare the electrophysiological 
properties of 7F2 cells and 7F2 cell-derived adipocytes, and to test the effects of ghrelin 
on these.   
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2.1. Cell culture 
2.1.1. Routine cell culture 
Minimum essential medium alpha (MEM-α) without ribonucleic or deoxyribonucleic 
acids, containing 2 mM L-glutamine, 1 nM sodium pyruvate and 50 mg/L ascorbic acid 
(Life Technologies, ThermoFisher Scientific) was supplemented with 10 % foetal 
bovine serum (FBS, Life Technologies, ThermoFisher Scientific). From here on, this will 
be referred to as basal medium. 
The 7F2 immortalized murine preosteoblastic cell line was originally a gift from the 
Department of Child Health, School of Medicine, Cardiff University, and used at 
passages 12 to 28. Cells were cultured in 25 cm² tissue culture flasks in 4 ml basal 
medium and incubated at 37°C in 5% CO2 humidified air. Medium was replaced every 
2-3 days.  
Confluent cultures were passaged weekly; cells were washed with 2 ml Dulbecco’s 
phosphate buffered saline (DPBS; calcium- and magnesium-free, GibcoTM, 
ThermoFisher Scientific) and detached with 500 µl of trypsin-EDTA (0.25%) solution 
(trypsin from porcine pancreas, GibcoTM, ThermoFisher Scientific). Cells were 
incubated with trypsin at 37°C for up to 5 minutes. When cells were detached, 2.5 ml of 
basal medium were added to stop the trypsinisation and cells were evenly suspended 
by gentle repeated pipetting. The suspension was then diluted in 7 mL basal medium 
(total volume 10 ml) and split at a 1:10 dilution in new culture flasks.  
2.1.2. Adipogenic differentiation of 7F2 cells 
2.1.2.1. Adipogenic differentiation medium 
Dexamethasone and indomethacin were purchased from Sigma-Aldrich. 
Dexamethasone and indomethacin stock solutions were prepared in ethanol at a 1 mM 
concentration and at a 25 mM concentration respectively, and stored at -20°C for up to 
one year. Basal medium was supplemented with 50 µM indomethacin and 100 nM 
dexamethasone (Sigma-Aldrich). For here on, this will be referred to as adipogenic 
medium. The composition of adipogenic medium was chosen based on the work by 
Thompson et al. (1998); here, MEM-α already contained 50 µg/ml ascorbic acid, so no 
further supplementation was required.  
Chapter 2 – Materials and Methods 
 
34 
 
2.1.2.2. Adipogenic differentiation for Oil Red O staining assay 
7F2 cells were plated into 12-well tissue culture plates (Fisher Scientific) at a density of 
2500 cells/cm² in adipogenic medium. Cells were incubated as usual for 7 days with 
medium replacement every 2-3 days. Digital photographs were taken daily under a 
microscope at 200x magnification to follow the apparition of lipid droplets within the 
cells.  
A stock solution of 4% paraformaldehyde (PFA) was prepared by adding 10 g PFA 
powder to 250 ml 1x PBS (GibcoTM, ThermoFisher Scientific). PFA was dissolved by 
heating the solution to 60°C. The solution was then filtered with Whatman paper and 
aliquoted to be frozen at -20°C. After 7 days of treatment, 7F2 cells were washed with 
DPBS, then fixated with 1 ml of 4% PFA solution per well. After 15 minutes at room 
temperature, 4% PFA was removed, the cells were washed twice with distilled water 
and air dried.  
A 60 % Oil Red O : 40 % distilled water working solution was freshly prepared from a 
stock solution (0.25 g in 50 ml isopropanol) and filtered through coarse filter paper. 
Cells were stained with the working solution for 20 minutes at room temperature, then 
washed with 60 % isopropanol to remove excess stain and washed three times with 
distilled water. Photographs were taken under a microscope at a magnification of 200x. 
Oil Red O stain was extracted by adding 100% isopropanol to the cells for 30 minutes at 
room temperature, and quantified by transferring 100 µl from each well to a 96-well 
plate and measuring spectrophotometrically at 490 nm, using 100% isopropanol as 
blank. 
2.1.2.3. Adipogenic differentiation for RT-PCR analysis 
7F2 cells were cultured in 25 cm² flasks with adipogenic medium as described in 
section 2.1.1. After 7 days of culture, the cells were detached using trypsin as described 
previously. The cells were pelleted by centrifuging at 1,400 rpm for 5 minutes; then the 
medium was removed, the cell pellets were resuspended in 1 ml DPBS and transferred 
to 1.5 ml eppendorf tubes. The cells were pelleted again by centrifuging at 1,400 rpm 
for 5 minutes, DPBS was removed and the pellets were immediately frozen at -80°C for 
future RNA extraction and RT-PCR and qPCR analysis. 
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2.2. Cell counting 
A Reichert Bright-Line haemocytometer (Sigma-Aldrich) and glass coverslip were 
cleaned with alcohol before use. The coverslip was moistened with water and fixed to 
the haemocytometer. The presence of Newton’s refraction rings under the coverslip 
indicated proper adhesion. 
7F2 cells were detached as above (see section 2.1.1). 50 µl of cell suspension were 
mixed with 50 µl of Trypan Blue (Sigma-Aldrich), staining dead cells in blue. 8 µl of the 
mix was pipetted into each of the haemocytometer counting chambers, allowing the cell 
suspension to be drawn out by capillary action. At 100x magnification under a 
microscope, focus was made on the grid lines of the haemocytometer. Live cells were 
counted using a hand tally counter in 4 sets of 16 corner squares for each counting 
chamber, including the cells located on the left and top boundary lines, but not those on 
the right and bottom boundary lines.  
The density of cell suspension was calculated by multiplying the average cell count 
from each of the sets of 16 corner squares by 10,000 (104) and by multiplying by 2 to 
correct for the 1:2 dilution from the Trypan Blue addition.  
2.3. Molecular biology 
2.3.1. RNA extraction and DNAse treatment 
Cells pellets were collected as described above (see section 2.1.2.3.). Cell pellets were 
thawed on ice and were resuspended in 1 ml Trizol (Invitrogen), pipetting repeatedly 
to lyse the cells. After 5 minutes at room temperature, 0.2 ml of cold chloroform (stored 
at 4°C; Sigma-Aldrich) was added and the microcentrifuge tubes were vortexed for 10 s, 
until the solution became pink. After 3 minutes at room temperature, the cell lysates 
were centrifuged at 14,000 rpm for 15 minutes at 4°C. The aqueous phase (500 µl) was 
collected into new tubes. 
500 µl of cold isopropanol (stored at -20°C; Sigma-Aldrich) were added to each tube. 
After 10 minutes at room temperature, the tubes were centrifuged at 14,000 rpm for 30 
minutes at 4°C.  
The supernatant was removed. 500 µl of 75% ethanol (stored at -20°C) were added to 
the tubes, which were then centrifuged at 14,000 rpm for 5 minutes at 4°C.  The ethanol 
was removed and the pellets were air dried for 5-10 minutes. The pellets were then 
resuspended in 22 µl of Ultrapure DNAse/RNAse-free distilled water (InvitrogenTM, 
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ThermoFisher). 2 µl were used to measure the RNA concentration with a NanoDrop 
2000 Spectrophotometer (Thermo Scientific), using Ultrapure DNAse/RNAse-free 
distilled water as blank.  The concentration of the remaining 20 µl was then adjusted to 
a 1 µg/µl concentration (1γ).  
mRNA was treated to remove possible DNA contaminant using the DNA-freeTM DNA 
Removal Kit (InvitrogenTM, ThermoFisher Scientific).  A mix of 5 µl 10X buffer, 10 µl 
mRNA (10 µg), 1 µl DNAse and 34 µl Ultrapure DNAse/RNAse distilled water was 
prepared, for a total volume of 50 µl. The mix was incubated at 37°C for 30 min, then 5 
µl of DNAse Inactive Reagent were added to stop the DNAse; the samples were 
vortexed several times for 2 minutes at room temperature, then centrifuged at 14,000 
rpm for 1.5 minutes. The DNA-free mRNA was transferred to a new tube for a final 
concentration of 0.2γ (0.2 µg/µl).  The remaining 1γ mRNA was frozen at -80°C.  
2.3.2. Reverse transcription 
0.2γ mRNA samples (see section 2.3.1) were thawed on ice. Reverse transcription was 
carried out with the High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems); compositions and conditions are detailed in tables 2.1 and 2.2 
respectively. For no RT controls, the Multiscribe Reverse Transcriptase was replaced 
with 1µl of nuclease-free water. The RT was run in a T100TM Thermal Cycler (Bio-Rad). 
After the reaction, 80 µl H2O were added and cDNAs were stored at -20°C. 
 
Components Final concentrations Volumes 
10X RT Buffer 1 X 5 µl 
25X dNTP 100 mM 1X 0.8 µl 
Multiscribe Reverse Transcriptase 
 
1 µl 
RNA (0.2 µg/ml) 
 
5 µl 
Nuclease-free water 
 
3.2 µl 
Total volume 
 
20 µl 
Table 2.1: Reverse transcription reaction composition 
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Step Temperature °C Time 
Step 1 25 10 min 
Step 2 37 120 min 
Step 3 85 5 min 
Step 4 4 Indefinite 
Table 2.2: Reverse transcription reaction conditions 
2.3.3. Polymerase chain reaction (PCR) 
Primers were designed from mouse gene sequences using FasterDB (Cancer Research 
Center of Lyon, CRCL) and Primer3 as follows: the FasterDB database was searched for 
genetic sequences in the mouse genome; part of mRNA sequences were selected so that 
they covered as many splicing isoforms as possible and copied into the ‘source 
sequence box’ of the web-based Primer3 primer design software. The software selected 
left and right primers for the given sequence without modification of the default 
software settings. Primer3-suggested primers were checked against the complete 
genetic sequence using the FasterDB ‘in silico PCR’ tool, to determine predicted 
amplicon sizes, especially when primer sequences were in different exons. Primers 
were obtained from Eurogentec (see Appendix, section 8.1 for primer details).  
PCR of 50 µl were routinely performed, using Herculase II Fusion DNA Polymerase PCR 
kit (Agilent Technologies). The PCR reaction composition is detailed in table 2.3. 
Ultrapure DNAse/RNAse distilled water was used as a negative control and three 
house-keeping genes, Hprt1, Eef2 and Gapdh, were used as positive controls.  
 
Components Final concentrations Volumes 
5X Herculase II Reaction Buffer 1 X 10 µl 
dNTPs (100 mM; 25 mM each dNTP) 250 µM each dNTP 0.5 µl 
Forward primer (10 µM) 0.2 µM 1 µl 
Reverse primer (10 µM) 0.2 µM 1 µl 
Herculase II Fusion DNA Polymerase   0.25 µl 
cDNA   5 µl 
Nuclease-free water   to 50 µl 
Table 2.3: PCR reaction composition 
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2.3.4. Gel electrophoresis 
The PCR amplification products were analysed by gel electrophoresis in 1% agarose 
gels. 1 L of 20X Sodium Borate (SB) buffer was prepared using 8 g NaOH (final 
concentration: 200 mM), 47 g Boric acid, and ddH2O. For small gels, 0.75g of agarose 
were added to 75 ml 1X SB buffer; for large gels, 1.5 g of agarose were added to 150 ml 
1X SB buffer. The agarose-containing buffer was warmed in a microwave until the 
agarose was dissolved; then SYBR Safe (Invitrogen) was added to stain DNA molecules. 
Electrophoresis ran at 200V for 20 minutes or at 100V for 40 minutes. Smartladder SF 
(Eurogentec) was used as a marker for each gel electrophoresis (Figure 2.1). 
 
Figure 2.1: Smartladder SF DNA ladder 
Using a standard loading of 5 µl, the bands correspond to an exact quantity of DNA, from 20 to 
100 ng. 
 
2.3.5. Quantitative PCR (qPCR) 
qPCR was carried out using Rotor-Gene SYBR Green PCR kit (Qiagen). The reaction 
composition and conditions are detailed in tables 2.4 and 2.5 respectively. Reactions of 
25 µl were performed; Ultrapure DNAse/RNAse-free distilled water was used as a 
negative control and three house-keeping (HK) genes, Hprt1, Eef2 and Gapdh were used 
as positive controls. Oligonucleotide primers were the same as for RT-PCR (see 
Appendix, section 8.1 for primer details).  
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Components Final concentrations Volumes 
2x Rotor-Gene SYBR Green  
PCR Master Mix 
1 X 12.5 µl 
Forward primer (10 µM) 1 µM  2.5 µl 
Reverse primer (10 µM) 1 µM 2.5 µl 
Template cDNA   100 ng 1 µl 
RNase-free water   6.5 µl 
Total volume 
 
25 µl 
Table 2.4: qPCR reaction composition 
 
Step Time Temperature 
PCR initial activation step 5 min 95°C 
Two-step cycling 
  Denaturation 5 s 95°C 
Combined annealing/extension 10 s 60°C 
Number of cycles  40 
 
Table 2.5: qPCR cycling conditions 
 
For each qPCR assay, there were 3 or 4 replicate samples per condition (experimental 
or control), except when stated otherwise. In each qPCR assay, all the replicate samples 
were run in duplicates. Data were analysed using the relative CT (∆∆Ct) method (Livak 
and Schmittgen, 2001; Schmittgen and Livak, 2008). Mean CT values of house-keeping 
genes (Hprt1, Eef2 or Gapdh) were substracted from mean CT values of each gene of 
interest, to obtain ∆Ct values of each gene of interest for each sample. For each gene, 
∆Ct values in the control treatment (basal medium) were used to normalize ∆Ct values 
of each treatment to obtain ∆∆Ct and mRNA fold expression values [2(-∆∆Ct)]. Standard 
deviation was determined from the replicate samples at each experimental condition. 
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2.3.6. Sequencing 
2.3.6.1. Gel extraction of PCR products 
PCR and gel electrophoresis were carried out as previously described (see sections 
2.3.3 and 2.3.4 respectively).  To maximise the amount of extracted PCR product, 50-55 
cycles of PCR were done, and the PCR products were loaded in 3 wells per sample, to be 
combined after excision from the gels. Electrophoresis ran at 100V for 40 minutes to 
fully separate the bands. A picture of the gel was taken under UV conditions before 
extracting the PCR products from the gels. 
The PCR products were extracted using the QIAquick Gel Extraction Kit (Qiagen). 
Selected DNA fragments were excised from the agarose gels using a scalpel and a UV 
transilluminator. The scalpel was cleaned between each sample by dipping the blade 
into 100% ethanol, then wiping the blade with tissue. The gel slices were weighed in 
1.5 ml eppendorf tubes, and 3 volumes of Buffer QG were added to the gel slices (i.e. 
300 µl of Buffer QG to each 100 mg of gel). The maximum amount of gel slice was 
limited to 400 mg per sample as per supplier’s instructions. The gel slices were 
incubated at 50°C for 10 minutes and vortexed every 2-3 minutes to help dissolve the 
agarose gel completely. After solubilising the agarose gels, the colour of the mixture 
was checked; if still yellow, indicating a pH   7.5, no additional step was needed to 
adjust pH; if colour was orange or violet, 10 µl of 3M sodium acetate, pH 5.0, were 
added. To increase the yield of < 500 bp DNA fragments, 1 volume of isopropanol was 
added to the samples, and the samples were mixed.  
The samples were then applied to QIAquick spin columns and centrifuged for 1 minute 
at 13,000 rpm at room temperature. The flow-through was discarded. 0.5 ml of Buffer 
QG was added to the QIAquick columns and the samples were centrifuged for 1 minute 
at 13,000 rpm to remove all traces of agarose. The samples were then washed by 
adding 0.75 ml of Buffer PE, leaving the samples stand for 2-5 minutes and then 
centrifuging for 1 minute at 13,000 rpm. The flow-through was discared and the 
samples were centrifuged for an additional 1 minute at 13,000 rpm to remove residual 
ethanol from Buffer PE. 
QIAquick columns were transferred to clean microcentrifuge tubes. 30 µl of Buffer EB 
were dispensed directly on the QIAquick columns membranes to elute bound DNA; to 
increase the DNA concentration, the columns were let to stand for 4 minutes before 
centrifuging for 1 minute at 13,000 rpm. The average eluate volume was 28 µl. The 
DNA concentration of eluates was measured using a NanoDrop 2000 
Chapter 2 – Materials and Methods 
 
41 
 
Spectrophotometer (Thermo Scientific), using Buffer EB as blank. The DNA samples 
were then frozen at -20°C. 
2.3.6.2. Sanger sequencing 
Sequencing of PCR products was carried out externally, via the LIGHTRUN sequencing 
service (Sanger sequencing, GATC Biotech) on an ABI 3730xl DNA Analyzer system. 5 µl 
of samples with a DNA concentration higher than 20 ng/µl were sent for sequencing in 
1.5 ml tubes along with 5 µl of 5 µM appropriate primer pairs for a total volume of 10 
µl.  
2.3.6.3. Analysis of sequencing data 
Sequencing data was provided by GATC Biotech as a set of three files per sample: a 
chromatogram (Ab1 Trace File) which contains the raw data (signal strength) of the 
sequence analysis and other ABI information alongside the graphically displayed 
individual bases; and two text files (FAS. and SEQ. files) which contain the sequence of 
the sample. The Phred basecaller calculates the respective quality value for each base 
using the peaks in the chromatogram (Phred score). Phred 20 means accuracy of 99%, 
meaning a read error probability of 1:100. In the text files, the notation of the bases is 
defined as follows: "N" is equivalent to quality value < Phred 10; a lower case letter, e.g. 
"a" is equivalent to a quality value of Phred 10-19; and an upper case letter, e.g. "A" is 
equivalent to a quality value of ≥ Phred 20. 
For analysis, chromatograms were opened using the GATCViewer software (GATC 
Biotech), and PCR product sequences were manually copied in a text file. They were 
then compared with the gene sequence to identify which regions of the gene were 
present in both sequences, using Clustal Omega (EMBL-EBI) (Goujon et al., 2010; 
Sievers et al., 2011; McWilliam et al., 2013). 
2.3.7. Statistical analysis 
Statistical analysis was performed as described in Figure 2.2 (McDonald, 2014; 
Mangiafico, 2015). The Shapiro-Wilk’s test was used to assess the normality of 
distribution of investigated parameters (for each variable). The F test was used to 
assess the homogeneity of variances when there were two variables; the Bartlett test 
and the Levene’s tests were used when there were more than two variables. Data were 
expressed as mean ± standard deviation; the number of repeat assays is indicated by 
“n” in each figure legend as appropriate. The values P < 0.05 were considered 
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statistically significant. Statistical analysis was done using the R software 
(https://www.r-project.org/, version 3.5.3). The Dunn test required the dunn.test 
package (https://cran.r-project.org/web/packages/dunn.test/index.html). 
 
 
Figure 2.2: Statistical analysis of data 
Normality of distribution and homogeneity of variances were assessed to choose the 
appropriate statistical test.  
 
2.4. Electrophysiology 
2.4.1. Physiological recording solution 
All chemical components were obtained from Sigma and were prepared in distilled H2O 
and stored at 2 – 8 °C. The volume of each solution (see table 2.6 for composition) was 
adjusted to 100 ml with distilled water. The pH of the Sodium “Locke” extracellular 
solution and that of the High K+ intracellular solution were adjusted to 7.4 and 7.2 
respectively, with NaOH or HCl. The electrophysiological solutions were stored at 4°C 
up to 1 week; they were warmed to room temperature before use, and filtered through 
a non-sterile 0.2 µm PVDF-membrane 4 mm syringe filter (Whatman) to avoid crystals 
that could block the microelectrode tip, or attach to the cells and prevent giga seal 
formation. 
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Sodium “Locke” extracellular solution: 100 ml 
Component Quantity Final concentration 
NaCl 877 mg 150 mM 
KCl 0.3 ml of 1 M stock 3 mM 
CaCl2 0.2 ml of 1 M stock 2 mM 
MgCl2 0.2 ml of 1 M stock 2 mM 
HEPES 238 mg 10 mM 
D-glucose 180 mg 10 mM 
 
High K+ intracellular solution: 100 ml 
Component Quantity Final concentration 
NaCl 0.5 ml of 1 M stock 5 mM 
KCl 1.045 g 140 mM 
CaCl2 100 µl of 100 mM stock 30 nM free [Ca2+] 
MgCl2 0.1 ml of 1 M stock 1 mM 
HEPES 238 mg 10 mM 
EGTA 2.2 ml of 50 M stock 11 mM 
Table 2.6: Composition of electrophysiological solutions 
 
2.4.2. Electrode fabrication 
Recording electrodes were pulled just before use from 1.5 mm outside-diameter, 0.86 
mm inside-diameter borosilicate glass capillaries (Warner Instruments) by a Narishige 
PP-83 two-stage electrode puller set to produce two equal length electrodes with a 
resistance of 4 – 8 MΩ for single channel patch-clamping, and 1 – 2 MΩ. A silver/silver 
chloride wire was used as reference electrode.  
2.4.3. Electrophysiology apparatus 
An Ag-AgCl recording wire was connected to an I-V converter amplifying headstage (CV 
203BU Headstage, Axon Instruments), which was mounted on a Scientifica three-
dimensional mechanical micromanipulator. The micromanipulator, as well as the 
inverted microscope, the recording chamber and the cells from which signals were 
recorded, were placed within a Faraday cage surrounding an anti-vibration table in 
order to minimise electrical and vibrational interference.  To further reduce electrical 
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noise, all metallic apparatus and electronic instruments in use were electrically 
earthed. 
Signals were amplified by an Axopatch amplifier (Axopatch 200, Axon Instruments) 
with filter cut-off at 5 kHz, digitised at 20 kHz and transmitted to a computer through a 
NIDAQ-MX interface (National Instruments), and visualised on the Windows Whole-
Cell Patch (WinWCP, for whole-cell patch-clamp, version v5.0.3) or Windows 
Electrophysiology Disk Recorder (WinEDR, for single-channel patch-clamp, version 
v3.6.0) software (Dr John Dempster, University of Strathclyde).  
2.4.4. Patch-clamp methodology 
2.4.4.1. Single-channel patch-clamp 
Cells were cultured for 1-7 days on 16 mm circular glass coverslips at seeding densities 
of 3,000 cells. Cultures were inspected by microscope before use to check they were 
healthy-looking and not confluent. Coverslips were washed in filtered sodium “Locke” 
extracellular solution before being transferred to a recording chamber, using a small 
amount of petroleum jelly to hold them in place. A few drops of filtered sodium “Locke” 
solution were then gently added onto the coverslip to form a convex meniscus of 
solution. The recording chamber was then transferred to the stage of the microscope, 
and the reference electrode tip was placed into solution. At 200x magnification, a cell 
was chosen to patch-clamp that was phase-bright, agranular and preferably not in 
contact with another cell.  
A recording electrode was backfilled using a Microfil 34G fused-silica syringe needle 
with filtered High K+ intracellular solution, then threaded over the Ag-AgCl wire and 
sealed into place. The electrode tip was advanced into the solution covering the cells 
using the micromanipulator, and positive pressure was applied inside the electrode to 
prevent the aggregation of debris on the tip. Junction potential was adjusted to zero 
using the pipette offset on the amplifier. A 20 mV DC oscillating square-wave pulse 
(seal test) was applied via the WinEDR software across the electrode tip to determine 
to electrode resistance from the current amplitude measured by the amplifier. The 
recording electrode tip was then advanced gently towards the cell. The microscope 
light was then switched off to avoid creating background noise and contact between the 
recording electrode tip and the cell was seen by an increase in electrical resistance in 
the seal test. Positive pressure was removed and negative pressure was gently applied 
to form a seal. When seal resistance increased slowly, negative voltages (-20 mV to -60 
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mV) were applied to help with seal formation. Seals with electrical resistance in the 
giga-Ohm range (a giga-seal) were typically achieved in a few seconds or a few minutes. 
Recordings were begun soon after at room temperature (around 20°C). Coverslips 
were discarded after one or two hours because the cells began to look unhealthy (figure 
2.2). 
 
Figure 2.3: Example of 7F2 cells before and after recording 
Cells began to look unhealthy after one or two hours of recording.  
2.4.4.2. Perforated patch-clamp 
The perforated patch-clamp technique was used to record from whole cells (Lippiat, 
2009; Ishibashi et al., 2012; Linley, 2013). A 40 mg/ml stock solution of Amphotericin B 
was prepared in distilled water and frozen up to 5 days; when used, it was kept on ice 
and away from light as Amphotericin B is light-sensitive (Lippiat, 2009). Cells were 
seeded on 16 mm circular glass coverslips and prepared for recording as described 
above.  
The tip of the recording electrode was dipped into a High K+ intracellular solution to fill 
the very tip with solution free of Amphotericin, which can prevent seal formation. Then 
the electrode was backfilled with High K+ intracellular solution containing various 
concentrations of Amphotericin B (ranging from 200 to 400 µg/ml) and threaded over 
the Ag-AgCl wire. A giga-seal was formed as described above, except that a 5 mV 
instead of 20 mV DC oscillating square-wave pulse (seal test) was applied across the 
electrode tip (Linley, 2013) to determine to electrode resistance. Ideal electrode 
resistances were between 2 and 4 MΩ (Linley, 2013). After seal formation, a voltage of -
70 mV was applied for 5 minutes to help get a perforated patch configuration (Linley, 
2013). 
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2.4.5. Data acquisition and analysis 
For cell-attached patches, recordings of thirty seconds and between   150 mV were 
made onto the hard-disk of a PC and saved as WCP or EDR files, using WinWCP (v5.0.3) 
or WinEDR (v3.6.0) softwares. Data were regularly saved to another PC for analysis and 
as back-up copies.  
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3.1. Introduction 
3.1.1. In vitro differentiation into adipocytes 
There are various published protocols to induce adipogenic differentiation in vitro. 
MSCs and preadipocytes can be differentiated into mature adipocytes when treated 
with a cocktail of adipogenic chemical stimuli such as dexamethasone, isobutyl-
methylxanthine (IBMX), insulin, indomethacin, or hydrocortisone (Scott et al., 2011; 
Hemmingsen et al., 2013). There is a lack of standardisation for in vitro adipogenic 
differentiation, even for established cell lines such as 3T3-L1 preadipocytes. To 
differentiate these preadipocytes, three ingredients are commonly used – 
dexamethasone, IBMX and insulin, but concentrations for each vary considerably (Scott 
et al., 2011). These three components are also often used to differentiate mouse and 
human BMSCs, again with a great variety between the protocols; some of which only 
use one or two drugs to promote adipogenic differentiation (Scott et al., 2011). 
The 7F2 cell line was derived from the bone marrow of p53-/- mice by Thompson et al. 
(1998). These cells are considered to be osteoblastic as they express ALP, secrete type I 
collagen and osteocalcin, and mineralise after 4-7 days of incubation with alpha 
modified essential medium (α-MEM) supplemented with 10 mM β-glycerophosphate 
and 50 µg/ml ascorbic acid. However, these clones can be induced to differentiate into 
adipocytes when cultured with adipogenic medium. This is accompanied by the 
complete loss of expression of all osteoblastic markers except ALP. The adipogenic 
medium used by Thompson et al. was derived from a protocol originally published by 
Dorheim et al., which contained 0.5 mM IBMX, 0.5 µM hydrocortisone and 50 µM 
indomethacin (Dorheim et al., 1993); using instead 50 µM indomethacin, 0.1 µM 
dexamethasone and 50 µg/ml ascorbic acid, which was found to accelerate the 
conversion to fat (Thompson et al., 1998). 
Indomethacin is a non-specific cyclooxygenase (COX) inhibitor and a non-steroidal 
anti-inflammatory drug (NSAID). NSAIDs, and in particular indomethacin, have been 
shown to promote adipogenesis and decrease osteogenesis. Styner et al. showed that 
indomethacin stimulated the adipogenic differentiation of both murine embryonic 
pluripotent cells and marrow-derived MSCs (Styner et al., 2010): indomethacin induced 
adipocyte protein 2 (aP2) and adiponectin production, as well as the formation of lipid 
droplets; it promoted early adipogenesis, significantly upregulating PPARγ2 and 
C/EBPβ expression. Indomethacin also suppressed prostaglandin E2 (PGE2), which is 
the principal product of COX2, and an anabolic agent that both promotes 
Chapter 3 – Protocol optimisation for the differentiation of murine 7F2 osteoblast-like 
cells into adipocytes 
49 
 
osteoblastogenesis and decreases adipogenesis. However, it seemed that the effects of 
indomethacin were prostaglandin-independent, as adding PGE2 did not reverse 
indomethacin-induced adipogenesis. This is in contrast with another study that showed 
that indomethacin increased the adipogenic differentiation of mouse embryonic 
fibroblasts, and that exogenous PGE2 could reverse the effect of indomethacin (Inazumi 
et al., 2011); PGE2 signalling suppressed adipogenesis by inhibiting PPARγ2 expression 
in an autocrine manner.  
Dexamethasone is an anti-inflammatory synthetic glucocorticoid, frequently used in the 
treatment of severe inflammatory diseases, such as rheumatoid arthritis or 
osteoarthritis (Shefrin and Goldman, 2009). Glucocorticoids signal via the 
glucocorticoid receptor which belongs to the steroid hormone receptor subclass of 
nuclear receptors. This receptor regulates gene expression as a dimer by binding to 
glucocorticoid responsive elements in the promoters of target genes, such as bone 
sialoprotein, osteocalcin, ALP, osteoprotegerin and type I collagen (Ogata et al., 1995; 
Moutsatsou et al., 2012). Many experimental and clinical studies report that 
glucocorticoids have many deleterious side effects in bone (Pereira et al., 2002; Liu et 
al., 2004; O’Brien et al., 2004; Ohnaka et al., 2005; Ton et al., 2005; Wang et al., 2005; 
Lane et al., 2006; Swanson et al., 2006; Ito et al., 2007; Leclerc et al., 2008; Koromila et 
al., 2014; Briot and Roux, 2015). Dexamethasone has been shown to stimulate both 
osteogenic and adipogenic differentiation depending on the cell differentiation stage 
(Mikami et al., 2011) and concentration of the drug (Ghali et al., 2015). Several studies 
report that 10 nM dexamethasone inhibits proliferation of human MSCs, induces 
osteoblast commitment, maturation and extracellular matrix mineralisation (Cheng et 
al., 1994; Siddappa et al., 2007; Piek et al., 2010); basal medium containing ascorbic 
acid and 10 nM dexamethasone increases ALP expression while decreasing BMP2 
expression (Barradas et al., 2012). On the contrary, others have shown that 10 nM 
dexamethasone stimulates adipogenesis in non-committed cells, but stimulates 
osteogenesis in cells already committed to the osteogenic lineage (Mikami et al., 2011). 
When MSCs are exposed to dexamethasone for a prolonged period of time, or to an 
increased concentration of the drug (1 nM to 1 µM), they yield higher numbers of 
adipocytes in cultures at the expense of osteoblasts (Yin et al., 2006). Similarly, 100 nM 
– 1 µM dexamethasone inhibits rat BMSC proliferation and promote adipogenesis and 
have time-dependent effects on osteoblastic marker expression, suppressing Runx2 
and ALP expression in the early stage of differentiation, but increasing expression of 
ALP and osteopontin in the late stage (Song et al., 2014). In vivo, administration of 
dexamethasone can induce osteoporosis in mice (Li et al., 2013a; Zhang et al., 2015). In 
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humans, it has been shown that long-term dexamethasone therapy is associated with 
bone loss, low BMD and increased fracture risk; dexamethasone-induced osteoporosis 
is accompanied by increased bone marrow adiposity (Staa et al., 2002; Yao et al., 2008; 
Weinstein, 2012).  
In addition to the adipogenic medium components, other factors such as cell adhesion, 
cell shape or culture conditions also play an important role in regulating adipogenesis; 
for example, the number of passages and the cell seeding density are important 
parameters. Cell seeding density has been reported to affect several cell processes, such 
as proliferation and differentiation (Bitar et al., 2008; Neuhuber et al., 2008). For MSCs, 
higher densities enhance adipogenesis while lower densities favour osteogenesis under 
an adipogenic-osteogenic co-induction medium (McBeath et al., 2004; Peng et al., 
2012). This may be due to the fact that cell spreading seems to promote osteogenesis; 
human MSCs cultured on larger islands of fibronectin differentiated along the 
osteogenic lineage, while human MSCs cultured on smaller islands differentiated into 
adipocytes (McBeath et al., 2004). Ca2+ may play a role in regulating cell morphology; 
higher extracellular Ca2+ concentrations are associated with smaller nuclei and larger 
cytoskeletons, increasing the cell area and perimeter and promoting the osteogenic 
differentiation of human MSCs (Barradas et al., 2012). Conventionally, cells are cultured 
to subconfluence before treatment with adipogenic medium, because this treatment 
inhibits cell proliferation (Murphy et al., 2003; Mauney et al., 2005); but it has also been 
reported that single-cell derived colonies of early passage human MSCs can 
differentiate into adipocytes (Sekiya et al., 2004).  
3.1.2. Chapter objectives and experimental strategies  
The objective in this chapter was to optimise the protocol to differentiate 7F2 
osteoblast-like cells into adipocytes, in order to test the effects of ghrelin or other 
pharmacological modulators on adipogenic differentiation in future experiments. 
Ideally, adipogenic differentiation should be efficient enough that a significant 
difference can be seen when comparing to 7F2 cells that were not induced to 
differentiate into adipocytes; but adipogenic differentiation should not be maximal, so 
that it will be possible in future experiments to detect a stimulatory effect of the tested 
pharmacological modulators (such as ghrelin) on adipogenesis.  
7F2 cells were cultured with basal medium as a control, or with adipogenic medium to 
induce adipogenic differentiation. To optimise the protocol, the effects of several 
factors on adipogenesis were tested, including cell seeding density, length of treatment, 
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and addition of insulin to the adipogenic medium; the efficiency of adipogenic 
differentiation was assessed by Oil Red O staining, which stains lipids in red, to quantify 
the amount of lipid droplets inside the cells. To assess adipogenic differentiation in the 
final protocol, in addition to Oil Red O staining, RT-PCR and qRT-PCR analysis was used 
to investigate the expression of osteoblastic (Runx2, ALP and osteocalcin) and 
adipocytic (PPARγ, C/EBPα, Glut4) markers.   
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3.2. Materials and Methods 
3.2.1. Cell culture and adipogenic differentiation of 7F2 cells 
7F2 cells were seeded and cultured as described in section 2.1. When testing the effects 
of the length of treatment on adipogenic differentiation, cells were seeded at a density 
of 5000 cells/cm². When testing the effects of insulin on adipogenic differentiation,        
5 µg/ml insulin (Sigma) was added to adipogenic medium (described in section 
2.1.2.1), and cells were seeded at a density of 5000 cells per cm².    
3.2.2. Molecular biology 
3.2.2.1. RNA extraction, DNAse treatment and reverse transcription 
See sections 2.3.1 and 2.3.2.  
3.2.2.2. PCR 
3.2.2.2.1. Oligonucleotide primers: house-keeping and differentiation marker genes 
See sections 8.1.1 and 8.1.2. 
3.2.2.2.2. PCR reaction compositions and conditions 
The PCR reaction composition is described in section 2.3.3. The PCR reaction conditions 
were optimised and are detailed in table 3.1. Nuclease-free water was used as a 
negative control and three house-keeping genes, Hprt1, Eef2 and Gapdh, were used as 
positive controls.   
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Hprt1, Pparg, and Gapdh primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
30 Annealing 58 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Eef2, Runx2, Alpl, and Cebpa primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
35 Annealing 58 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Glut4 primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
40 Annealing 56 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Osteocalcin primers (both sets): 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
40 Annealing 58 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Table 3.1: PCR reaction conditions 
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3.2.2.3. Gel electrophoresis 
See section 2.3.4. 
3.2.2.4. Quantitative PCR 
See section 2.3.5. 
3.2.3. Statistical analysis 
Statistical analysis was performed as described in section 2.3.7. Data were expressed as 
mean ± standard deviation; the number of repeat assays is indicated by “n”. Two-sided 
Student’s t-tests (parametric), two-sided Wilcoxon tests and two-sided Welch’s t-tests 
(non-parametric) were used when basal medium was compared with adipogenic 
medium, i.e. when investigating the effects of the length of adipogenic treatment, the 
effects of seeding density (when comparing matching seeding densities), and when 
assessing the final adipogenic protocol (amount of Oil Red O stain and qRT-PCR 
analysis). Kruskal-Wallis tests (with Dunn post-hoc analysis) and Welch’s anova (with 
Games-Howell post-hoc analysis) were used when investigating the effects of seeding 
density (comparing the amount of Oil Red O between the various seeding densities in 
basal or adipogenic medium) and the effects of insulin. P values lower than 0.05 were 
considered as statistically significant. The calculations were performed using the R 
software (https://www.r-project.org/, version 3.5.3). 
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3.3. Results 
3.3.1. Length of treatment 
To determine the length of treatment that would allow a difference to be detected 
between cells cultured with basal medium and cells cultured with adipogenic medium, 
7F2 cells were seeded on 12-well plates and cultured for 2, 4 or 7 days, then stained 
with Oil Red O. Photographs were taken daily at 200x magnification under a 
microscope; figure 3.1.A shows photographs of 7F2 cells after 2, 4 or 7 days, before and 
after Oil Red O staining. Oil Red O was extracted and quantified by measuring the 
absorbance at 490 nm with a spectrophotometer (figure 3.1.B). Lipid droplets were 
already visible after 2 days of culture with adipogenic medium but were too small to 
cause a significant difference in the amount of Oil Red O (p = 0.661; two-sided Student’s 
t-test; n = 1 with 3 replicates per condition); the mean absorbance was quite high in 
both conditions (> 0.15) despite the absence of large lipid droplets, due to the presence 
of extracellular Oil Red O crystals. At 4 and 7 days, the amount of Oil Red O was higher 
in the wells of cells cultured with adipogenic medium compared with basal medium, 
although the difference was not statistically significant (day 4: p = 0.114 and day 7: p = 
0.058; two-sided Student’s t-test, n = 1 with 3 replicates per condition).  
3.3.2. Seeding density has a strong effect on adipogenic trans-differentiation 
7F2 cells were seeded at four different densities: 2500, 5000, 7500 or 10 000 cells/cm². 
Figure 3.2.A shows pictures of cells after 2, 4 and 7 days of adipogenic treatment. After 
2 days of culture, multiple small lipid droplets could be seen in several cells in the wells 
with seeding densities of 7500 and 10 000 cells/cm² while being relatively rare in wells 
with seeding densities of 2500 and 5000 cells/cm². The amount and size of lipid 
droplets seemed to increase more rapidly in higher seeding densities, particularly at 
7500 and 10 000 cells/cm², during the rest of the treatment. Oil Red O staining showed 
the presence of large lipid droplets inside the cells, particularly at higher densities 
(figure 3.2.B). There was no significant difference in the amount of Oil Red O in cells 
cultured with basal medium between the various seeding densities (p = 0.3829, n = 2, 3 
replicates per condition, Kruskal-Wallis and Dunn tests). The amount of ORO increased 
with higher seeding density when the cells were cultured with adipogenic medium, but 
this increase was not statistically significant (p = 0.2756, n = 2, Kruskal-Wallis and 
Dunn tests) (figure 3.2.C). For identical cell seeding densities, the amount of Oil Red O 
was significantly higher in adipogenic medium compared with basal medium for 2500 
cells/cm² (p = 0.038, n = 2, two-sided Student’s t-test); 7500 cells/cm² (p = 0.015, n = 2, 
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two-sided Wilcoxon test); and 10000 cells/cm² (p = 0.013, n = 2, two-sided Wilcoxon 
test) (figure 3.2.D).  
When the cells were not well distributed within the wells – thus creating areas of 
higher cell density and areas of lower cell density – the efficiency of adipogenic 
differentiation varied greatly (figure 3.2.E). In areas where cell density was higher from 
the beginning of the treatment, lipid droplets appeared sooner and increased in size 
and number more rapidly than in the rest of the well, regardless of the number of cells 
over the whole well.  
3.3.3. Insulin failed to further stimulate adipogenic trans-differentiation 
Among the various adipogenic cocktails that can be found in the literature, some 
contain insulin to help promote and maintain adipocyte proliferation and 
differentiation (Scott et al., 2011). Therefore, the effect of insulin on adipogenic 
differentiation of 7F2 cells was tested. 7F2 cells were cultured with basal medium 
(BM), adipogenic medium (AM), or adipogenic medium with 5 µg/ml insulin (AM + Ins) 
(Molchadsky et al., 2013; Zhang et al., 2013; Bozec and Hannemann, 2016; Meyer et al., 
2016) (figure 3.3). Photographs were taken daily to monitor the emergence of lipid 
droplets at 200x magnification under a microscope; figure 3.3.A shows photographs 
taken after 3, 5 and 7 days of culture. Lipid droplets began to appear at day 2-3 of 
culture in the cells cultured with adipogenic medium in the presence and in the absence 
of insulin. The cells were stained using Oil Red O after 7 days of culture (figure 3.3.B). 
There was no visible difference in the size and number of lipid droplets in cells cultured 
with adipogenic medium in presence or in absence of insulin. The amount of Oil Red O 
was lower by 24% in cells cultured with adipogenic medium + insulin compared with 
adipogenic medium alone but the difference was not statistically significant (p = 0.4, n = 
6, 2-3 replicates per condition, Kruskall-Wallis test and Dunn post-hoc analysis) 
(figures 3.3.C and D).  
3.3.4. Adipogenic treatment: final protocol 
3.3.4.1. Adipogenic treatment increases lipid content and decreases cell number 
7F2 cells were seeded at 2500 cells/cm² and cultured for 7 days with basal or 
adipogenic medium. Figure 3.4.A shows photographs of 7F2 at days 2, 4 and 7 of 
culture. Adipogenic treatment induced the apparition of small lipid droplets after 2 
days of culture; these droplets increased in size and number as the treatment 
continued. No lipid droplet was observed in cells cultured with basal medium. These 
observations were confirmed by Oil Red O staining (figure 3.4.B) and quantification of 
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staining (figure 3.4.C): the amount of Oil Red O staining was significantly higher in wells 
treated with adipogenic medium (0.17 ± 0.14) compared with basal medium (0.07 ± 
0.05; p = 0.02, n = 17; two-sided Welch’s t-test). This was also the case when Oil Red O 
quantification was normalised to basal medium for each repeat (p = 0.0003, n = 17; 
two-sided Welch’s t-test): the amount of Oil Red O was 135% higher in cells cultured 
with adipogenic medium compared to cells cultured with basal medium. After 7 days of 
culture, the number of cells was 80% lower in wells cultured with adipogenic medium 
compared with basal medium (p < 0.0001, n = 5; two-sided Welch’s t-test) (figure 
3.4.D). 
3.3.4.2. mRNA expression levels of adipogenic markers increase while mRNA 
expression levels of osteoblastic markers decrease 
To confirm that 7F2 cells differentiated into adipocytes, the mRNA expression of 
several adipocytic markers – PPARγ, C/EBPα, and Glut4, which is a target of C/EBPα 
(Moseti et al., 2016) – as well as several osteoblastic markers – osteocalcin, Runx2, and 
ALP – were analysed by RT-PCR (figure 3.5.A). A band of the expected size was detected 
for each differentiation marker. When 7F2 cells were treated with adipogenic medium, 
the bands corresponding to the PCR products of two adipocytic markers, PPARγ and 
C/EBPα, seemed to be more intense; Glut4 mRNA was barely detected in 7F2 cells 
cultured with basal medium but it was much more visible for cells treated with 
adipogenic medium. On the contrary, the band corresponding to the osteoblastic 
marker Runx2 PCR product seemed to be less intense for 7F2 cells cultured with 
adipogenic medium compared to cells cultured with basal medium. The bands 
corresponding to osteocalcin PCR products were faint (figure 3.5.A). The reverse 
primer of the first set of primers was located in intron 3, which can be retained in the 
mRNA (GenBank: BC069910.1) (Mammalian Gene Collection (MGC) Program Team, 
2002). Another reverse primer located in exon 4 was designed (figure 3.5.B); the band 
corresponding to the expected size (178 bp, with no intron retention) was more 
intense in cells treated with basal medium compared with adipogenic medium. Another 
faint band of ~ 450 bp was observed; it seemed to correspond to the band that was 
detected using the first set of primers and that retains intron 3.  
The mRNA expression of differentiation markers was also analysed by quantitative PCR 
(figures 3.5.C and D). PPARγ mRNA expression was significantly higher in cells cultured 
with adipogenic medium (fold change = 5.46 ± 0.22) compared to cells cultured with 
basal medium (p = 0.024, n = 2, two-sided Welch’s t-test). Similarly, C/EBPα mRNA 
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expression was higher in cells cultured with adipogenic medium (fold change = 25.3 ± 
0.21) compared to cells cultured with basal medium (p = 0.0048, n = 2, two-sided 
Welch’s t-test). The mRNA expression of the osteoblastic markers was not significantly 
lower in cells treated with adipogenic medium.  
Figure 3.6 shows PCR data with no RT controls. No RT controls were not available for 
all samples. No band was observed in these gels, except very faint bands that 
correspond to probable dimers of primers (< 100 bp).   
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3.4. Discussion 
3.4.1. Adipogenic differentiation of 7F2 cells 
The aim of this chapter was to optimise the protocol to differentiate 7F2 cells into 
adipocytes, in a way that would allow detecting either a stimulatory or an inhibitory 
effect of ghrelin or other pharmacological modulators in future experiments. Culturing 
the cells for 7 days, with a seeding density of 2500 cells/cm² and changing the medium 
every 2-3 days, seemed to trigger a relatively efficient adipogenic differentiation, while 
still leaving room for a possible stimulatory effect of ghrelin or other pharmacological 
modulators. Adipogenic medium induced the apparition of lipid droplets inside the 
cells, significantly upregulated the mRNA expression of several adipocytic markers 
(PPARγ and C/EBPα) but did not significantly downregulate osteoblastic markers. 
Altogether, these results indicated that our model, the 7F2 cell line, reliably 
differentiated into adipocytes when cultured with dexamethasone and indomethacin. 
The adipogenic medium used here was similar to the one used by the team that isolated 
7F2 cells from p53-/- mice (Thompson et al., 1998), since it contained indomethacin and 
dexamethasone. However, it was not supplemented with ascorbic acid, which was 
reported to accelerate conversion to fat: ascorbic acid was already present in basal 
medium, at the same concentration as the one used by Thompson et al. (1998).  
Oil Red O staining, while allowing lipid droplets to be detected by staining them in red, 
did not seem to be an accurate technique to detect small differences in the amount of 
lipid droplets; there were often many Oil Red O crystals (precipitates) in the wells, 
which created a high background noise. These crystals proved impossible to get rid of 
despite several washings; and they tended to accumulate even more when there were 
many cells in the wells, particularly in wells containing basal medium in comparison 
with adipogenic medium. Filtering the solution twice instead of once helped a little but 
there did not seem to be enough staining left, as the color of the stained lipid droplets 
was closer to orange/pale red than to the bright red usually observed. The older the 
solution, the more Oil Red O crystals there were, so a fresh solution was prepared for 
each staining assay.  
The osteoblastic markers osteocalcin, Runx2 and ALP were still expressed in the cells 
cultured with adipogenic medium. This is probably due to the fact that the cells did not 
all differentiate into adipocytes; there were still many osteoblast-like cells, which 
looked fibroblastic with no visible lipid droplets. ALP expression did not seem to be 
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affected by adipogenic medium, which is consistent with the observations of Thompson 
et al. that the 7F2 cell-derived adipocytes did not lose ALP expression (Thompson et al., 
1998). Interestingly, two of the tested adipocytic markers were expressed at the mRNA 
levels in 7F2 cells cultured with basal medium, the adipogenic transcription factors 
PPARγ and C/EBPα. However, Glut4, which is a target of C/EBPα (Moseti et al., 2016), 
was barely detected in 7F2 cells cultured with basal medium. C/EBPα, despite being 
expressed at the mRNA level in these cells, may not be expressed at the protein level, or 
not at a high enough level to activate the transcription of Glut4.  
3.4.2. Chapter conclusions 
The objective of this chapter was to optimise the protocol to differentiate 7F2 cells into 
adipocytes, in a way that would allow detecting either a stimulatory or an inhibitory 
effect of ghrelin or other pharmacological modulators in future experiments. Optimum 
conditions for adipogenic differentiation which met the criteria for my experiments 
were an adipogenic medium containing dexamethasone and indomethacin, but without 
insulin, at a seeding density of 2500 cells/cm². Having optimised the protocol to 
differentiate 7F2 cells into adipocytes, the next step was to investigate whether these 
cells expressed genes from ghrelin signalling.  
Chapter 3 – Protocol optimisation for the differentiation of murine 7F2 osteoblast-like cells into adipocytes 
61 
 
 
Figure 3.1: Oil Red O staining and quantification after 2, 4 and 7 days of treatment  
(part 1) 
7F2 cells were seeded on 12-well plates, cultured with basal (BM) or adipogenic medium (AM) for 2, 4 or 7 days, then stained with Oil Red O. A: 
Photographs taken before and after Oil Red O staining.  
Chapter 3 – Protocol optimisation for the differentiation of murine 7F2 osteoblast-like 
cells into adipocytes 
62 
 
 
Figure 3.1: Oil Red O staining and quantification after 2, 4 and 7 days of treatment  
(part 2) 
B: Quantification of Oil Red O by measuring the absorbance at 490 nm (n = 1 with 3 samples per 
condition; two-sided Student’s t-tests); data are mean absorbance ± SD.  
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Figure 3.2: Effect of seeding density on the trans-differentiation of 7F2 cells (part 1) 
7F2 cells were seeded at four different densities (2,500, 5,000, 7,500 and 10,000 cells/cm²) and 
cultured for 7 days with basal (BM) or adipogenic medium (AM). Photographs of the cells were 
taken daily at 200x magnification under a microscope; photographs after 2, 4 and 7 days are 
shown in A.  
 
A 
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Figure 3.2: Effect of seeding density on the trans-differentiation of 7F2 cells (part 2) 
B: Photographs of the cells stained with Oil Red O after 7 days of culture. C: Oil Red O was 
extracted and absorbance was measured with a spectrophotometer at 490 nm to quantify the 
amount of stain; the graph shows the mean absorbance for each culture media and seeding 
density ± SD (n = 2, with  3 replicates per condition in each assay; Kruskal-Wallis tests and Dunn 
post-hoc analyses).  
 
B 
C 
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Figure 3.2: Effect of seeding density on the trans-differentiation of 7F2 cells (part 3) 
D: Separate mean absorbance for each seeding density, comparing cells cultured with basal 
medium (BM) to cells cultured with adipogenic medium (AM) (n=2, with 3 replicates per 
condition in each assay; 2,500 cells/cm²: two-sided Student’s t-test; 5,000 cells/cm², 7,500 
cells/cm² and 10,000 cells/cm²: two-sided Wilcoxon tests).  
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Figure 3.2: Effect of seeding density on the trans-differentiation of 7F2 cells (part 4) 
E: Photographs showing the effect of local density within the wells, without and with Oil Red O 
staining. Cell density could vary greatly within the wells. 
 
  
E 
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Figure 3.3: Effects of 5 µg/ml insulin on adipogenic differentiation (part 1) 
A: Photographs of 7F2 cells cultured with basal medium (BM), adipogenic medium (AM; 
containing dexamethasone and indomethacin), or adipogenic medium + 5 µg/ml insulin (AM + 
Ins; containing dexamethasone, indomethacin and insulin), after 2, 4 and 7 days of culture. B: 
Photographs of 7F2 cells stained with Oil Red O after 7 days of culture with basal medium (BM), 
adipogenic medium (AM) or adipogenic medium + insulin (AM + Ins). Photographs were taken 
at 200x magnification.  
B 
A 
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Figure 3.3: Effects of 5 µg/ml insulin on adipogenic differentiation (part 2) 
C: Quantification of Oil Red O staining by measuring the absorbance at 490 nm (n = 6; 2-3 
replicate samples per condition for a total of 13 replicates per condition; Welch’s anova and 
Games-Howell post-hoc analysis). D: Quantification of Oil Red O staining, normalised to basal 
medium (n = 6; 2-3 replicate samples per condition, for a total of 13 replicates per condition; 
Kruskal-Wallis test and Dunn post-hoc analysis). Data are mean absorbance ± SD. 
  
C 
D 
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Figure 3.4: Effect of adipogenic treatment on 7F2 cell lipid content and cell number 
(part 1) 
A: Photographs of 7F2 cells cultivated with basal medium (BM) or adipogenic medium (AM) at 
days 2, 4 and 7.  
A 
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Figure 3.4: Effect of adipogenic treatment on 7F2 cell lipid content and cell number (part 2) 
B: Photographs of 7F2 cells stained with Oil Red O after 7 days of culture with basal or adipogenic medium. 
B 
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Figure 3.4: Effect of adipogenic treatment on 7F2 cell lipid content and cell number 
(part 3) 
C: Quantification of Oil Red O staining by measuring the absorbance at 490 nm; raw data and 
data normalised to basal medium (n = 17, with 2-3 replicates per condition in each assay; two-
sided Welch’s t-tests). D: Number of cells cultivated with basal medium or adipogenic medium 
for 7 days; raw data and data normalised to basal medium (n = 5, with 1-2 replicate samples per 
condition in each assay; two-sided Welch’s t-tests). Cells were counted using Trypan Blue. Data 
are mean absorbance or mean number of cells ± SD. 
D 
C 
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Figure 3.5: Effect of adipogenic medium on the mRNA expression of differentiation 
markers (part 1) 
A: RT-PCR for PPARγ, C/EBPα, Glut4 (adipocytic markers); osteocalcin (first set of primers), 
Runx2 and ALP (osteoblastic markers).  
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Figure 3.5: Effect of adipogenic medium on the mRNA expression of differentiation 
markers (part 2) 
B: RT-PCR for osteocalcin (second set of primers). C: qRT-PCR data for C/EBPα and PPARγ (n = 
2, 3 replicate samples per condition in each assay; each sample was run in duplicate). Data are 
mean Ct ± SD (left graphs; two-sided Wilcoxon test for C/EBPα; two-sided Welch’s t-test for 
PPARγ), and fold change ± SD (right graphs; two-sided Welch’s t-tests); the relative fold 
expression was normalised by the reference gene EEF2. RNA was extracted from 7F2 cells 
cultured for 7 days with basal medium or with adipogenic medium.   
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Figure 3.5: Effect of adipogenic medium on the mRNA expression of differentiation 
markers (part 3) 
D: qRT-PCR for osteocalcin, Runx2 and ALP (n = 2, with 3 replicate samples per condition in 
each assay; each sample was run in duplicate). Data are mean Ct ± SD in graphs on the left (two-
sided Welch’s t-test for osteocalcin, two-sided Student’s t-test for Runx2 and two-sided 
Wilcoxon test for ALP), and fold change ± SD in graphs on the right (two-sided Student’s t-test 
for osteocalcin; two-sided Welch’s t-tests for Runx2 and ALP); the relative fold expression was 
Chapter 3 – Protocol optimisation for the differentiation of murine 7F2 osteoblast-like 
cells into adipocytes 
75 
 
normalised by the reference gene EEF2. RNA was extracted from 7F2 cells cultured for 7 days 
with basal medium or with adipogenic medium.   
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 Figure 3.6: No RT controls for differentiation markers 
RT-PCR for PPARγ, C/EBPα, Glut4 (adipocytic markers); osteocalcin (first set of primers), Runx2 
and ALP (osteoblastic markers) with no RT controls. 
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4.1. Introduction 
4.1.1. Ghrelin: one gene that encodes a variety of peptides 
4.1.1.1. Structure of the ghrelin gene 
The structure of the mouse ghrelin gene was described by Tanaka et al. (2001a) using 
ghrelin cDNA cloned from the stomach; it contains five exons (Ex1-Ex5) and four 
introns (In1-In4) (Tanaka et al., 2001a). The first exon is short and contains only 19 bp, 
which encode part of the 5’UTR (untranslated region). Exons 2 to 5 encode 
preproghrelin which is 117 amino acid-long, which contains a 23-amino-acid signal 
peptide encoded by exon 2. The signal peptide is cleaved from preproghrelin, giving 
rise to proghrelin. Proghrelin is acylated, then transported to the Golgi (Zhu et al., 
2006), where it is cleaved to generate two peptides: 28-amino-acid mature ghrelin, 
encoded by exons 2 and 3; and 23-amino-acid obestatin, encoded by exon 4 and a few 
nucleotides from exon 5 (figure 4.1) (Kojima and Kangawa, 2005; Yang et al., 2008). 
The enzyme PC1/3 (proprotein convertase, also called prohormone convertase) is 
required for the conversion of preproghrelin to mature ghrelin and obestatin; PC1/3 
generates the C-terminus of mature ghrelin by cleaving after Arg28 of proghrelin (Zhu 
et al., 2006). PC1/3 has been shown to be expressed in rats, in the pituitary, the 
hypothalamus (Nillni, 2007; Dong and Day, 2013) and the gastrointestinal tract (Macro 
et al., 1996), which also produce ghrelin.  
Ghrelin is extremely well conserved in mammals; ghrelin homologues have been 
identified in human, rhesus monkey, rat, mouse, Mongolian gerbil, cow, pig, sheep and 
dog. The sequences of the gene and its promoter are well conserved. In particular, the 
first 10 residues are identical in mammals, and the sequence of the mature peptide 
from rats and mice differs by two amino acids from human ghrelin (Davenport et al., 
2005; Kojima and Kangawa, 2005). The first five residues of mature ghrelin play a 
central role in the activity of the peptide, particularly the Ser3 residue which can be 
acylated; acylation is necessary for ghrelin to bind to its receptor GHSR1a in 
hypothalamus and pituitary, regulating GH secretion, food intake and energy stores 
(Kojima and Kangawa, 2005). 
In humans, the ghrelin gene also contains five exons, named exon 0 to exon 4 (Ex0-
Ex4), and four introns. The short first exon contains only 20 bp and encodes part of the 
5’UTR. There are two different transcriptional initiation sites in the ghrelin gene; one at 
80 bp and the other at 555 bp upstream of the ATG codon, giving rise to two distinct 
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mRNA transcripts, transcript-A and transcript-B. Transcript-A, which is an alternative 
splicing product from exon 1 to exon 4, is the main form of human ghrelin mRNA in 
vivo; it is translated into 117-amino acid preproghrelin. 28-amino-acid ghrelin is 
encoded by exons 1 and 2. Exons 2, 3 and 4 encode for 66-amino-acid C-ghrelin (C-
terminal peptide of ghrelin), which contains 23-amino-acid obestatin. Obestatin is 
entirely encoded by exon 3 (Seim et al., 2007).  
 
 
Figure 4.1: From the mouse ghrelin gene to mature peptide 
Asterisk indicates the Ser3 residue acylated by Ghrelin O-acyltransferase (GOAT). 
4.1.1.2. Alternative splicing of the ghrelin gene 
Alternative splicing is a mechanism through which a single gene can give rise to 
multiple transcripts. It contributes significantly to protein diversity in humans and 
mice, generating multiple proteins that can play important roles in regulating 
physiological processes. Aberrant alternative splicing is often involved in 
pathophysiological processes, particularly in cancers, generating altered proteins that 
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promote carcinogenesis (Venables et al., 2009; David and Manley, 2010; Pal et al., 
2012).  
The ghrelin gene is complex and generates multiple peptides in addition to ghrelin and 
obestatin, by alternative splicing (Hosoda et al., 2000b; Tanaka et al., 2001a; Jeffery et 
al., 2002; Kawamura et al., 2003; Jeffery et al., 2005a). A number of transcript variants 
have been identified in humans, sheep, rats and mice. Some of these variants are 
conserved between multiple species, suggesting the existence of mammalian-specific 
alternative splicing of the ghrelin gene and that these ghrelin gene-derived transcripts 
are functional (Seim et al., 2016).  
For example, In1-ghrelin is a variant that contains Ex0-1, In1, and Ex2 but lacks Ex3-4, 
which shifts the reading frame of this transcript. This variant has been identified in 
various human tissues (Genbank #GU942497) including thymus, testis, kidney, 
stomach, uterus, brain, and mammary tissues (Gahete et al., 2011). It has also been 
identified in Olive baboons (Genbank #HM048926) (Gahete et al., 2011). It may encode 
a propeptide that retains the first 36 amino acids of native preproghrelin, including the 
signal peptide and the first 12 amino acids of native ghrelin, but has a different C-
terminal tail that does not produce obestatin. The Ser3 residue that can be acylated by 
GOAT in native ghrelin is retained in this variant sequence, and the expression level of 
In1-ghrelin mRNA seem to correlate strongly with those of GOAT, suggesting that it 
could be a substrate for this enzyme. In1-ghrelin may play a role in the pathophysiology 
of cancer (Gahete et al., 2011). 
Another variant, In2-ghrelin, has been identified in mice (Genbank #DQ993169). It has 
a completely different structure containing Ex2, In2, and Ex3; Ex1, Ex4 and Ex5 are 
absent from this variant. Interestingly, the sequence of In2 varied from that originally 
reported by Tanaka et al. (2001a) (Genbank #AB060078), with eight TG repeats in 
tandem in the middle of the In2, instead of seven. Since Ex1 is absent from this variant 
and has been identified as a 5’UTR, its exclusion would not modify the predicted start 
codon of In2-ghrelin. This transcript variant contains a putative peptide that retains the 
first 36 amino acids of native preproghrelin including the five first residues of native 
ghrelin (GSSFL), and a novel 19 amino-acid C-terminal tail encoded by In2 
(VSQSVSLSPHIYPDLCVCV). Since exons 4 and 5 are missing, obestatin is probably not 
produced.  
In2-ghrelin mRNA was not detected in the stomach extracts but was expressed in the 
pituitary and hypothalamus, and seemed to be dependent on energy intake, suggesting 
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that this transcript may encode a peptide that plays an important role in coordinating 
the neuroendocrine response to metabolic stress. This peptide may be acylated and 
bind GHSR1a as it retains the first five residues of native ghrelin, and pituitary GOAT 
expression seemed to parallele the changes on In2-ghrelin expression (Gahete et al., 
2010). 
A number of other variants have been identified, such as ghrelin gene-derived 
transcript (GGDT) (Tanaka et al., 2001b), Des-Gln14-ghrelin (Hosoda et al., 2000b; 
Kojima and Kangawa, 2005), In2c-ghrelin (Seim et al., 2013), exon 2-deleted 
preproghrelin (Seim et al., 2016), or exon 3-deleted proghrelin (Jeffery et al., 2002, 
2005b; Yeh et al., 2005). 
4.1.2. Chapter hypothesis, objectives and experimental strategies 
The chapter hypothesis is 1) that 7F2 osteoblast-like cells and 7F2 cell-derived 
adipocytes express the key genes from ghrelin signalling (presented in Chapter 1, 
section 1.4.1), i.e. Ghrl, Ghsr and Mboat4, at the mRNA level, and 2) that ghrelin 
treatment exerts some feedback on their expression levels.  
The objectives of this chapter were to investigate the expression of Ghrl, Ghsr and 
Mboat4 using RT-PCR analysis in 7F2 cells cultured with basal or adipogenic medium. 
qRT-PCR was used to quantify the expression levels of these three genes, and to assess 
the effects of ghrelin treatment on these, in 7F2 cells cultured with basal or adipogenic 
medium and treated with two different concentrations of ghrelin (20 nM and 200 nM). 
RT-PCR and sequencing were used to investigate the structure of Ghrl mRNA isoforms 
expressed in 7F2 osteoblast-like cells and 7F2 cell-derived adipocytes, using various 
sets of primers spanning the gene sequence.  
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4.2. Materials and Methods 
4.2.1. Adipogenic differentiation and ghrelin treatment of 7F2 cells 
7F2 cells were seeded at a density of 2500 cells/cm² and cultured with basal and 
adipogenic medium as described in section 2.1., and treated with 20 nM or 200 nM 
ghrelin (Cambridge Bioscience) for 7 days. After 7 days of culture, 7F2 cells were 
stained with Oil Red O as described in section 2.1. 
4.2.2. Molecular biology 
4.2.2.1. RNA extraction, DNAse treatment and reverse transcription 
See sections 2.3.1 and 2.3.2.  
4.2.2.2. PCR 
4.2.2.2.1. Oligonucleotide primers: house-keeping and ghrelin signalling genes 
See sections 8.1.1., 8.1.3. and 8.1.4. 
4.2.2.2.2. PCR reaction compositions and conditions 
The PCR reaction composition is described in section 2.3.3. The PCR reaction conditions 
were optimised and are detailed in table 4.1. Nuclease-free water was used as a 
negative control and three house-keeping genes, Hprt1, Eef2 and Gapdh, were used as 
positive controls.   
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Hprt1 and Gapdh primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
30 Annealing 58 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Eef2, Ex 1 – Ex 3, Ex 2 – In 2 (both sets of primers), and Ex 2 – Ex 3 primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
35 Annealing 58 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Ex 3 – Ex 4 and Ex 4 – Ex 5 primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
40 Annealing 56 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Table 4.1: PCR reaction conditions 
4.2.2.3. Gel electrophoresis 
See section 2.3.4. 
4.2.2.4. Gel extraction of PCR products and sequencing 
See section 2.3.6. PCR reactions were performed as described above (section 4.2.2.2.2), 
but with 50-55 cycles instead of the usual 30-40 cycles, to increase the number of 
copies. 
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4.2.2.5. Quantitative PCR 
See section 2.3.5.  
4.2.3. Statistical analysis 
Statistical analysis was performed as described in section 2.3.7. Data were expressed as 
mean ± standard deviation; the number of repeat assays is indicated by “n”. In qRT-PCR 
experiments, ANOVA tests (with Tukey-Kramer post-hoc analysis), Kruskal-Wallis tests 
(with Dunn post-hoc analysis) and Welch’s anova (with Games-Howell post-hoc 
analysis) were used to compare the expression levels of the GOIs between the 
experimental conditions, using the raw CT values and fold changes. P values lower than 
0.05 were considered as statistically significant. The calculations were performed using 
the R software (https://www.r-project.org/, version 3.5.3). 
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4.3. Results 
4.3.1. 7F2 cells express Ghrl, Ghsr, and Mboat4 
mRNA was extracted from 7F2 cells cultured for 7 days with basal or adipogenic 
medium. RT-PCR analysis was performed for three genes: Ghrl, Ghsr and Mboat4 (figure 
4.2). A band of the expected size was detected for Mboat4 (240 bp) and Ghsr (215 bp), 
both in 7F2 cells and 7F2 cells treated with adipogenic medium. However, for the 
ghrelin gene, only a faint band of the expected size (220 bp) could be observed; there 
was a much more intense band which was about 90 bp longer than the expected size 
(figure 4.2.A). Since the primers were located on exon 2 and exon 3, this longer band 
could retain intron 2, which has been reported to be 93 bp long (Tanaka et al., 2001a), 
or 95 bp long (Kineman et al., 2007). No band was observed for the no RT controls 
(figure 4.2.B), confirming that the cDNA samples were not contaminated with genomic 
DNA. 
4.3.2. mRNA expression of ghrelin signalling system is responsive to adipogenic 
medium and exogenous ghrelin 
mRNA was extracted from 7F2 cells cultured for 7 days with basal or adipogenic 
medium, with or without 20 nM or 200 nM ghrelin. qRT-PCR analysis was performed 
for three genes: Ghrl (figure 4.3), Ghsr (figure 4.4) and Mboat4 (figure 4.5). Data were 
normalised to two house-keeping genes: HPRT1, which is commonly used for qPCR 
analysis, and EEF2, which has been shown to have similar expression levels in many 
tissues, including bone and fat tissues (Kouadjo et al., 2007).  
For Ghrl, the mean Ct was significantly lower in cells cultured with basal medium + 200 
nM ghrelin (24.45 ± 0.49) compared to basal medium alone (26.95 ± 2.05; p = 0.015, n 
= 2, 3 replicates per condition, Welch’s anova and Games-Howell post-hoc analysis). 
Similarly, the mean Ct was lower in cells cultured with adipogenic medium + 200 nM 
ghrelin (24.27 ± 0.69) compared with adipogenic medium alone (26.30 ± 1,78;  p = 
0.032, n = 2, 3 replicates per condition, Welch’s anova and Games-Howell post-hoc 
analysis) (figure 4.3.B). In data normalised to HPRT1, Ghrl mRNA levels were higher in 
cells cultured with basal medium + 200 nM ghrelin (144.84 ± 0.58) compared with 
basal medium alone (1 ± 0.73; p = 0.0102, n = 2, Kruskal-Wallis test and Dunn post-hoc 
analysis) and compared with basal medium + 20 nM ghrelin (104.21 ± 0.23; p = 
0.0141). Similarly, Ghrl mRNA levels were higher in cells cultured with adipogenic 
medium + 200 nM ghrelin (123.07 ± 0.33) compared with adipogenic medium alone 
Chapter 4 – 7F2 osteoblast-like cells and 7F2 cell-derived adipocytes express Ghsr, 
Mboat4 and several isoforms of Ghrl 
 
86 
 
(0.79 ± 0.40; p = 0.0089) and compared with adipogenic medium + 20 nM ghrelin 
(111.04 ± 0.15; p = 0.0152). When data was normalised to EEF2, Ghrl mRNA levels 
were higher in cells cultured with basal medium + 200 nM ghrelin (15.07 ± 0.44) 
compared with basal medium alone (1 ± 0.65; p = 0.0072, n = 2, Kruskal-Wallis test and 
Dunn post-hoc analysis), and they were also higher in adipogenic medium + 200 nM 
ghrelin (18.79 ± 0.47) compared with adipogenic medium alone (1.91 ± 0.20; p = 
0.0161). However, there was no significant difference between basal medium + 20 nM 
ghrelin and basal medium + 200 nM ghrelin, or between adipogenic medium + 20 nM 
and adipogenic medium + 200 nM ghrelin. 
Ct values were high (> 30) for Ghsr and Mboat4, indicating that their mRNA expression 
levels were low (figures 4.4.A, 4.4.B, 4.5.A and 4.5.B). There was no significant 
difference in their expression levels between basal and adipogenic medium alone 
(figures 4.4.C and 4.5.C). However, when treating the cells with 20 nM or 200 nM 
ghrelin, the results were contradictory depending on which house-keeping gene 
expression was normalised to. There was no significant difference in the fold changes 
for both Ghsr (normalised to HPRT1: p = 0.09; normalised to EEF2: p = 0.075, Welch’s 
anova tests) and Mboat4 (normalised to HPRT1: p = 0.054, ANOVA test; normalised to 
EEF2: p = 0.087, Kruskal-Wallis test).  
4.3.3. Identification of ghrelin variant expressed in 7F2 cells 
4.3.3.1. Ghrelin mRNA retains several introns in 7F2 cells 
Since 7F2 osteoblast-like cells and 7F2 cell-derived adipocytes express a variant 
isoform of ghrelin, the next stage of this study consisted of characterising the structure 
of this variant, using RT-PCR analysis with several combinations of primers spanning 
the various exons of Ghrl. Figure 4.6 shows the agarose gels corresponding to various 
combinations of primers.  
RT-PCR with primers located on exon 1 and exon 3 (Ghrl30_E1f - Ghrl753_E3r) 
revealed the presence of 4 bands; 3 of these bands were present in all the treatments, 
while the fourth was only visible when the cells were treated with ghrelin. The smaller 
band corresponded to 199 bp, which may contain exon 1, intron 2 and exon 3. The 
larger bands corresponded to 648 bp, which may contain exon 1, intron 1, exon 2 and 
exon 3; and 741 bp, which may contain exon 1, intron 1, exon 2, intron 2 and exon 3. 
The fourth band, which was ~400 bp long, may contain exon 1, exon 2, intron 2 and 
exon 3, although in theory this PCR product should be 332 bp long. The 199 bp and 741 
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bp bands were more intense when the cells were treated with 200 nM ghrelin 
compared with cells cultured with basal or adipogenic medium alone. 
RT-PCR with primers located on exon 2 and exon 3 (Ghrl458_E2f - Ghrl753_E3r) 
showed two bands, as in previous experiments. The smaller bands corresponded to 
exon 2 and exon 3 (220 bp) while the longer bands retained intron 2. The longer band 
was much more intense in 7F2 cells treated with 200 nM ghrelin compared with cells 
cultured with basal or adipogenic medium alone. On the contrary, the smaller band was 
fainter in cells treated with 200 nM ghrelin. 
RT-PCR with primers located on exons 3 and 4 (Ghrl698_E3f - Ghrl2752_E4r) did not 
detect any band for 7F2 cells cultured with basal or adipogenic medium; but a very 
faint band corresponding to the expected size (126 bp) was detected for 7F2 cells 
treated with 200 nM ghrelin. Using a forward primer spanning the end of exon 3 and 
the beginning of exon 4, coupled with a reverse primer on exon 5, showed the presence 
of 2 bands; the small one corresponded to 146 bp, which may contain exons 3, 4 and 5; 
and the longer band corresponded to 2088 bp, which may retain intron 3.  
A set of primers was used to detect a PCR product containing exon 2 and intron 2 
(Ghrl458_E2f - Ghrl607_In2r), with a reverse primer located at the beginning of intron 
2. A band corresponding to the expected size (169 bp) was detected. Similarly to the 
other gels, in the presence of 200 nM ghrelin, the band was more intense than in the 
absence of ghrelin treatment. An additional band was detected but it is not known what 
it could correspond to.  
RT-PCR with primers located on exons 4 and 5 (Ghrl2751_E4f - Ghrl3657_E5r) showed 
the presence of a 141 bp-long band, which corresponds to exon 4 and exon 5, without 
intron 4, for 7F2 cells cultured with basal and adipogenic medium alone. An additional, 
a faint band was detected for cells treated with 200 nM ghrelin; this band corresponded 
to 924 bp and may contain exon 4, intron 4 and exon 5. Finally, RT-PCR with primers 
located on exons 1 and 4, and exons 1 and 5, did not show any band.  
No band was observed for the no RT controls (figure 4.7). 
To summarise, the presence of exon 1, intron 1, exon 2, intron 2, exon 3, exon 4, intron 
4 and exon 5 were detected at the mRNA level and 7F2 cells and 7F2-cell derived 
adipocytes expressed several variant isoforms of ghrelin. The expression levels of the 
variant isoform(s) were not affected by adipogenic medium, but were upregulated by 
treatment with 200 nM ghrelin in both basal and adipogenic medium.   
Chapter 4 – 7F2 osteoblast-like cells and 7F2 cell-derived adipocytes express Ghsr, 
Mboat4 and several isoforms of Ghrl 
 
88 
 
4.3.3.2. Sequencing data 
PCR products were sequenced to confirm the presence of the various exons and introns 
detected by RT-PCR analysis (see Appendix, section 8.2.).  
The first sequenced PCR product (24BA88) was obtained with primers located on 
exons 1 and 3; sequencing and sequence alignment with the mouse ghrelin gene 
confirmed the presence of intron 1, exon 2, intron 2, and the beginning of exon 3. Here, 
intron 2 contained 8 TG repeats instead of 7, and was 95 bp long. The second 
sequenced PCR product (24BA89) was obtained with primers located on exons 2 and 3; 
sequencing and sequence alignment confirmed the presence of exon 2, intron 2 and 
exon 3. The third sequenced PCR product (24BA90) was obtained with primers located 
on exons 4 and 5; sequencing and sequence alignment confirmed the presence of exon 
4, intron 4 and exon 5. Finally, the fourth sequence PCR product (24BA45) was 
obtained with a forward primer located on the junction between exons 3 and 4, and a 
reverse primer on exon 5; sequencing and sequence alignment also confirmed the 
retention of intron 4. For all the PCR products, the sequencing reaction did not seem to 
be very efficient in the area flanking the primers. 
4.3.4.3. Prediction of protein structure 
The prediction of the protein structure was done on a hypothetical sequence containing 
exon 1, intron 1, exon 2, intron 2, exon 3, exon 4 and exon 5, based on the RT-PCR and 
sequencing data presented in the previous sections. The ExPASy tool predicted four 
open reading frames (ORFs).  
Two ORFs are short, encoding peptides that contain only 15 and 28 amino acids; BLAST 
against existing proteins in mice do not show any significant alignment with existing 
sequences.  
Another ORF encodes a putative 55 amino acid peptide, which retains the signal 
peptide (MLSSGTICSLLLLSMLWMDMAMA) and the first 12 amino acids of native 
ghrelin (GSSFLSPEHQKA) with a novel C-terminal sequence 
(QVSQSVSLSPHIYPDLCVCV). It is encoded by exon 2 and part of intron 2, which 
introduces a new stop codon.  
The last ORF encodes a 46 amino acid putative peptide that would be encoded by exons 
4 and 5 (MLPSMLASSCQELSISSMAGPWGSFFRISSGKRSKRRQLTSNHGQA); this 
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sequence does not align significantly with existing peptides; the ProP 1.0 Server tool 
does not predict any signal peptide, but predicts a cleavage site at Arg36.  
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4.4. Discussion 
The aim of this chapter was to verify if 7F2 osteoblast-like cells and 7F2 cell-derived 
adipocytes expressed the key genes from ghrelin signalling, i.e. Ghrl, Ghsr, and Mboat4, 
at the mRNA level, and to study the effects of ghrelin treatment on the expression levels 
of these genes.  
4.4.1. 7F2 cells express Ghsr, Mboat4, and variant isoforms of Ghrl 
RT-PCR analysis showed that Ghsr, Mboat4 and Ghrl were expressed both in 7F2 
osteoblast-like cells and in 7F2 cell-derived adipocytes. Interestingly, two bands were 
detected for Ghrl, one that was the expected size (220 bp) but was faint, and a much 
more intense band that was about 90 bp longer, suggesting that these cells expressed a 
variant isoform of ghrelin.  
To characterise this variant isoform, RT-PCR analysis was performed with several 
primer sets (Kineman et al., 2007) located on the various exons of the mouse ghrelin 
gene and PCR products were sequenced. Among the various PCR products obtained 
with the primer sets spanning the mouse ghrelin gene, only a few could be sent for 
sequencing; despite 50-55 cycles of PCR, most of the bands that were detected with RT-
PCR analysis were too faint and did not contain enough PCR products for the 
sequencing reaction to work. Sequences are attributed a quality score (Phred score) to 
each base of the sequence. Phred20 means that the base was identified with 99% 
accuracy (error probability of 1:100). Among the PCR products with a high enough 
concentration that were sent for sequencing, only a few had a high overall Phred score. 
N bases correspond to Phred < 10. There are several possible causes for the low Phred 
score. There could have been mutations in the PCR products due to the high number of 
PCR cycles; also, DNA molecules could have been cross-linked due to the use of U.V. 
light during gel extraction, even though the duration of exposure was limited.  
RT-PCR with primers located on exons 1 and 3 showed several bands. The sequence 
obtained for the longer band (741 bp) had a high Phred score overall (> 20 for almost 
all bases) and had a strong identity to the mouse ghrelin gene sequence, so the 
sequencing data seemed reliable. It confirmed the full retention of introns 1 and 2. For 
the PCR product with primers located on exons 2 and 3, the overall Phred score was 
lower, but the sequence still aligned relatively well with the mouse ghrelin gene, 
further confirming the retention of intron 2. Exon 4, intron 4 and exon 5 were also 
detected by RT-PCR analysis. Also, RT-PCR with primers located on exons 3 and 4 did 
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not seem to detect any band. However, results with other primer sets confirmed the 
presence of exons 3 and 4, so intron 3 may be retained, but was too long for the PCR 
reaction to work, as intron 3 is 1972 bp long in the mouse ghrelin gene. Similarly, PCR 
with primers located on exons 1 and 5 did not show any band; this too may be due to 
the fact that the PCR products would have been too long due to the retention of introns, 
especially intron 3. Overall, the data indicate that 7F2 osteoblast-like cells and 7F2 cell-
derived adipocytes expressed several isoforms of ghrelin, one of which contains exon 1, 
intron 1, exon 2, intron 2, exon 3, and may contain exons 4 and 5 as well. Since the PCR 
reaction with primers on exons 1 and 5 did not work, it is difficult to conclude on the 
exact number and structures of variants expressed by these cells. 
Ghrelin is ubiquitously expressed; the highest levels of expression are detected in the 
stomach and intestine (Gnanapavan et al., 2002), but local concentrations in other 
tissues that produce ghrelin may be relatively high. GHSR expression may be more 
restricted, although data on GHSR expression are contradicting; Gnanapavan et al. 
(2002) reported that the highest levels of expression were detected in the pituitary and 
brain, while other tissues such as the stomach, the small intestine, or the liver, had low 
expression levels. Others have reported a wider tissue distribution: GHSR mRNA was 
detected in many organs such as the heart, lung, liver, kidney, pancreas, and adipose 
tissue, indicating that ghrelin may have multiple functions in these tissues (Kojima and 
Kangawa, 2005). Very low GHSR expression levels have been detected in white adipose 
tissue and brown adipose tissue (Sun et al., 2007; Davies et al., 2009; Lin et al., 2011). 
The fact that 7F2 cells and 7F2 cell-derived adipocytes express Ghrl, Ghsr and Mboat4 at 
the mRNA level suggests that they may produce acylated ghrelin, and that this hormone 
may have auto- and/or paracrine effects. This is consistent with previous studies that 
demonstrated that ghrelin, apart from its role in regulating GH release, food intake, 
energy balance and glucose metabolism, also has functions in bone, stimulating 
osteoblast proliferation and differentiation in rats, mice, and humans (Choi et al., 2003; 
Kim et al., 2005; Maccarinelli et al., 2005; Delhanty et al., 2006). Ghrl and Mboat4 mRNA 
expression has been demonstrated in mice by others (Delhanty et al., 2014a; Hopkins et 
al., 2017). Although some studies did not detect GHSR1a mRNA in bone cells from 
human (Delhanty et al., 2006), rat and mouse (Costa et al., 2011), others have detected 
GHSR1a mRNA in osteoblasts from mice (Kim et al., 2005; Delhanty et al., 2014b), rats 
(Fukushima et al., 2005) and humans (Costa et al., 2011). Interestingly, in humans, 
GHSR was only found to be expressed in 25-30% of bone marrow and osteoblasts 
samples (Costa et al., 2011); Ghsr may be expressed by a subpopulation of cells, or 
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expression varies among individuals, which could explain why some studies do not 
detect Ghsr mRNA while others do. Also, acylated ghrelin and unacylated ghrelin were 
shown to induce proliferation of osteoblasts even when GHSR1a expression was not 
detected, suggesting the existence of another receptor (Delhanty et al., 2006). Here, 
Ghsr expression was detected at the mRNA level but the bands were relatively faint in 
comparison to ghrelin, suggesting it may not be highly expressed. This was confirmed 
by qRT-PCR analysis. If ghrelin has an effect on 7F2 cells, it may be mediated by 
another receptor. Finally, of the variant isoforms of ghrelin expressed by 7F2 cells may 
encode for a peptide that retains the first 12 amino acids of native ghrelin, including the 
third serine residue that can be acylated by GOAT; hence, this variant, if expressed at 
the protein level, may be acylated, bind GHSR1a or another receptor, and exert 
biological functions in 7F2 cells. 
Several studies report GHSR-independent effects of acylated ghrelin in various tissues, 
including fat and bone (Thompson et al., 2004; Delhanty et al., 2006; Costa et al., 2011; 
Parsons et al., 2015). Ghrelin is very likely to have other receptors. Unacylated ghrelin, 
which is almost inactive at GHSR1a, has been reported to mimic the effects of acylated 
ghrelin in several tissues, even in the absence of GHSR1a, and acylated ghrelin binding 
seems to be competitively reduced by unacylated ghrelin. Unacylated ghrelin may also 
have specific receptors at which acylated ghrelin is inactive (Callaghan and Furness, 
2014). In addition, GHSR1a and GHSR1b form heterodimers with other GPCRs, which 
have different pharmacological properties and mediate effects on various processes 
such as lipid accumulation, myoblast differentiation, osteoblast proliferation, insulin 
secretion, cardioprotection, and tumour cell proliferation (Callaghan and Furness, 
2014).  
4.4.2. Ghrelin treatment promotes ghrelin mRNA expression 
The aim of this chapter was also to study whether ghrelin treatment affected the mRNA 
expression levels of the key genes from ghrelin signalling, i.e. Ghsr, Ghrl, and Mboat4. 
qRT-PCR analysis showed no effect of 20 nM ghrelin on the expression levels of Ghsr 
and Mboat4, which were relatively low. On the contrary, 20 nM and 200 nM ghrelin 
clearly upregulated the expression of Ghrl, in particular the isoforms that retained 
Intron 2, suggesting a positive feedback loop and that this variant isoform of ghrelin 
may play an important role in bone metabolism.  
Recently, it has been demonstrated that the ghrelin gene is very complex and gives rise 
to many transcripts, notably in mice and humans; some retain introns, and some exons 
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are deleted in other variants (Kineman et al., 2007; Seim et al., 2007, 2016; Gahete et 
al., 2011). Some of these variant isoforms of ghrelin can have biological functions. For 
example, In1-ghrelin is upregulated in various types of cancers, and promotes cancer 
progression (Hormaechea-Agulla et al., 2017).  One of the variants expressed by 7F2 
cells contains exon 1, intron 1, exon 2, intron 2 and exon 3, and may also contain exons 
4 and 5. Prediction of protein sequence from a transcript containing exon 1, intron 1, 
exon 2, intron 2, exon 3, exon 4 and exon 5 would contain four ORFs; two of them 
would encode short novel peptides of 15 and 28 amino acids. Another ORF would give 
rise to a peptide that is encoded by exon 2 and part of intron 2; this peptide would 
retain the signal peptide, as well as the first 12 amino acids of native ghrelin. This 
putative peptide has been predicted in another study that identified an In2-ghrelin 
variant (Kineman et al., 2007), which contains exon 2, intron 2 and exon 3, but lacks 
exons 1, 4 and 5. However, the putative peptide encoded by this variant has yet to be 
identified at the protein level. The fourth ORF predicted in the 7F2 cells transcript 
would give rise to a 46 amino acid peptide that is encoded by exons 4 and 5; this 
putative peptide sequence does not align significantly with any known peptide in mice. 
Despite being encoded by exons 4 and 5, it does not correspond to obestatin sequence 
due to a translational frameshift. If one or several of these ORFs encode a peptide, this 
novel isoform of ghrelin could have osteoblast-specific effects, and could be involved in 
the effects of ghrelin in bone.  
4.4.3. Chapter conclusions 
The hypothesis that 7F2 osteoblast-like cells and 7F2 cell-derived adipocytes expressed 
the three genes from ghrelin signalling, i.e. Ghrl, Ghsr and Mboat4, at the mRNA level 
was verified. It was shown in this section of work that 7F2 cells and 7F2 cell-derived 
adipocytes express Ghsr, Mboat4 and Ghrl mRNA, although Ghsr and Mboat4 expression 
levels were low. This suggests that, if ghrelin has any effect on 7F2 cells, these effects 
may be mediated by a receptor other than GHSR1a. The hypothesis that ghrelin 
treatment exerted some feedback on their expression levels was also verified, as 
treatment with 200 nM ghrelin significantly increased Ghrl mRNA expression in both 
7F2 cells an 7F2-cell derived adipocytes. 
In addition, this study shows for the first time that 7F2 cells and 7F2 cell-derived 
adipocytes express several variant isoforms of ghrelin, one of which contains exon 1, 
intron 1, exon 2, intron 2 and exon 3, and may contain exons 4 and 5. This previously 
un-reported isoform was more highly expressed than native ghrelin. Ghrelin treatment 
Chapter 4 – 7F2 osteoblast-like cells and 7F2 cell-derived adipocytes express Ghsr, 
Mboat4 and several isoforms of Ghrl 
 
94 
 
increased the mRNA expression of Ghrl, especially that of the variant isoform retaining 
intron 2. This suggests that this variant isoform may play an important role in 7F2 cells. 
However, it was only detected at the mRNA level, and it would be interesting to study 
whether this variant isoform is expressed at the protein level, and whether it is 
acylated by GOAT, like native ghrelin. 
Having identified that 7F2 cells and 7F2-cell derived adipocytes expressed genes from 
ghrelin signalling, the next stage was to test whether ghrelin had any effect on the 
proliferation and adipogenic differentiation of 7F2 cells.  
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Figure 4.2: RT-PCR for the genes from ghrelin signalling  
mRNA was extracted from 7F2 cells cultured with basal (BM) or adipogenic medium (AM) for 7 
days. A: PCR with cDNA samples. B: PCR with corresponding no RT controls. 
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Figure 4.3: qRT-PCR analysis of Ghrl expression in 7F2 cells treated with ghrelin 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 20 nM or 200 nM ghrelin. After 7 days of culture, RNA 
was extracted and gene expression was analysed using qRT-PCR. A: Raw Ct values and fold changes. B: Graph showing mean Ct values ± SD for each 
condition (n = 2; 3 replicate samples per condition; each sample was run in duplicate; Welch’s anova and Games-Howell post-hoc analysis). C: Expression 
of Ghrl normalised to HPRT1 (top) and to EEF2 (bottom). Data are fold change ± SD; numbers above the horizontal lines are p values (n = 2; 3 replicate 
samples per condition, each sample was run in duplicate; Kruskal-Wallis + Dunn tests). 
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Figure 4.4: qRT-PCR analysis of Ghsr expression in 7F2 cells treated with ghrelin 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 20 nM or 200 nM ghrelin. After 7 days of culture, RNA 
was extracted and gene expression was analysed using qRT-PCR. A: Raw Ct values and fold changes. B: Graph showing mean Ct values ± SD for each 
condition (n = 1; 3 replicate samples per condition, each sample was run in duplicate; Kruskal-Wallis test). C: Expression of Ghsr normalised to HPRT1 
(top) and to EEF2 (bottom). Data are fold change ± SD (n = 1; 3 replicate samples per condition, each samples was run in duplicate; Welch’s anova).  
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Figure 4.5: qRT-PCR analysis of Mboat4 expression in 7F2 cells treated with ghrelin 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 20 nM or 200 nM ghrelin. After 7 days of culture, RNA 
was extracted and gene expression was analysed using qRT-PCR. A: Raw Ct values and fold changes. B: Graph showing mean Ct values ± SD for each 
condition (n = 1; 3 replicate samples per condition, each sample was run in duplicate; Kruskal-Wallis test). C: Expression of Mboat4 normalised to HPRT1 
(top) and to EEF2 (bottom). Data are fold change ± SD (n = 1; 3 replicate samples per condition, each samples was run in duplicate; ANOVA test for data 
normalised to HPRT1; Kruskal-Wallis test for data normalised to EEF2). 
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Figure 4.6: Characterisation of the ghrelin variant expressed in 7F2 cells by RT-PCR 
analysis (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic (AM) medium, with or without 
200 nM ghrelin. After 7 days, RNA was extracted and RT-PCR analysis was performed with 
various sets of primers spanning the ghrelin gene. 
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Figure 4.6: Characterisation of the ghrelin variant expressed in 7F2 cells by RT-PCR 
analysis (part 2) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic (AM) medium, with or without 
200 nM ghrelin. After 7 days, RNA was extracted and RT-PCR analysis was performed with 
various sets of primers spanning the ghrelin gene. 
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Figure 4.6: Characterisation of the ghrelin variant expressed in 7F2 cells by RT-PCR 
analysis (part 3) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic (AM) medium, with or without 
200 nM ghrelin. After 7 days, RNA was extracted and RT-PCR analysis was performed with 
various sets of primers spanning the ghrelin gene. 
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Figure 4.7: No RT controls for the ghrelin variants (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic (AM) medium, with or without 
200 nM ghrelin. After 7 days, RNA was extracted and RT-PCR analysis was performed for the no 
RT controls, with various sets of primers spanning the ghrelin gene. 
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Figure 4.7: No RT controls for the ghrelin variants (part 2) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic (AM) medium, with or without 
200 nM ghrelin. After 7 days, RNA was extracted and RT-PCR analysis was performed for the no 
RT controls, with various sets of primers spanning the ghrelin gene. 
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Chapter 5 – The influence of ghrelin and K+ channel ligands on 
adipogenic differentiation of 7F2 cells 
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5.1. Introduction 
5.1.1. KATP channels 
KATP channels are a subfamily of inwardly-rectifying potassium (Kir) channels (Hibino 
et al., 2010). The property of inward rectification refers to the current-voltage 
relationship of these channels; when the current flowing through the channel is plotted 
against membrane potential, the inward (negative) current is much larger than the 
outward (positive) current. In other words, these channels conduct larger inward 
currents at membrane voltage negative to the potassium equilibrium potential, than 
outward currents at more positive voltages. Inward rectification is not an inherent 
property of the protein itself which forms the channel (Lopatin et al., 1994); rather, it is 
caused by intracellular cations (such as Mg2+) and polyamines, which block the outward 
flow of potassium ions in a voltage-dependent manner by binding to the inner ion-
conducting vestibule of the channel.  
KATP channels are “weak” rectifiers, as they can carry a measureable outward K+ 
current, while “strong” rectifiers cannot. KATP channels open spontaneously in inside-
out membrane patch, and they control the resting membrane potential. They are 
sensitive to changes in [ATP]i; their opening is inhibited by intracellular ATP and 
activated by intracellular nucleoside-diphosphates (NDP), such as ADP (Hibino et al., 
2010). They are composed of 4 Kir6.x subunits (Kir6.1 or Kir6.2), and 4 sulfonylurea 
receptor (SUR) subunits (SUR1, SUR2A and SUR2B). The Kir subunits have two 
transmembrane domains, which are the pore-forming subunits and contain the ATP-
binding site, which is located at the interface between the N- and C-termini (Hibino et 
al., 2010); Kir6.1 is encoded by Kcnj8 and Kir6.2 is encoded by Kcnj11. The SUR 
subunits are regulatory and are encoded by two genes: Abcc8 (SUR1) and Abcc9, which 
has several isoforms, including SUR2A and SUR2B; they possess two binding domains 
for nucleotides (figure 5.1) (Hibino et al., 2010).  
KATP channels can be subcategorised into smaller conductance Kir6.1 channels (35 – 40 
pS) or larger conductance Kir6.2 channels (65 – 80 pS), according to their subunit 
composition and their pharmacology. It is possible to construct Kir6.1/6.2 heteromers 
in vitro (Pountney et al., 2001); but the presence of such heteromeric channels in vivo 
remains controversial (Hibino et al., 2010). KATP channels are voltage-independent; 
they are inwardly-rectifying at depolarising potentials, due to blockage by Mg2+ ions in 
the pore (Lopatin et al., 1994). The accessory SUR subunits are targets for drugs that 
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can open or block KATP channels; KATP channels are all sensitive to inhibition by 
sulphonylurea drugs such as glibenclamide and tolbutamide; but they do not respond 
to the same KATP channel openers. For example, pinacidil activates channels built with 
SUR2 but not SUR1, and the effect is greater for SUR2B than for SUR2A (Babenko et al., 
2000); diazoxide activates both SUR1 and SUR2B (Gribble Fiona M. et al., 1997; Shyng 
et al., 1997). Hence, different combinations of Kir6.x and SUR subunits lead to tissue-
specific KATP channels with particular physiological and pharmacological properties 
(Inagaki et al., 1996; Seino et al., 2000). 
KATP channels are present in many cells and regulate a variety of cellular functions by 
coupling cell metabolism with membrane potential. For example, they play an 
important role in glucose-mediated insulin secretion (Ashcroft, 2005; Diehlmann et al., 
2011; Rorsman and Ashcroft, 2018); genetic modification of Kir6.2 or SUR1 leads to 
various phenotypes of glucose homeostasis disorders (Hibino et al., 2010), and a 
mutation activating Kir6.2 causes permanent neonatal diabetes (Gloyn et al., 2004). 
KATP channels are expressed in osteoblasts, osteoclasts, and adipocytes (Hibino et al., 
2010), where they have roles in cell proliferation, secretion, and metabolism. A study 
showed that human MSCs expressed Kir6.1, Kir6.2 and SUR2A; upon adipogenic 
differentiation, Kir6.1 and SUR2A were downregulated; upon osteogenic 
differentiation, Kir6.2 was strongly upregulated (Diehlmann et al., 2011). Changes of 
KATP channel expression suggest that these channels may contribute to in vitro 
differentiation of MSCs. Another study showed that Kir6.1 and SUR2B were expressed 
in human adipose tissue, but not SUR1, SUR2A or Kir6.2 (Gabrielsson et al., 2004). KATP 
channels are involved in mediating ghrelin signalling: in pancreatic β-cells, KATP 
channels composed of Kir6.2 and SUR1 subunits, mediate the inhibition of insulin 
secretion by ghrelin (MacDonald and Wheeler, 2003; Dezaki et al., 2007).  
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Figure 5.1: KATP channel structure 
A: Top view of a functional KATP channel. KATP channels are heterooactamers composed of 4 
Kir6.x subunits and 4 SUR subunits. B: Molecular constituents of KATP channels. Each SUR unit 
has 2 nucleotide-binding domains (NBD). SUR2A and SUR2B differ in the COOH-terminal 42 
amino acids (C42). TMD: transmembrane domain. Adapted from (Hibino et al., 2010). 
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5.1.2. BK channels 
Also called KCa1.1, Big K channels, or maxi-K channels, BK channels are large 
conductance calcium-activated and voltage-sensitive potassium channels: they are 
activated by micromolar increases in intracellular Ca2+ concentration, sensitive to 
changes in membrane potential (depolarisation), and are responsible for negative 
feedback of Ca2+ entry (Lee and Cui, 2010).  They are formed by 4 α-subunits, which are 
pore-forming and encoded by Kcnma1; and 4 auxiliary, regulatory β-subunits, encoded 
by Kcnmb1 to Kcnmb4 (see figure 5.2). The α-subunits are structurally similar to those 
of the voltage-dependent K+ channels; they are composed of 7 transmembrane domains 
(S0 – S6) and have an extracellular N-terminus, contrary to other KCa channels. S4 
contains positively charged arginine and lysine residues which are responsible for the 
voltage sensitivity of the channel, and S5 – S6 contain the pore-forming loop and the K+ 
selective region. The four β-subunits can be homotetrameric or heterotetrameric, 
which modulates the activity of the ion channel, particularly the sensitivity to activating 
or inhibitory ligands.  
BK channels are expressed in many cell types (Ge et al., 2014). Alternative splicing and 
the various patterns of expression of the regulatory subunits give rise to many 
subtypes of BK channels, allowing them to have different biophysiological properties in 
different tissues and modifying the susceptibility to various channel modulators (Li, 
2012; Kyle and Braun, 2014). BK channels have conductances in the range 150 – 300 
pS, although typically > 200 pS. They are sensitive to inhibition by the scorpion 
peptides charybdotoxin, which blocks BK channels and other types of voltage-gated 
potassium channels, and iberiotoxin, which is a specific blocker of most BK channels 
(Wang et al., 2014; Yu et al., 2016). They are also sensitive to the non-specific K+ 
channel blocker tetraethylammonium (TEA) (Henney, 2008).  
The pore-forming subunit KCNMA1 is widely expressed in most cells and tissues, 
including neuronal cells, vascular smooth muscle cells, endothelial cells, and bone cells 
(Henney et al., 2009; Zhang et al., 2014). BK channels are also expressed in human 
preadipocytes and osteoblasts (Wann et al., 2004; Hirukawa et al., 2008) and in human 
MSCs (Li et al., 2005). BK channels are involved in human bone marrow-derived MSC 
proliferation and differentiation (Zhang et al., 2014): silencing BK channels significantly 
reduces adipogenic differentiation, with decrease of lipid accumulation and expression 
of adipocytic marker PPARγ. Zhang et al. (2014) also showed that silencing BK channels 
decreases osteogenic differentiation with reduction of mineralisation and osteocalcin 
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secretion. Other studies showed that BK channels regulate preadipocyte proliferation 
(Hu et al., 2009), osteoblast and osteoblast-like cell proliferation, osteoblast 
differentiation and mineralisation (Henney et al., 2009; Li, 2012), and osteocalcin 
secretion (Moreau et al., 1997; Henney, 2008). This indicates that BK channels play an 
important role in maintaining bone marrow physiological function and bone 
homeostasis (Zhang et al., 2014). 
 
 
Figure 5.2: BK channel structure 
Molecular constituents of BK channels, which are composed of 4 α-subunits and 4 β-subunits. 
VSD: voltage-sensor domain; PGD: pore-gate domain; RCK: regulator of K+ conductance. Adapted 
from (Li and Yan, 2016). 
5.1.3. Chapter hypothesis, objectives and experimental strategy 
As mentioned in the main introduction (chapter 1, section 1.4.2), ghrelin is an essential 
player of bone homeostasis, affecting both osteoblastogenesis and bone marrow 
adipogenesis, and ion channels are also involved in regulating cell proliferation and 
differentiation, including in bone. Do ghrelin and potassium channels play a role in 7F2 
cell proliferation and adipogenic trans-differentiation?  
The objective of this chapter was to investigate whether ghrelin and potassium channel 
ligands can influence 7F2 cell numbers and adipogenic differentiation, using cell 
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counting, Oil Red O staining and RT-PCR and qRT-PCR tools. The effects of ghrelin 
treatment on cell numbers, lipid content and mRNA expression of differentiation 
markers were analysed; the hypothesis was that ghrelin could inhibit 7F2 cell 
adipogenic differentiation. The mRNA expression of several potassium channel 
subunits was investigated using RT-PCR, and the effects of potassium channel ligands 
on lipid content and cell numbers were tested. The hypothesis was that potassium 
channel blockers could inhibit 7F2 cell adipogenic differentiation and that potassium 
channel openers could promote 7F2 cell adipogenic differentiation.  
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5.2. Materials and Methods 
5.2.1. Cell culture 
5.2.1.1. Adipogenic differentiation and ghrelin treatment of 7F2 cells 
7F2 cells were seeded at a density of 2500 cells/cm² and cultured with basal and 
adipogenic medium as described in section 2.1, and treated with 20 nM or 200 nM 
ghrelin (Cambridge Bioscience) for 7 days. After 7 days of culture, 7F2 cells were 
stained with Oil Red O as described in section 2.1. 
5.2.1.2. Cell counting 
See section 2.2. 
5.2.1.3. Inhibition of GHSR 
7F2 cells were cultured with basal and adipogenic medium as described previously, 
and treated with 20 nM ghrelin with or without 1mM of the GHSR blocker D-[Lys3] 
GHRP-6 (DLS, from Sigma). After 7 days of culture, mRNA was extracted and analysed 
by RT-PCR and qRT-PCR.  
5.2.1.4. Treatment with tetraethylammonium (TEA) 
A 3 mM stock solution of TEA was prepared by dissolving 24.855 mg of TEA in 45 ml of 
α-MEM. Medium was then filtered, then supplemented with 5 ml FBS (final 
concentration 10%). 7F2 cells were plated into 12-well tissue culture plates (Fisher 
Scientific) at a density of 2500 cells/cm² in basal or adipogenic medium with or 
without TEA at various concentrations (0.3 mM, 1 mM and 3 mM). Cells were incubated 
as usual for 7 days with medium replacement every 2-3 days. Pictures were taken daily 
under a microscope at a 200x magnification, except on week-ends. After 7 days, the 
cells were stained with Oil Red O as described in section 2.1.2.2. Cells were counted as 
described in section 2.2. 
5.2.1.5. Treatment with diazoxide 
A 40 mM stock solution of diazoxide was prepared by dissolving 92 mg of diazoxide in 
1 ml of DMSO. 7F2 cells were plated into 12-well tissue culture plates (Fisher Scientific) 
at a density of 2500 cells/cm² in basal or adipogenic medium alone for 3 days; then the 
cells were cultured with basal or adipogenic medium with or without diazoxide at 
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various concentrations (1 µM, 10 µM and 100 µM), or with DMSO alone (0.25%), for the 
last 4 days of culture. After 7 days of culture, the cells were stained with Oil Red O as 
described in section 2.1.2.2.  
5.2.2. Molecular biology 
5.2.2.1. RNA extraction, DNAse treatment and reverse transcription 
See sections 2.3.1 and 2.3.2.  
5.2.2.2. PCR 
5.2.2.2.1. Oligonucleotide primers 
See sections 8.1.1 and 8.1.5. 
5.2.2.2.2. PCR reaction compositions and conditions 
The PCR reaction composition is described in section 2.3.3. The PCR reaction conditions 
were optimised and are detailed in table 5.1. Nuclease-free water was used as a 
negative control and three house-keeping genes, Hprt1, Eef2 and Gapdh, were used as 
positive controls.   
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Hprt1 and Gapdh primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
30 Annealing 58 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Eef2, Runx2, Alpl, and Cebpa primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
35 Annealing 58 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Osteocalcin primers (both sets): 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
40 Annealing 58 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Glut4, Kcnj8, Kcnj11, Kcnd2, Kcnma1, Kcnmb1, Kcnmb2, Kcnmb3 and Kcnmb4 
primers: 
Step Temperature °C Time No. of cycles 
Initial denaturation 95 1 min 1 
Denaturation 95 30 s 
40 Annealing 56 30 s 
Extension 68 30 s 
Final extension 68 5 min 1 
Soak 4 Indefinite   
Table 5.1: PCR reaction conditions 
5.2.2.2.4. Gel electrophoresis 
See section 2.3.4. 
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5.2.2.3. Quantitative PCR 
See section 2.3.5. 
5.2.3. Statistical analysis 
Statistical analysis was performed as described in section 2.3.7. Data were expressed as 
mean ± standard deviation; the number of repeat assays is indicated by “n”. Differences 
were tested by ANOVA tests (with Tukey-Kramer post-hoc analysis), Kruskal-Wallis 
tests (with Dunn post-hoc analysis) and Welch’s anova (with Games-Howell post-hoc 
analysis). In qRT-PCR experiments, the statistical analyses were performed using raw 
CT values and fold changes. P values lower than 0.05 were considered as statistically 
significant. The calculations were performed using the R software (https://www.r-
project.org/, version 3.5.3). 
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5.3. Results 
5.3.1. Effects of ghrelin on 7F2 cells and 7F2 cell-derived adipocytes 
5.3.1.1. Effects of ghrelin on cell number 
7F2 cells were cultured with basal or adipogenic medium, with or without 20 nM 
ghrelin, for 7 days; after 7 days of culture, cells were counted using a haemocytometer 
(figure 5.3). As observed previously, after 7 days of culture, the number of cells was 
significantly lower in wells cultured with adipogenic medium compared with basal 
medium (p < 0.0001; n = 9, 3 replicates per condition; Kruskal-Wallis and Dunn tests). 
Adding ghrelin to basal or adipogenic medium did not seem to affect cell numbers 
compared to basal or adipogenic medium alone, respectively. 
5.3.1.2. Effects of ghrelin on adipogenic differentiation 
5.3.1.2.1. Effect on lipid content 
7F2 cells were cultured with basal or adipogenic medium, with or without 20 nM 
ghrelin, for 7 days and pictures were taken daily, except on week-ends. Figure 5.4.A 
shows pictures of cells taken at days 2, 4 and 7 of culture. Similarly to previous 
experiments, lipid droplets began to appear in cells at day 2 and continued growing 
over the length of the treatment in 7F2 cells cultured with adipogenic medium. 
Similarly, in 7F2 cells cultured with adipogenic medium + 20 nM ghrelin, lipid droplets 
began to form at day 2 of culture and became larger over time. No difference was 
observed between 7F2 cells cultured with basal medium alone or with basal medium + 
20 nM ghrelin. After 7 days of culture, the cells were stained with Oil Red O (figure 
5.4.B). Again, no difference was observed between 7F2 cells treated with ghrelin, and 
cells cultured in the absence of ghrelin. This was confirmed by extracting and 
quantifying the Oil Red O stain by measuring the absorbance at 490 nm (figure 5.4.C); 
there was no difference between adipogenic medium alone and adipogenic medium + 
20 nM ghrelin (p = 0.3198, n = 11, 3 replicates per condition, Kruskal-Wallis test and 
Dunn post-hoc analysis), and no difference between basal medium alone and basal 
medium + 20 nM ghrelin (p = 0.2015, n = 11, 3 replicates per condition; Kruskal-Wallis 
test and Dunn post-hoc analysis). Similar results were obtained when treating the cells 
with 200 nM ghrelin (figure 5.5) (n = 1, 3 replicates per condition; ANOVA test and 
Tukey-Kramer post-hoc analysis).  
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5.3.1.2.2. Effect on differentiation marker mRNA expression 
To further assess the effects of ghrelin treatment on the adipogenic differentiation of 
7F2 cells, the mRNA expression of several osteoblastic and adipogenic differentiation 
markers was analysed using RT-PCR and qRT-PCR. 7F2 cells were cultured for 7 days 
with basal or adipogenic medium, with or without 20 nM or 200 nM ghrelin. Figure 5.6 
shows pictures of agarose gels for two osteoblastic markers, Runx2 and ALP, and two 
adipocytic markers, PPARγ and C/EBPα. The bands corresponding to Runx2 and ALP 
appeared less intense when the cells were cultured with adipogenic medium; whereas 
the band corresponding to ALP was more intense in cells cultured with basal medium 
containing ghrelin compared to cells cultured with basal medium alone. On the 
contrary, PPARγ and C/EBPα mRNA expression was upregulated in cells cultured with 
adipogenic medium compared with basal medium; this effect was attenuated in 7F2 
cells cultured with adipogenic medium + 20 nM ghrelin. 
The mRNA expressions of osteoblastic and adipogenic markers were also analysed 
using qRT-PCR (n=2, 3 replicate samples per condition; each sample was run in 
duplicate in each assay) (figure 5.7). 7F2 cells were treated with 20 nM or 200 nM 
ghrelin. Osteocalcin mRNA expression was higher in 7F2 cells treated with 20 nM and 
200 nM ghrelin in both basal medium and adipogenic medium, but the differences were 
not significant (p = 0.23, Kruskal-Wallis test). Similarly, 20 nM and 200 nM ghrelin did 
not significantly affect ALP mRNA expression (p = 0.11, Kruskal-Wallis test). Runx2 
mRNA expression was significantly lower in 7F2 cells cultured with adipogenic medium 
(0.21 ± 0.49) compared to cells cultured with basal medium (1 ± 0;73; p = 0.0073, 
Kruskal-Wallis test and Dunn post-hoc analysis), but 20 nM and 200 nM ghrelin had no 
significant affect on Runx2 mRNA expression levels (figure 5.7. B). The mRNA 
expression of C/EBPα was  higher in 7F2 cells cultured with adipogenic medium alone 
(10.47 ± 0.48) compared to cells cultured with basal medium alone (1 ± 0.74;                    
p = 0.0003, Kruskal-Wallis test and Dunn post-hoc analysis); C/EBPα expression was 
also higher in cells cultured with adipogenic medium + 20 nM ghrelin (39.56 ± 0.10) 
compared to cells cultured basal medium + 20 nM ghrelin (1.36 ± 0.46; p = 0.0005, 
Kruskal-Wallis and Dunn tests) and higher in cells cultured with adipogenic medium + 
200 nM ghrelin (13.95 ± 0.19)  compared to cells cultured with basal medium + 200 nM 
ghrelin (1.02 ± 0.55; p = 0.0052, Kruskal-Wallis and Dunn tests), respectively (figure 
5.7.D). However, 20 nM and 200 nM ghrelin had no significant effect on C/EBPα 
expression compared to basal or adipogenic medium alone. Similar results were 
obtained for PPARγ expression (figure 5.7.D). 
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5.3.1.2.3. The effects of ghrelin in 7F2 cells may be mediated by GHSR 
To test whether the effects of ghrelin on the mRNA expression of differentiation 
markers were mediated by GHSR, a blocker of GHSR, D-[Lys3] GHRP-6 (DLS, 1 mM) was 
added to basal medium and adipogenic medium containing 20 nM ghrelin. 7F2 cells 
were cultured for 7 days and RNA was extracted and analysed using RT-PCR and qRT-
PCR. These experiments were only performed once. mRNA expression of differentiation 
markers was analysed using RT-PCR and photographs of agarose gels are shown in 
figure 5.8. When 7F2 cells were treated with adipogenic medium, the bands 
corresponding to osteoblastic markers osteocalcin, Runx2 and ALP PCR products 
appeared fainter, while the bands corresponding to adipocytic markers PPARγ, C/EBPα 
and Glut4 PCR products appeared more intense. In cells cultured with adipogenic 
medium + 20 nM ghrelin, the bands corresponding to osteoblastic markers appeared 
even fainter, except for ALP. However, in the presence of 1 mM DLS, these bands 
appeared more intense, except for ALP. Similarly, in cells cultured with adipogenic 
medium + 20 nM ghrelin, the bands corresponding to adipocytic markers appeared 
slightly more intense, except for PPARγ, but were fainter when the cells were cultured 
in the presence of 1 mM DLS. No RT controls are shown in figure 5.10; no PCR product 
was observed for any of the differentiation markers.  
qRT-PCR analysis on differentiation markers was also performed to test the effects of 1 
mM DLS on mRNA expression levels (figure 5.9). Adipogenic medium decreased the 
expression levels of Runx2 and ALP by 80% and 60% respectively, while the expression 
of C/EBPα and PPARγ were respectively ten times and two times higher, compared to 
basal medium. When the cells were cultured with adipogenic medium + 20 nM ghrelin, 
the expression levels of both osteoblastic and adipocytic markers were increased 
compared to the expression levels in cells cultured with adipogenic medium alone. 
However, in cells cultured with adipogenic medium + 20 nM ghrelin + 1 mM DLS, the 
expression levels of all markers were decreased compared to cells cultured with 
adipogenic medium + 20 nM ghrelin, without DLS. Expression levels of all tested 
markers were lower in cells cultured with basal medium + 20 nM ghrelin + 1 mM DLS 
compared to cells cultured with basal medium + 20 nM ghrelin, without DLS.  
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5.3.1.3. Ionic mechanisms in 7F2 cells and 7F2 cell derived adipocytes, and the 
effects of ghrelin on these 
5.3.1.3.1. KATP channels 
mRNA was extracted from 7F2 cells cultured for 7 days with basal or adipogenic 
medium, with or without 20 nM ghrelin. RT-PCR analysis was performed for the KATP 
channel subunits (figure 5.11): the two pore-forming subunits Kir6.1 (Kcnj8) and Kir6.2 
(Kcnj11) (figure 5.11.A); and the regulatory subunits SUR1 (Abcc8), and SUR2 (Abcc9), 
which has several isoforms (figure 5.11.B). Two sets of primers were used for SUR2 
(Abcc9): the first one detected SUR2 mRNA for all isoforms, while the second one 
allowed to distinguish between the two isoforms SUR2A and SUR2B, with PCR product 
expected sizes of 397 bp and 221 bp, respectively. Kcnj8 was detected at the mRNA 
level (figure 5.11.A), but the results were inconsistent: on some repeats, no PCR 
product could be detected, while on other repeats, one or several bands were detected, 
one of which corresponded to the expected size (155 bp). Kcnj11 mRNA expression was 
not detected on the various repeats (n = 6) in cells cultured with basal or adipogenic 
medium alone in the early stage of this study, so it was not tested in cells treated with 
ghrelin. The regulatory subunit SUR1 (Abcc8) was also not detected at the mRNA level 
(figure 5.11.B). SUR2 (Abcc9) mRNA expression was detected; RT-PCR analysis with the 
second set of primers showed a band at 221 bp, which was the expected size for the 
SUR2B subunit.  
qPCR analysis was performed for the KATP channel subunits that were detected at the 
mRNA level: Kir6.1 (Kcnj8) and SUR2 (Abcc9), with the first set of primers only, which 
detects all SUR2 isoforms at the mRNA level (figure 5.12). qPCR data confirmed that 
Kcnj8 mRNA expression was low, with mean Cts of 29.52 for 7F2 cells cultured with 
basal medium, 30.85 for 7F2 cells cultured with adipogenic medium, 28.63 for 7F2 cells 
cultured with adipogenic medium + 20 nM ghrelin, and 32.20 for 7F2 cells cultured 
with basal medium + 20 nM ghrelin (n = 1, 3 replicate samples per condition; each 
replicate sample was run in duplicate) (figure 12.A). Abcc9 expression levels were 
significantly higher in 7F2 cells cultured with adipogenic medium + 20 nM ghrelin 
(166.96 ± 0.13) compared to cells cultured with basal medium + 20 nM ghrelin (31.13 ± 
0.14; p = 0.0248; Kruskal Wallis and Dunn tests; n = 1, 3 replicate samples per 
condition; each replicate sample was run in duplicate), and higher in cells cultured with 
adipogenic medium + 200 nM ghrelin (202.48 ± 0.31) compared to cells cultured with 
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basal medium + 200 nM ghrelin (32.94 ± 0.27; p = 0.0163, Kruskal-Wallis and Dunn 
tests) (figure 12.B).  
5.3.1.3.2. BK channel 
mRNA was extracted from 7F2 cells cultured for 7 days with basal or adipogenic 
medium. RT-PCR analysis was performed for the BK channel subunits (figure 5.13): the 
pore-forming α subunit encoded by Kcnma1 and the four regulatory β1-4 subunits 
encoded by Kcnmb1 to Kcnmb4. A band of 167 bp was observed in most repeats for 
Kcnma1; it appeared fainter for 7F2 cells cultured with adipogenic medium compared 
with basal medium. No band was detected for Kcnmb1, Kcnmb3 and Kcnmb4. A faint 
band corresponding to 155 bp was observed for Kcnmb2.  
qPCR analysis was performed for the BK channel subunit Kcnma1 (n = 1, 3 replicate 
samples per condition; each replicate sample was run in duplicate) (figure 5.14). The 
mean Cts were relatively high, indicating that the Kcnma1 mRNA expression level was 
low. Kcnma1 mRNA expression was lower in adipogenic medium (0.18 ± 0.21) 
compared with basal medium (1 ± 0.49; p = 0.04, ANOVA test and Tukey-Kramer post-
hoc analysis), which is consistent with the RT-PCR data, but it was restored when the 
cells were cultured with adipogenic medium containing 20 nM ghrelin (0.99 ± 0.30). 
Kcnma1 mRNA expression was upregulated in cells cultured with basal medium + 20 
nM compared with basal medium alone. 
5.3.2. Pharmacological modulation of K+ channels: effect on adipogenesis 
Having detected the expression of various ion channel subunits by RT-PCR, the next 
step was to investigate whether drugs which modify the activity of these ion channels 
could affect cell processes such as proliferation and differentiation, using 
tetraethylammonium (TEA), which is a generic blocker of voltage-dependent and Ca2+-
activated K+ channels, and diazoxide, which is a KATP channel opener. 
5.3.2.1. Effects of TEA 
5.3.2.1.1. TEA decreases the amount of lipids in 7F2-cell derived adipocytes 
7F2 cells were cultured with basal or adipogenic medium, with or without TEA at 
various concentrations (0.3 mM, 1 mM and 3 mM), for 7 days. Figure 5.15.A, B and C 
show pictures of the cells at days 2, 4 and 7 of culture. In 7F2 cells treated with 
adipogenic medium, lipid droplets began to appear around day 2 of treatment and grew 
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in size and number over the rest of the treatment. Treating 7F2 cells with TEA did not 
prevent the apparition of lipid droplets; however TEA seemed to limit the size of these 
lipid droplets. This effect was concentration-dependent and was particularly visible in 
cells cultured with adipogenic medium containing 3 mM TEA. This was confirmed by 
Oil Red O staining after 7 days of treatment; the cells cultured with adipogenic medium 
containing TEA possessed smaller lipid droplets than the cells cultured with adipogenic 
medium alone (figure 5.15.D). The Oil Red O stain was extracted and quantified by 
measuring the absorbance at 490 nm; data are presented in figure 5.15.E (n = 4, with 2-
3 replicates per condition); data were normalised to basal medium in figure 5.15.F. The 
absorbance value was relatively high (> 0.11) in cells cultured with basal medium due 
to the presence of many Oil Red O crystals in the wells despite repeated washings. 
Quantification of Oil Red O stain did not show any significant difference between the 
cells treated with the various concentrations of TEA (p = 0.64, Kruskal-Wallis test), but 
a trend could be seen, especially for cells cultured with adipogenic medium + TEA: the 
amount of Oil Red O stain decreased with increasing concentrations of TEA.   
5.3.2.1.2. TEA decreases cell proliferation 
7F2 cells were cultured for 7 days with basal or adipogenic medium, with or without 
various concentrations of TEA, for 7 days. Figure 5.15.A shows pictures of the cells at 
days 2, 4 and 7 of culture. TEA decreased cell proliferation in a dose-dependent 
manner. This was confirmed by counting the cells, using a haemocytometer, although 
the differences in cell numbers were not statistically significant (p = 0.06, Kruskal-
Wallis test, n = 1, with 2 replicates per condition) (figure 5.16). 
5.3.2.2. Effects of diazoxide on 7F2 cell adipogenic differentiation 
The KATP channel opener diazoxide was tested at various concentrations against the 
adipogenic differentiation of 7F2 cells over a period of 7 days. 7F2 cells were cultured 
with basal or adipogenic medium for 3 days; then, culture medium was replaced with 
basal or adipogenic medium containing various concentrations of diazoxide (1 µM, 10 
µM and 100 µM) for the last 4 days of culture. Figure 5.17.A shows pictures of the cells 
at day 7 of culture, and figure 5.17.B shows pictures of cells stained with Oil Red O after 
7 days of culture. Diazoxide did not seem to affect the development and growth of lipid 
droplets. Diazoxide did not seem to affect cell number either; however, cell morphology 
was modified in the presence of diazoxide, especially at 100 µM. This may be due to the 
presence of DMSO, as the cells presented similar morphologies in the wells with basal 
or adipogenic medium + DMSO.  
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The Oil Red O stain was extracted and quantified by measuring the absorbance at 490 
nm; data are presented in figure 5.17.C (n = 3, with 3-4 replicates per condition in each 
repeat); data were normalised to basal medium in figure 5.17.D. Similarly to 
experiments with TEA, the absorbance was high (> 0.21) in wells of cells cultured with 
basal medium and adipogenic medium, due to the many Oil Red O crystals in the wells. 
Quantification of Oil Red O stain did not show any significant difference basal and 
adipogenic medium, and between the various concentrations of diazoxide (p = 0.85, 
Kruskal-Wallis test). However, a trend could be seen for cells cultured with adipogenic 
medium + diazoxide: the amount of Oil Red O stain decreased with increasing 
concentrations of diazoxide.  
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5.4. Discussion 
This section of work aimed to study the effects of ghrelin treatment and potassium 
channel ligands on the proliferation and adipogenic differentiation of 7F2 cells. 
5.4.1. Ghrelin treatment affects 7F2 cell differentiation, but not proliferation 
Overall, 20 nM ghrelin treatment had no effect on 7F2 cells numbers, suggesting that it 
did not stimulate nor suppress cell proliferation, at least within the timeframe used (7 
days). 20 nM and 200 nM ghrelin had no effect on lipid content: lipid droplets appeared 
at the same time as in cells cultured with adipogenic medium alone; Oil Red O staining 
showed no visible difference in the size or abundance of lipid droplets, which was 
confirmed by quantification of Oil Red O stain. qRT-PCR analysis showed that treatment 
with 20 nM and 200 nM ghrelin did not significantly alter the expression levels of both 
osteoblastic and adipocytic markers, although their expression levels were higher in 
the presence of 20 nM ghrelin compared to basal or adipogenic medium alone The 
effects of 20 nM ghrelin on mRNA expression was attenuated by the addition of 1 mM 
DLS, which is a GHSR antagonist, suggesting that ghrelin signalling was mediated via 
GHSR. However, the effect of DLS was only tested once and further studies on this 
aspect of the work would be advised to gain confidence in the results.   
Adipose tissue is a major endocrine organ, secreting various hormones and cytokines, 
called adipokines, in the circulation. These adipokines play crucial roles in regulation of 
various physiologic and pathologic processes, including metabolism and metabolic 
disorders; they affect various tissues, particularly bone. Leptin is one of the most 
abundant adipokines and is involved in the regulation of glucose metabolism; it is 
highly expressed in bone marrow adipocytes and has been shown to inhibit osteoblast 
function and bone formation (Rodeheffer and Horowitz, 2016; Yue et al., 2016). 
Interestingly, ghrelin and leptin antagonise each other in the regulating energy balance, 
and these hormones have been shown to interact in regulation of bone metabolism, 
sensing the availability of nutrients and regulating directly and indirectly bone 
formation via paracrine and endocrine mechanisms (Delhanty et al., 2014a). Consistent 
with this, ghrelin has been shown by multiple studies to stimulate bone formation and 
osteoblast proliferation and differentiation, both in vivo and in vitro (Kim et al., 2005; 
Choi et al., 2013). On the other hand, in vivo experiments also show that ghrelin 
increases bone marrow adiposity (Thompson et al., 2004); in vitro, some studies have 
shown that preadipocyte proliferation and differentiation was directly stimulated by 
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ghrelin, but others have reported that overexpression of ghrelin inhibited adipogenesis 
(Zhang et al., 2004). Ghrelin is very likely to have tissue- and cell type-specific actions; 
in bone, it is unclear whether ghrelin alters MSC differentiation, or whether ghrelin 
stimulates the differentiation of cells already committed to the osteoblastic or 
adipocytic lineages.   
It is difficult to say whether ghrelin promoted or suppressed the adipogenic 
differentiation of 7F2 cells in this study. The effects on lipid content were inconsistent; 
no effect was detected when observing the cells stained with Oil Red O under the 
microscope, and when analysing the Oil Red O stain quantification data, from one 
repeat to another, ghrelin either increased, decreased, or had no visible effect on lipid 
content, suggesting that there was a great variability from one repeat to another. 
Several factors may have contributed to this variability; Oil Red O crystals formed even 
though the staining solution was filtered. These crystals attached to the cells, despite 
repeated washings, and they were not homogenous between the wells and between the 
repeats. Also, as shown in Chapter 3, local cell density has an influence on lipid content, 
with higher densities increasing lipid content of the cells. Overall, ghrelin did not seem 
to have a stimulatory or inhibitory effect on lipid content. In addition, treatment with 
20 nM ghrelin promoted the mRNA expression of both osteoblastic and adipocytic 
markers, but these changes in expression levels were not statistically significant. This 
may be due to the fact that there was a great variability between qRT-PCR repeats, and 
that few repeat assays were performed.  
The absence of a clear effect of ghrelin treatment may be due to several factors. First, 
here 7F2 cells were treated with human ghrelin instead of mouse ghrelin. Ghrelin is 
highly conserved, especially in mammals; mouse ghrelin differs from human ghrelin by 
2 amino acids, and the region that can be acylated and that is involved in GHSR binding 
is conserved (Kojima and Kangawa, 2005), but treating 7F2 cells with mouse ghrelin 
may have a stronger, clearer effect on adipogenic differentiation. In addition, ghrelin 
has a very short half-life in cell culture (Zhang et al., 2004); overexpressing ghrelin or 
replacing ghrelin more frequently in the culture medium may have a stronger effect on 
7F2 cell adipogenic differentiation. Ghrelin at nanomolar concentrations can activate 
GHSR1a in vitro (Kojima et al., 1999) and circulating levels of ghrelin are in the range 
0.1 to 0.5 nM (Callaghan and Furness, 2014). However, since many tissues express 
ghrelin, local concentrations in those tissues may be higher; consistent with this, assays 
that detect bound peptide measure higher levels of ghrelin (3-4 nM) (Callaghan and 
Furness, 2014). Here, concentrations of 20 nM and 200 nM were used, but a wider 
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range of concentrations may be used in future investigations. Moreover, 7F2 cells 
express a ghrelin variant retaining intron 2, and mRNA of this variant is much more 
abundant than that of native ghrelin. If this variant is expressed at the protein level, it 
would be interesting investigate whether it can affect cell proliferation or adipogenic 
differentiation of 7F2 cells.  
5.4.2. Potassium channel ligands modulate proliferation and adipogenic 
differentiation of 7F2 cells 
The expression of various potassium channel subunits was analysed by RT-PCR and 
qRT-PCR. Several ion channels subunits were detected in both 7F2 cells and 7F2 cell-
derived adipocytes, in particular the KATP subunits KCNJ8 (Kir6.1) and SUR2B, and the 
BK channel subunits KCNMA1 (KCa1.1) and KCNMB2; however KCNJ8 and KCNMA1 
expression levels were low. SUR2B was slightly upregulated in 7F2 cell-derived 
adipocytes compared to 7F2 cells cultured with basal medium, and strongly 
upregulated when the cells were treated with 20 nM and 200 nM ghrelin.  
BK channels are expressed in several human osteoblastic cells, including primary 
human HOB-c osteoblasts, MG63 and SaOS-2 human osteoblast-like cell lines. MG63 
cells and primary osteoblasts express the α subunit and all four associated β subunits, 
and functional BK channels could be readily recorded in single-channel patch clamp 
experiments, suggesting that these channels are abundant (Henney, 2008) and that BK 
channels play an important role in human osteoblasts. In the present study however, 
BK channel α subunit expression was relatively low and only a very low expression of 
β2 could be detected by RT-PCR analysis. In addition, the α subunit was downregulated 
in 7F2 cell-derived adipocytes compared to 7F2 osteoblastic cells. This suggests that 
this family of channel may not play a central role in 7F2 cells, which are murine 
osteoblast-like cells; in this cell type, BK channels in may be an artefact from cell 
culture. Ion channel expression patterns, and particularly potassium channel 
expression patterns, seem to be species-specific. For example, mouse BMSCs highly 
express intermediate-conductance Ca2+-activated K+ channels (Tao et al., 2007), 
whereas it is not detected in human BMSCs, which rather express BK channels 
(Heubach et al., 2004; Li et al., 2005).  
As the expression of several potassium channel subunits was detected in 7F2 cells, the 
role of potassium channels in regulating proliferation and adipogenic differentiation 
was tested by modulating ion channel activity via two types of pharmacological agents: 
TEA, which is a blocker of voltage-dependent and Ca2+-activated K+ channels, and 
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diazoxide, which is a KATP opener. The effects of TEA and diazoxide on adipogenic 
differentiation were assessed by Oil Red O staining of lipid droplets and quantification 
of stain; the effects of TEA and diazoxide on the mRNA expression levels of 
differentiation markers could not be tested due to lack of time.  
Diazoxide has an inhibitory effect on rat preadipocyte proliferation and differentiation 
(50 µM, 100 µM and 150 µM diazoxide) (Wang et al., 2007) and 100 µM diazoxide was 
shown to activate KATP channels in electrophysiology experiments (Larsson et al., 
1993), although diazoxide is more effective when applied to the intracellular rather 
than the extracellular side of the membrane (Kozlowski et al., 1989). Here, diazoxide (1 
µM, 10 µM and 100 µM) did not have any significant effect on 7F2 cell numbers or lipid 
content, suggesting that KATP channels may not play a role in 7F2 cell proliferation or 
adipogenic differentiation. However, a mistake was made when preparing the culture 
medium containing diazoxide: the concentration of DMSO was not adjusted between 
the various doses of diazoxide tested, which very likely biased the results. Hence, 1 µM 
diazoxide contained 0.0025% DMSO, 10 µM diazoxide contained 0.025% DMSO, and 
100 µM diazoxide contained 0.25% DMSO. The concentration of the DMSO control was 
adjusted to match that of 100 µM diazoxide (0.25% DMSO).  Repeating this experiment 
with correct preparation of the the medium containing diazoxide may provide more 
exploitable data. Also, only one KATP channel opener was tested; using other KATP 
channel openers or channel blockers may provide useful data on the role of KATP 
channels in 7F2 cells. Besides, KATP channels regulate osteocalcin secretion in 
osteoblasts (Moreau et al., 1997) as well as secretion of other hormones such as insulin 
(Seino et al., 2000; Ashcroft, 2005) and leptin (Standridge et al., 2000). KATP channels 
may regulate osteocalcin secretion from 7F2 cells and adipokine secretion for 7F2 cell-
derived adipocytes, which was not tested here.  
Contrary to diazoxide, TEA (0.3 mM, 1 mM and 3 mM) decreased cell number and 
limited the size of lipid droplets inside 7F2 cell-derived adipocytes in a concentration-
dependent manner. This range of concentrations was chosen based on concentrations 
used in other studies: 3mM TEA increased MG63 cell numbers without increasing the 
number of dead cells, whereas 10-30 mM TEA caused cell death (Li, 2012). In 
electrophysiology experiments using mouse neuroblastoma cells, the concentration for 
half maximal block of voltage-dependent potassium channels by external TEA was 80 
µM in excised membrane patches (Im and Quandt, 1992), and 0.6 mM TEA blocked 
delayed rectifier potassium channels in whole-cell configuration when applied to the 
external solution (Quandt and Im, 1992). The fact that TEA limited the size of lipid 
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droplets suggests that K+ channels may be involved in the regulation of the adipogenic 
differentiation of 7F2 cells. K+ channels, and particularly voltage-dependent and Ca2+-
activated K+ channels, are involved in regulating proliferation and adipogenic 
differentiation of MSCs and preadipocytes. For example, the intermediate conductance 
Ca2+-activated K+ channels KCa3.1 participate in regulating cell proliferation in mouse 
preadipocytes (Zhang et al., 2012).  
5.4.2. Chapter conclusions 
The hypothesis that ghrelin could stimulate 7F2 cell proliferation was not verified. 
There was no experimental evidence that ghrelin inhibits adipogenic differentiation 
either; 20 nM ghrelin did not affect lipid content, but increased the expression levels of 
both osteoblastic and adipocytic markers, although this effect was not statistically 
significant. However, only two concentrations of ghrelin were tested (20 nM and 200 
nM), and the ghrelin used here was human; testing other concentrations, and using 
mouse ghrelin may be interesting in future work. In addition, the effects of 20 nM 
ghrelin on the expression of differentiation markers were attenuated in the presence of 
a GHSR blocker, DLS, suggesting that the effects of ghrelin are mediated by this 
receptor.  
Expression of several K+ channel subunit was detected in 7F2 cells and adipocytes, 
including KATP channel subunits (Kir6.1 and SUR2B) and BK channel subunits (α and 
β2); Kir6.1 and SUR2B  were upregulated by 20 nM ghrelin. TEA, but not diazoxide, 
decreased cell proliferation and adipogenic differentiation in 7F2 cells, suggesting a 
role for K+ channels in these processes.  
Since K+ channels may play a role in regulating 7F2 cell proliferation and adipogenic 
differentiation, the next stage of this study was to identify the ion channels present in 
7F2 cells, using electrophysiology techniques.  
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Figure 5.3: Effects of 20 nM ghrelin on cell numbers 
7F2 cells were cultured with basal (BM) or adipogenic medium (AM) with or without 20 nM 
ghrelin for 7 days. After 7 days of culture, cells were counted. Data are mean ± SD (n=9, 3 
replicates per condition in each assay; Kruskal-Wallis and Dunn tests). 
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Figure 5.4: Effects of 20 nM ghrelin on the lipid content (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 20 nM ghrelin. A: Pictures of cells at days 2, 4 and 7 of 
culture.  
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Figure 5.4: Effects of 20 nM ghrelin on the lipid content (part 2) 
B: Pictures of 7F2 cells stained with Oil Red O. C and D: Quantification of Oil Red O by measuring the absorbance at 490 nm; (C) represents raw data, and 
(D) represents data normalised to basal medium. Data are mean ± SD (n = 11, 3 replicates per condition in each assay; Kruskal-Wallis tests and Dunn post-
hoc analyses).  
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Figure 5.5: Effects of 200 nM ghrelin on lipid content (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 200 nM ghrelin. A: Pictures of cells at days 2, 4 and 7 of 
culture. 
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Figure 5.5: Effects of 200 nM ghrelin on lipid content (part 2) 
B: Pictures of 7F2 cells stained with Oil Red O. C and D: Quantification of Oil Red O by measuring the absorbance at 490 nm; (C) represents raw data, and 
(D) represents data normalised to basal medium. Data are mean ± SD (n = 1, 3 replicates per condition; raw data: ANOVA test; normalised data: Kruskal-
Wallis test and Dunn post-hoc analysis).
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Figure 5.6: RT-PCR analysis of differentiation markers in 7F2 cells treated with 20 nM 
ghrelin 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 
20 nM ghrelin. After 7 days of culture, RNA was extracted and gene expression was analysed 
using RT-PCR. A: RT-PCR for two osteoblastic markers, Runx2 and ALP. B: RT-PCR analysis of 
two adipocytic markers, PPARγ and C/EBPα.  
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Figure 5.7: qRT-PCR analysis of differentiation markers in 7F2 cells treated with 20 nM 
and 200 nM ghrelin (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 
20 nM or 200 nM ghrelin. After 7 days of culture, RNA was extracted and gene expression was 
analysed using RT-PCR. A: qRT-PCR analysis for the osteoblastic markers osteocalcin, Runx2, 
and ALP. Data are mean Ct + SD (n = 2, with 3 replicate samples per condition in each assay; 
each sample was run in duplicates; Kruskal-Wallis tests and Dunn post-hoc analysis for 
osteocalcin and Runx2; Welch’s anova and Games-Howell post-hoc analysis for ALP). 
Chapter 5 – The influence of ghrelin and K+ channel ligands on adipogenic 
differentiation of 7F2 cells 
 
134 
 
 
Figure 5.7: qRT-PCR analysis of differentiation markers in 7F2 cells treated with 20 nM 
and 200 nM ghrelin (part 2) 
B: qRT-PCR analysis for the osteoblastic markers osteocalcin, Runx2, and ALP. Data are fold 
change + SD, normalised to HPRT1 expression (n = 2, 3 replicate samples per condition in each 
assay; each sample was run in duplicate; Kruskal-Wallis tests and Dunn post-hoc analysis). 
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Figure 5.7: qRT-PCR analysis of differentiation markers in 7F2 cells treated with 20 nM 
and 200 nM ghrelin (part 3) 
C: qRT-PCR analysis for the adipocytic markers PPARγ and C/EBPα. Data are mean Ct + SD (n = 
2, 3 replicate samples per condition in each assay; each sample was run in duplicate; Welch’s 
anova and Games-Howell post-hoc analyses). 
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Figure 5.7: qRT-PCR analysis of differentiation markers in 7F2 cells treated with 20 nM 
and 200 nM ghrelin (part 4) 
D: qRT-PCR analysis for the adipocytic markers PPARγ and C/EBPα. Data are fold change + SD, 
normalised to HRPT1 expression (n = 2, 3 replicate samples per condition in each assay; each 
sample was run in duplicate; Kruskal-Wallis tests and Dunn post-hoc analyses). 
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Figure 5.8: Role of GHSR in the effects of ghrelin on the adipogenic differentiation of 
7F2 cells: RT-PCR analysis 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 
20 nM ghrelin, and with or without GHSR blocker DLS. A; RT-PCR analysis of the osteoblastic 
markers osteocalcin, Runx2 and ALP. B: RT-PCR analysis of the adipogenic markers PPARγ, 
C/EBPα and Glut4 (n=1). 
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Figure 5.9: Role of GHSR in the effects of ghrelin on the adipogenic differentiation of 
7F2 cells: qRT-PCR analysis (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 
20 nM ghrelin, and with or without GHSR blocker DLS. After 7 days of culture, RNA was 
extracted and gene expression was analysed using RT-PCR. A; qRT-PCR analysis of the 
osteoblastic markers Runx2 and ALP. Data are fold change ± SD (n = 2, 3 replicate samples per 
condition in each assay, except for AM + Ghrl 20 nM + DLS and BM + Ghrl 20 nM + DLS, where 
the experiment was only performed once (n = 1), with only one sample per condition; each 
sample was run in duplicate). Expression was normalised to HPRT1. 
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Figure 5.9: Role of GHSR in the effects of ghrelin on the adipogenic differentiation of 
7F2 cells: qRT-PCR analysis (part 2) 
B: qRT-PCR analysis of the adipogenic markers C/EBPα and PPARγ. Data are fold change ± SD (n 
= 2, 3 replicate samples per condition in each assay, except for AM + Ghrl 20 nM + DLS and BM + 
Ghrl 20 nM + DLS, where the experiment was only performed once (n = 1), with only one sample 
per condition; each sample was run in duplicate). Expression was normalised to HPRT1. 
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Figure 5.10: No RT controls for the differentiation markers (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 20 nM ghrelin, and with or without GHSR blocker DLS. A; 
No RT controls of the RT-PCR analysis of the osteoblastic markers osteocalcin, Runx2 and ALP.  
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Figure 5.10: No RT controls for the differentiation markers (part 2) 
7F2 cells were cultured for 7 days with basal or adipogenic medium, with or without 20 nM ghrelin, and with or without GHSR blocker DLS. B: No RT 
controls of the RT-PCR analysis of the adipogenic markers PPARγ, C/EBPα and Glut4. 
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Figure 5.11: RT-PCR analysis for the KATP channel subunits 
mRNA was extracted from 7F2 cells cultured for 7 days with basal (BM) or adipogenic medium 
(AM) with or without 20 nM ghrelin, except for KCNJ11, which was only tested in cells cultured 
with basal or adipogenic medium alone. RT-PCR was performed for the two pore-forming KATP 
channel subunits: Kir6.1 (KCNJ8) and Kir6.2 (KCNJ11) (A), and the accessory subunits SUR1 
(ABCC8) and SUR2 (ABCC9) (B). For ABCC9, two sets of primers were used; the first set detected 
mRNA expression of all known ABCC9 isoforms, while the second set (SUR2AB) could 
distinguish between the two isoforms SUR2A and SUR2B.   
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Figure 5.12: qPCR analysis for KATP channel subunits (part 1) 
mRNA was extracted from 7F2 cells cultured for 7 days with basal (BM) or adipogenic medium 
(AM), with or without 20 nM ghrelin. A: qPCR analysis for Kir6.1 (KCNJ8) (n = 1, 3 replicate 
samples per condition; each sample was run in duplicate). Data are mean Ct ± SD (top graph; 
Welch’s anova and Games-Howell post-hoc analysis) and mean fold change ± SD (bottom graph; 
ANOVA test); the relative fold expression was normalised by the reference gene EEF2.  
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Figure 5.12: qPCR analysis for KATP channel subunits (part 2) 
B: qPCR analysis for SUR2 (Abcc9) (n = 1, 3 replicate samples per condition; each sample was 
run in duplicate). Data are mean Ct ± SD (top graph; Kruskal-Wallis test and Dunn post-hoc 
analysis) and mean fold change ± SD (bottom graph; Kruskal-Wallis test and Dunn post-hoc 
analysis); the relative fold expression was normalised by the reference gene EEF2. 
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Figure 5.13: RT-PCR analysis for the BK channel subunits 
mRNA was extracted from 7F2 cells cultured for 7 days with basal (BM) or adipogenic (AM) 
medium, with or without 20 nM ghrelin. RT-PCR was performed for the pore-forming subunit 
KCNMA1, and for the four regulatory subunits KCNMB1 to KCNMB4.  
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Figure 5.14: qPCR analysis for Kcnma1 
mRNA was extracted from 7F2 cells cultured for 7 days with basal (BM) or adipogenic (AM) 
medium, with or without 20 nM ghrelin. qPCR analysis was performed for Kcnma1 (n = 1, 3 
replicate samples per condition; each sample was run in duplicate). Data are mean Ct ± SD (top 
graph; ANOVA test and Tukey-Kramer post-hoc analysis) and fold change ± SD (bottom graph; 
ANOVA test and Tukey-Kramer post-hoc analysis); the relative fold expression was normalised 
by the reference gene EEF2.  
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Figure 5.15: Effects of TEA on 7F2 cell adipogenic differentiation (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM), with or without 
various concentrations of TEA (0.3 mM, 1 mM, and 3 mM) (n=4, with 2 or 3 replicates per 
repeat). A: Pictures of 7F2 cells at day 2. 
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Figure 5.15: Effects of TEA on 7F2 cell adipogenic differentiation (part 2) 
B: Pictures of 7F2 cells at day 4. 
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Figure 5.15: Effects of TEA on 7F2 cell adipogenic differentiation (part 3) 
C: Pictures of 7F2 cells at day 7. 
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Figure 5.15: Effects of TEA on 7F2 cell adipogenic differentiation (part 4) 
D: Pictures of 7F2 cells stained with Oil Red O after 7 days of culture. 
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Figure 5.15: Effects of TEA on 7F2 cell adipogenic differentiation (part 5) 
E: Oil Red O stain was extracted and quantified by measuring the absorbance at 490 nm. F: 
Quantification data was normalised to basal medium. Data are mean absorbance ± SD (n = 4; 2-3 
replicates per condition in each assay for a total of 10 replicates; Kruskal-Wallis tests).   
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Figure 5.16: Effects of TEA of cell numbers 
7F2 cells were cultured with basal (BM) or adipogenic medium (AM), with or without TEA in 
various concentrations (0.3 mM, 1 mM and 3 mM). Cells were counted after 7 days of culture (n 
= 1, 2 replicates per condition; Kruskal-Wallis test). 
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Figure 5.17: Effects of diazoxide on the adipogenic differentiation of 7F2 cells (part 1) 
7F2 cells were cultured for 7 days with basal (BM) or adipogenic medium (AM) for 3 days, then 
culture medium was replaced with medium containing various concentrations of diazoxide (1 
µM, 10 µM and 100 µM) (n=3, with 3 or 4 replicates per repeat). A; Pictures of 7F2 cells at day 7 
of culture.  
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Figure 5.17: Effects of diazoxide on the adipogenic differentiation of 7F2 cells (part 2) 
B: Pictures of 7F2 cells stained with Oil Red O after 7 days of cultures.  
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Figure 5.17: Effects of diazoxide on the adipogenic differentiation of 7F2 cells (part 3) 
C: Oil Red O stain was extracted and quantified by measuring the absorbance at 490 nm. D: 
Quantification data was normalised to basal medium (n = 3, 3-4 replicates per condition in each 
assay for a total of 10 replicates; Kruskal-Wallis tests).   
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6.1. Introduction 
As established in the main introduction (see chapter 1), ion channels, and particularly 
potassium channels, are involved in regulating major cell processes such as 
proliferation and differentiation, particularly in bone. Ion channels have also been 
involved in mediating ghrelin signalling in various tissues.  
6.1.1. Ionic mechanisms in ghrelin signalling 
Ion channels, particularly calcium and potassium channels, are involved in mediating 
the effects of ghrelin signalling in various cell types. GHSR is a GPCR and GHSR 
activation can in turn activate ion channels via various G proteins. In the brain, GHSR1a 
is coupled to phospholipase C and inositol phosphate production through the G 
proteins Gαq/Gα11, triggering Ca2+ entry from intracellular stores (Holst et al., 2003; 
Alexander SPH et al., 2011b). Activation of phospholipase C may also lead to tyrosine 
phosphorylation of potassium channels, which inhibits these channels and causes 
membrane depolarisation, activating L-type voltage-gated calcium channels and 
stimulating GH secretion (Petersenn et al., 2001). In neurons of the arcuate nucleus, 
GHSR1a has been reported to activate the G protein Gαs, leading to activation of protein 
kinase A (PKA) and increased cytoplasmic Ca2+ via opening of N-type Ca2+ channels 
(Kohno et al., 2003). In addition, the orexigenic actions of ghrelin in the nodose ganglia 
are mediated by KATP channels containing the Kir6.2 subunit (Grabauskas et al., 2015). 
Ghrelin signalling is also mediated by ion channels in other organs. Ghrelin has been 
shown to increase T-type Ca2+ channel expression and inhibit proliferation in PC-3 
human prostate carcinoma cells (Díaz-Lezama et al., 2010). Ghrelin and des-acyl 
ghrelin exert vasodilator effects in rat mesenteric vascular bed via activation of small- 
and intermediate-conductance Ca2+-activated K+ channels, inwardly-rectifying K+ 
channels and the Na+/K+ ATPase pump (Moazed et al., 2009). In the pancreas, ghrelin 
attenuates glucose-induced insulin secretion from pancreatic beta cells via its receptor 
GHSR1a, the G protein Gαi2 and the activation of delayed outward voltage-gated K+ 
channels Kv2.1 (Dezaki et al., 2007; Yada et al., 2014). Ghrelin binding to GHSR1a 
activates the G protein Gαi2, decreasing cAMP production and activating voltage-gated 
potassium channels, which attenuates membrane excitability and suppresses glucose-
induced Ca2+ entry into the cytosol, suppressing insulin release (figure 6.1). This effect 
is diminished in the presence of TEA, which blocks voltage-dependent potassium 
channels (Im and Quandt, 1992; Quandt and Im, 1992; Dezaki et al., 2004); 30 mM TEA 
has been reported to block K+ currents through Kv2.1 by 87% (Ikeda and Korn, 1995). 
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In addition, perforated-patch clamp experiments in rat pancreatic beta cells indicate 
that ghrelin increases the amplitude of KV currents in a reversible manner at potentials 
positive to – 30 mV. This effect is not blocked by tolbutamide, which is a blocker of KATP 
channels, but is suppressed in the presence of TEA and stromatoxin, which is a specific 
blocker of Kv2.1 (Dezaki et al., 2007).  
 
Figure 6.1: Ghrelin inhibits insulin secretion via activation of Kv2.1  
Ghrelin binds and activates GHSR1a, which in turn activates Gαi2, leading to decreased cAMP 
production and activation of Kv2.1 channels. Activation of Kv2.1 channels reduces membrane 
excitability, inhibiting voltage-dependent Ca2+ channels and blocking the entry of Ca2+ in the 
cytosol, which suppresses insulin release. Adapted from (Alamri et al., 2016). 
6.1.2. Chapter objectives and hypothesis 
As ion channels are known to be involved in regulating cell proliferation and 
differentiation, and in mediating ghrelin signalling, the objective of this chapter was to 
investigate and compare the electrophysiological properties of 7F2 osteoblast-like cells 
and 7F2 cell-derived adipocytes, and the effects of ghrelin treatment on these, using 
electrophysiology techniques. Ion channel activity was recorded in single-channel 
patch clamping experiments. The hypothesis was that adipogenic differentiation and 
ghrelin treatment would modify the electrophysiological properties of 7F2 osteoblast-
like cells.  
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6.2. Materials and Methods 
6.2.1. Adipogenic differentiation and ghrelin treatment of 7F2 cells 
7F2 cells were cultured for 1-7 days on 16 mm circular glass coverslips at seeding 
densities of 3,000 cells with basal or adipogenic medium and, where indicated, treated 
with 20 nM ghrelin (Cambridge Bioscience) for 3 to 7 days.  
6.2.2. Electrophysiology 
See section 2.4.  
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6.3. Results 
The number of successful patches was 38 for 7F2 cells cultured with BM (success rate: 
46.9 %), 30 successful patches for 7F2 cells cultured with AM (71.4%), 53 successful 
patches for 7F2 cells cultured with AM + Ghrl (74.6%) and 21 successful patches for 
7F2 cells cultured with BM + Ghrl (48.8 %) (table 6.1). When 7F2 cells were cultured 
with adipogenic medium, only cells containing lipid droplets were selected for 
electrophysiological study. Cell-attached patches were disrupted and spontaneously 
excised to inside-out configuration patches very readily, especially in cells cultured 
with adipogenic medium, but a few patches remained cell-attached (table 6.1). Patch 
configurations are illustrated in figure 6.2. 
Analysis of single channel data indicated the presence of several currents: 22 currents 
were detected in 7F2 cells cultured with BM, 12 currents were detected in 7F2 cells 
cultured with AM, 19 currents were detected in 7F2 cells cultured with AM + Ghrl and 
12 currents in 7F2 cells cultured with BM + Ghrl (table 6.2). Some of these currents 
were similar, and a few patches presented several types of currents. Other potential 
currents were detected but too little data were obtained through infrequent 
appearances in recordings, which prevented reliable characteristation of these 
currents. The various currents detected in patch-clamp experiments were categorised 
according to their electrophysiological characteristics (summarised in table 6.3), 
including mean conductance and similarities in current amplitudes and voltage range 
of activation. Conductance (γ) was calculated according to γ = V/I, by linear regression 
over the linear portions of the current-voltage plots.  
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BM AM AM + Ghrl BM + Ghrl 
Number of attempts 81 42 71 43 
Number of successful patches 38 30 53 21 
Number of currents detected 22 12 19 12 
Cell-attached patches 7 4 3 8 
Excised inside-out patches 3 5 12 3 
Undetermined patch configuration 12 3 4 1 
Table 6.1: Summary of electrophysiology recordings 
 
Current/Mean conductance BM AM AM + Ghrl BM + Ghrl 
Current 1: 6.2 ± 3 pS     ✓ ✓ 
Current 2: 6.5 ± 4.1  pS     ✓ ✓ 
Current 3: 28.5 ± 2 pS ✓   ✓ ✓ 
Current 4: 34.1 ± 1 pS ✓       
Current 5: 42.1 ± 5.4 pS ✓ ✓ ✓   
Current 6: 67.5 ± 2.1 pS     ✓   
Current 7: 80.8 pS        ✓ 
Current 8: 158.4 pS ✓       
Current 9: 200.1 pS       ✓ 
Current 10: 6.3 pS  from -70 to 
+60 mV; 65,9 pS from +60 to 
+150 mV 
✓   ✓   
Current 11: 1,3 pS from -150 
mV to -40 mV; 28,7 pS from -40 
mV to +80 mV 
  ✓     
Current 12: 14.6 pS from +20 to 
+100 mV and 233.3 pS from 
+110 to +140 mV 
    ✓   
Table 6.2: List of the currents detected 
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Conductance Reversal potential 
Voltage-
sensitive? 
Voltage-
dependent? 
Rectifying? 
6.2 ± 3 pS 
 
Yes Yes Yes 
6.5 ± 4.1  pS 
  
Yes 
 
28.5 ± 2 pS 
Cell-attached: 
-69.2 ± 10.5 mV (-109 mV 
for AM + Ghrl; -81 mV for 
BM + Ghrl); 
Excised-inside out: -55 mV 
Yes Yes No 
34.1 ± 1 pS 
Unknown patch 
configuration: 
-22.5 ± 0.7 mV 
Yes No 
Weakly 
rectifying 
42.1 ± 5.4 pS 
Cell-attached: 
-2.4 ± 9.1 mV 
Excised inside-out: 
-24 ± 8.5 mV 
Yes No 
Weakly 
rectifying 
67.5 ± 2.1 pS Excised inside-out: -36 mV Weakly No No 
80.8 pS Excised inside-out: -60 mV 
 
Yes 
 
158.4 pS 
 
Yes Yes 
 
200.1 pS Cell-attached: -24 mV 
 
Yes 
Weakly 
rectifying 
6.3 pS  from -70 to +60 
mV; 65,9 pS from +60 to 
+150 mV 
 
Yes No Yes 
1,3 pS from -150 mV to -
40 mV; 28,7 pS from -40 
mV to +80 mV 
Cell-attached: -16 mV;     
Excised inside-out: -17 mV   
Yes 
14.6 pS from +20 to 
+100 mV; 233.3 pS from 
+110 to +140 mV 
  
Yes 
 
Table 6.3: Summary of the characteristics of the currents detected 
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6.3.1. Small conductance currents 
6.3.1.1. Current 1 
This current was detected in 26% (n = 5) of successful patches of 7F2 cells cultured 
with adipogenic medium + 20 nM ghrelin in excised inside-out configurations, and 25% 
(n = 3) of successful patches of 7F2 cultured with basal medium + ghrelin in cell-
attached configurations. Representative current tracings of this channel activity and the 
corresponding I/V relationship are shown in figures 6.3 and 6.4. It was an inward 
current that increased linearly with increasing pipette voltage and had a mean 
conductance of 6.2 ± 3 pS in 7F2 cells cultured with adipogenic medium + ghrelin, and 
2.3 pS  ± 6.7 pS in 7F2 cells cultured with basal medium + ghrelin. No outward current 
was detected in these patches. 
6.3.1.2. Current 2 
This current was detected in 11% (n = 2) of successful patches of 7F2 cells cultured 
with adipogenic medium + 20 nM ghrelin (excised inside-out configurations), and in 
one successful patch of 7F2 cultured with basal medium + ghrelin; it is not known 
whether it was in cell-attached or in excised inside-out configuration. Representative 
current tracings of this channel activity and the corresponding I/V relationship are 
shown in figures 6.5 and 6.6. It was an outward current that increased linearly with 
increasing pipette voltage; it has a mean conductance of 6.5 ± 4.1 pS in 7F2 cells 
cultured with adipogenic medium + ghrelin, and 13.9 pS in 7F2 cells cultured with basal 
medium + ghrelin. 
6.3.1.3. Current 3 
This channel was detected in 13% (n=5) of successful patches of 7F2 cells cultured with 
basal medium (cell-attached configurations) and in 25% (n = 3) of successful patches of 
7F2 cultured with basal medium + ghrelin (cell-attached configurations). It was also 
detected in 21% (n=4) successful patches of 7F2 cells cultured with adipogenic medium 
+ 20 nM ghrelin; one was in cell-attached configuration, and three were in excised 
inside-out configurations. Representative current tracings of this channel activity and 
the corresponding I/V relationship are shown in figures 6.7, 6.8, 6.9 and 6.10. The 
current increased linearly with increasing electrode voltage and had a mean 
conductance of 28.5 ± 2 pS in 7F2 cells cultured with basal medium, 24.6 ± 4.1 pS in 
7F2 cells cultured with adipogenic medium + ghrelin, and 28.6 ± 3.7 pS in 7F2 cells 
cultured with basal medium + ghrelin.  
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6.3.1.4. Current 4 
This channel was detected in 5% (n=2) of successful patches of 7F2 cells cultured with 
basal medium. It was not possible to determine if the cell was still attached, or if the 
patch was in excised inside-out configuration. Representative current tracings of this 
channel activity and the corresponding I/V relationship are shown in figure 6.11. The 
current increased linearly with increasing pipette voltage, displayed inward 
rectification, and had a mean conductance of 34.1 ± 1 pS.  
6.3.1.5. Current 5 
This channel was detected in 13% (n=5) of successful patches of 7F2 cells cultured with 
basal medium (cell-attached configurations), 10% (n=3) of successful patches from 7F2 
cell-derived adipocytes (excised inside-out configurations), and 11% (n=2) of 
successful patches of 7F2 cells cultured with adipogenic medium + 20 nM ghrelin 
(undetermined patch configurations). Representative current tracings of this channel 
activity and the corresponding I/V relationship are shown in figures 6.12, 6.13 and 
6.14. The current increased linearly with increasing electrode voltage, displayed 
inward rectification, and had a mean conductance of 42.1 ± 5.4 pS in 7F2 cells cultured 
with basal medium, 39.9 ± 0.8 pS in 7F2 cells cultured with adipogenic medium, and 
43.3 ± 0.6 pS in 7F2 cells cultured with adipogenic medium + ghrelin.  
 
6.3.2. Intermediate conductance currents 
6.3.2.1. Current 6 
This current was detected in 11% (n=2) of successful patches of 7F2 cells cultured with 
adipogenic medium + 20 nM ghrelin in excised inside-out configurations. 
Representative current tracings of this channel activity and the corresponding I/V 
relationship are shown in figure 6.15. The current increased with increasing pipette 
voltage and had a mean conductance of 67.5 ± 2.1 pS.  
6.3.2.2. Current 7 
This current was detected in one successful patch of 7F2 cells cultured with basal 
medium + 20 nM ghrelin in excised inside-out configuration. Representative current 
tracings of this channel activity and the corresponding I/V relationship are shown in 
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figure 6.16. The current increased linearly with increasing pipette voltages and had a 
conductance of 80.8 pS. 
 
6.3.3. Large conductance currents 
6.3.3.1. Current 8 
This current was detected in 8% (n = 3) of patched 7F2 cells cultured in basal medium; 
two of these patches were in cell-attached configuration and one was in excised inside-
out configuration. This channel was not active spontaneously at 0 mV holding potential; 
it became active when voltages of   100 mV were applied several times, and then 
remained active over a large range of voltages (0 mV to +150 mV). In one of the cell-
attached patch and in the excised inside-out patch, only partial data could be recorded. 
Figure 6.17 shows data records corresponding to the cell-attached patch where the BK 
channel could be recorded over a full range of voltages (0 mV to +150 mV); the current 
increased linearly with increasing pipette voltage and had a conductance of 158.4 pS. 
Figure 6.18 shows the recording data for the large conductance channels detected in 
7F2 cells cultured in basal medium in excised inside-out configuration, although there 
is little data. The current had a conductance of 244.1 pS.  
6.3.3.2. Current 9 
This current was detected in one successful patch of 7F2 cells cultured with basal 
medium + 20 nM ghrelin in excised inside-out configuration. Representative current 
tracings of this channel activity and the corresponding I/V relationship are shown in 
figure 6.19. The current increased linearly with increasing pipette voltages and had a 
conductance of 200.1 pS. 
 
6.3.4. Rectifying currents 
3 types of rectifying currents were recorded. The first one (current 10) was detected in 
one cell-attached patch of 7F2 cells cultured with basal medium, and one excised 
inside-out patch of 7F2 cells cultured with adipogenic medium + 20 nM ghrelin. 
Representative current tracings of this channel activity and the corresponding I/V 
relationship are shown in figures 6.20 and 6.21. In 7F2 cells cultured with basal 
medium, this current had a 6.3 pS conductance from -70 mV to +60 mV and a 
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conductance of 65.9 pS from +60 mV to +150 mV. In 7F2 cells cultured with adipogenic 
medium + ghrelin, the conductance was 4 pS from -120 mV to 80 mV and 269.5 pS from 
80 to 100 mV.  
The second one (current 11) was detected in 6.7% (n = 2) of 7F2 cells cultured with 
adipogenic medium, one in a cell-attached configuration, and one in an excised inside-
out configuration. Both had very similar characteristics, with similar conductances and 
zero-current potentials. Representative current tracings of this channel activity and the 
corresponding I/V relationship are shown in figure 6.22. The current in the cell-
attached patch had a conductance of 1.3 pS from -150 mV to -40 mV and a conductance 
of 28.7 pS from -40 mV to +80 mV; in the excised inside-out patch, it had a conductance 
of 3.2 pS from -140 mV to -70 mV and a conductance of 30.9 pS from -60 mV to +70 mV.  
The third one (current 12) was detected in one excised patch from a 7F2 cell cultured 
with adipogenic medium + ghrelin (figure 6.23). It had a conductance of 14.6 pS from 
20 mV to 100 mV and 233.3 pS from 110 mV to 140 mV. 
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6.4. Discussion 
6.4.1. Problems encountered while recording electrophysiological data 
Several difficulties were met during electrophysiogical experiments; in particular, at 
times recordings contained a lot of electrical noise, which interfered with the 
characterisation of very small currents (< 2 pA) during analysis, especially at early 
stage experiments. Although this was filtered carefully, both during recording at 5 kHz 
and digitally afterwards at 20 kHz, it was impossible to separate the electrical noise 
from the signal sufficiently which prevented the analysis of ion channel kinetics such as 
dwell times, and probably artificially increased open probability.  
Attempts were made to further study the electrophysiological properties of 7F2 cells 
and adipocytes by whole-cell patch clamp experiments (fig. 6.2), which may have 
overcome many of the signal-to-noise ratio problems that occurred. This technique also 
allows testing various channel openers or blockers to characterise functional ion 
channels present in a cell, more easily than the single-channel patch clamp technique, 
which allows characterising a single ion channel, by calculating its conductance and 
investigating its kinetics. However, despite a very large number of attempts (n = 92) 
over many months of experimental time, the whole-cell configuration could not be 
obtained with 7F2 cells and 7F2 cell-derived adipocytes. Part of the problem was the 
difficulty in achieving high resistance seals (> 1 GΩ), as the whole-cell patch clamp 
methods require larger microelectrode tips (1-3 MΩ resistance instead of 4-8 MΩ for 
single-channel patch clamp); this may be due to the fact that cell membranes are not 
smooth, which was more likely to interfere with seal formation. Another part of the 
problem may have been membrane fragility: cell-attached patches were disrupted and 
spontaneously excised to inside-out configuration patches very readily, preventing 
whole-cell patch configurations.  
Attempts with an alternative technique, the perforated patch-clamp technique (fig. 6.2), 
were also made, to no avail (n = 22). This technique uses an antibiotic such as 
amphotericin B to create pores in the patch of membrane within the tip of the 
microelectrode. In the case of amphotericin B, these pores are permeable to the small 
monovalent ions (Na+, K+ and Cl-), allowing recording the currents carried by these ions, 
but present a physical barrier to impermeable ions (e.g. Ca2+) and molecules with a 
molecular weight above approximately 200 g/mol such as ATP. Amphotericin B usually 
acts within 15 minutes of entering in contact with the membrane, but in this study, it 
did not seem to work no matter how long the substance was left to act (> 30 min), or 
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what concentration was used (Lippiat, 2009; Ishibashi et al., 2012; Linley, 2013). 
Amphotericin B concentrations were between 200 and 400 µg/ml; concentrations 
could not be too high, as amphotericin B tends to prevent initial seal formation. In 
addition, the tip of the microelectrode was dipped in amphotericin B-free High K+ 
solution for 5-15 seconds, as advised in protocols, so that amphotericin B would need 
to diffuse to the tip before it could create pores in the membrane, and would not 
interfere with seal formation. Also, amphotericin B is light-sensitive, so the stock 
powder was stored wrapped in aluminium foil, as was the solution as soon as it was 
prepared, so the exposure to light would be limited. The inefficiency of this technique 
may also be due to the fact that cell-attached patches spontaneously excised to inside-
out configuration patches.  
In single-channel patch clamp experiments, cell-attached patches were disrupted very 
readily, especially in cells cultured with adipogenic medium, suggesting that cell 
membrane was fragile. After recording, the patch configuration was verified by 
checking seal resistance before and after moving the microelectrode away from the cell. 
If seal resistance suddenly changed (for example, dropping from > 2 GΩ to below 1 GΩ), 
then the patch was considered as cell-attached during recording; on the contrary, if seal 
resistance did not change when the microelectrode was moved away, then the patch 
was considered as excised during recording. It was assumed that the cell-attached 
patches spontaneously excised to inside-out configuration, not outside-out, due to the 
fact that outside-out configuration is usually obtained from a whole-cell configuration, 
which was found to be very difficult to achieve in this study, with 7F2 cells. 
With the available single-channel data, it was possible to calculate the unitary 
conductance and measure the open probability of several of the currents detected in 
7F2 osteoblastic and adipocytic cells; however, these data are not sufficient to identify 
the corresponding ion channels. That being said, candidates can be proposed for many 
of these currents. 
6.4.2. Ion channel candidates 
Some of the electrophysiological properties of 7F2 cells and 7F2 cell-derived 
adipocytes have been previously investigated in other studies (Henney, 2008; Li, 2012), 
but not extensively. Interestingly, these studies showed the presence of a number of 
different membrane currents in 7F2 cells, but no current was detected in 7F2 cell-
derived adipocytes. In particular, 7F2 osteoblastic cells possess a voltage-independent, 
small conductance (31 ± 7 pS) channel, a voltage-dependent, large conductance (154 ± 
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11 pS) K+ channel, and TRPV1 channels. The latter may be involved in regulation of 
differentiation into adipocytes (Henney, 2008). The present study reports the presence 
of 12 types of functional ion channels in both 7F2 cells and 7F2 cell-derived adipocytes, 
treated or not with ghrelin. 2 of the channels detected in previous studies, the voltage-
independent, small conductance (31 ± 7 pS) channel and the voltage-dependent, large 
conductance (154 ± 11 pS) K+ channel, may correspond to the 34.1 ± 1 pS channel and 
the 158.4 pS channel, respectively: they have similar characteristics and were present 
in 7F2 cells cultured with basal medium, but not adipogenic medium. The other 10 
currents detected in this study have not been reported in 7F2 cells before; hence, this 
thesis brings new information about ionic mechanisms in 7F2 osteoblasts and 7F2-cell 
derived adipocytes. It is likely that some of these currents are carried by ions other 
than potassium, in particular calcium and chloride ions.  
6.4.2.1. Currents detected only in 7F2 osteoblast-like cells 
Some of the currents were detected in 7F2 osteoblast-like cells only (with or without 
ghrelin), and may be osteoblast-like-specific, such as the 34.1 ± 1 pS and the large 
conductance channels which are mentioned in the previous section. The 34.1 ± 1 pS 
channel may correspond to ClC-Ka; this channel, when co-expressed with the accessory 
beta-subunit barttin, is constitutively active, has a conductance of 34-40 pS, and has 
voltage-independent open probability (Fischer et al., 2010; L’Hoste et al., 2013). 
Alternatively, the 34.1 pS conductance channel may correspond to the two P domain K+ 
channel K2P1.1. This family of channels mediate many of the background K+ currents 
and activate over the physiological voltage-range (Alexander Stephen PH et al., 2017); 
they are expressed in human osteoblasts and are involved in regulating bone 
remodelling (Hughes et al., 2006). The K2P1.1 current-voltage relationship is nearly 
linear in symmetrical 140 mM K+ across the membrane and the channel has a 
conductance of 32 ± 2.2 pS with a reversal potential of 0 mV (Rajan et al., 2005). Here 
however, the 34.1 pS conductance channel had a reversal potential of -22.5 ± 0.7 mV.   
The large conductance channel had a unitary conductance of 158.4 pS in cell-attached 
configuration, and 244.1 pS in excised inside-out configuration. This channel seemed to 
behave like the BK channel: it gave rise to large currents (> 20 pA at > 100 mV), was 
voltage-sensitive and was not spontaneously active, but instead required the 
membrane to be depolarised/hyperpolarised several times to open, after which it 
remained active. The conductance was a little low in cell-attached configuration but 
still in the very broad window of conductance values for this channel type (150 - 300 
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pS). The fact that this channel was only detected in 3 patches is consistent with the RT-
PCR and qRT-PCR data for the BK channel subunits (see Chapter 5), which indicated 
low expression levels, and further suggests that BK channels do not play a central role 
in 7F2 cells. 
6.4.2.2. Currents detected only in 7F2 cells treated with ghrelin 
Some currents were only detected when 7F2 cells were cultured with 20 nM ghrelin; in 
particular, the inward, 6.2 ± 3 pS current and the outward, 6.5 ± 4.1  pS current. In 
addition, no intermediate conductance current was recorded in the absence of ghrelin 
treatment, whereas a 67.5 ± 2.1 pS conductance current was detected in 7F2 cells 
cultured with adipogenic medium + ghrelin, and a 80.8 pS conductance current was 
detected in 7F2 cells cultured with basal medium + ghrelin. Ghrelin treatment may 
have promoted the expression of the corresponding ion channels.  
The inward, 6.2 ± 3 pS conductance channel was voltage-dependent, as it was not 
activated at voltages > 0 mV. It was also clearly voltage-sensitive, as open probability 
decreased with increasing pipette voltage (toward depolarising voltages). It may 
correspond to two inwardly rectifying potassium channels, Kir2.4 or Kir2.3, although 
the conductance was lower than what was reported for these two channels (Alexander 
Stephen PH et al., 2017). Alternatively, these ion channels may belong to another 
family, such as calcium channels; the T-type Ca2+ channel (Cav3.1) has a conductance of 
7 pS (Monteil et al., 2000).  
The 6.5 pS conductance, outward current may correspond to various ion channels. 
Voltage-dependency could not be determined as open probability could not be analysed 
for these channels, due to the presence of several types of currents in the recordings. 
However, various voltage-gated potassium channels give rise to outward currents with 
similar conductances, such as Kv1.1, Kv1.3, Kv1.4, Kv1.5, Kv1.6 or Kv2.1 (Alexander 
Stephen PH et al., 2017). Interestingly, Kv2.1 has been associated with ghrelin and 
leptin signalling in several studies.  Indeed, Kv2.1 is involved in ghrelin regulation of 
insulin release in pancreatic beta cells; ghrelin has been shown to increase Kv2.1 
current amplitudes, inhibiting membrane excitability and insulin secretion (Dezaki et 
al., 2007; Yada et al., 2014). Leptin has been shown to increase Kv2.1  and KATP channel 
densities in the same cell type, which may also inhibit membrane excitability and 
insulin secretion (Wu et al., 2015). Kv2.1 expression has been identified in human 
primary osteoblasts (Pangalos et al., 2011; Li et al., 2013b); it is also expressed in 
adipocytes derived from human bone MSCs and is involved in regulating adipogenic 
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differentiation (You et al., 2013). RT-PCR and qRT-PCR analysis should be performed to 
verify if 7F2 cells express this ion channel, and whether it is upregulated when 7F2 
cells are treated with ghrelin. Also, using specific Kv2.1 blockers such as stromatoxin or 
guangxitoxin in electrophysiology experiments would confirm that this channel is 
present and functional.  
Two intermediate conductance channels were detected in 7F2 cells treated with 20 nM 
ghrelin. The 67.5 pS conductance channel was voltage-independent; this channel may 
correspond to the Ca2+-activated intermediate conductance K+ channel (KCa3.1) 
(Alexander Stephen PH et al., 2017). It could also have been a KATP channel containing 
Kir6.2, encoded by Kcnj11; however, this subunit was not detected by RT-PCR analysis 
(see Chapter 5). The other intermediate conductance current was detected in 7F2 cells 
cultured with basal medium + 20 nM ghrelin; it was a 80.8 pS conductance, outward 
current and it may correspond to K2P2.1, which has been reported to have a 
conductance of 85 pS in rats (Alexander Stephen PH et al., 2017). 
6.4.2.13. Currents detected in 7F2 cells both in absence and in presence of ghrelin 
Several currents were detected 7F2 cells both in absence and in presence of ghrelin 
treatment. In particular, the 28.5 pS conductance current, was one of the most 
frequently observed currents. It was identified in 13% of patches from 7F2 cells 
cultured with basal medium (n = 5), 21% of patches from 7F2 cells cultured with 
adipogenic medium + ghrelin (n = 4) and 25% of patches from 7F2 cells cultured with 
basal medium + ghrelin (n = 3). This channel was activated by depolarising voltages. In 
cells cultured with basal medium with or without ghrelin, open probability seemed to 
decrease very slightly with increasing pipette voltage. However, electrical noise 
certainly artificially increased open probability at lower voltages (0 mV to +20 mV), 
suggesting that open probability was not affected by changes in pipette voltage, and 
that this ion channel was voltage-independent. However, in cells cultured with 
adipogenic medium + ghrelin, open probability increased with increasing pipette 
voltage between 0 mV and +60 mV, then plateaued between +60 mV and +140 mV, 
indicating that the ion channel was voltage-sensitive. This ion channel may correspond 
to the voltage-gated K+ channel Kv3.1, which has been reported to have a conductance 
of 27.0 pS in mouse and is present in unexcitable cells (Yasuda et al., 2013; Alexander 
Stephen PH et al., 2017). 
Another ion channel, the 43.3 pS conductance channel, was present in 13% (n=5) of 
cells cultured with basal medium, 10% (n=3) of cells cultured with adipogenic medium, 
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and in 11% (n=2) of 7F2 cells cultured with adipogenic medium + 20 nM ghrelin. 
Similarly to the 28.5 pS conductance channel, open probability decreased with 
increasing pipette voltage in patches from 7F2 cells cultured with basal or adipogenic 
medium alone, suggesting that the ion channel was voltage-sensitive, but when 7F2 
cells were cultured with adipogenic medium + ghrelin, open probability increased with 
depolarising voltages. The channel displayed inward rectification and may correspond 
to two ion channels: Kir6.1/SUR2B and Kir1.1/SUR2B. Kir6.1/SUR2B has a 
conductance of 32.9-50 pS (Alexander Stephen PH et al., 2017); a study reported that 
Kir6.1/SUR2B had a conductance of 32.9 pS both in cell-attached and excised inside-out 
patches, with a microelectrode containing 145 mM K+ (Yamada et al., 1997). Here, 
microelectrodes contained 140 mM K+. In addition, 7F2 cells express both Kir6.1 and 
SUR2B subunits. Alternatively, the inward rectifier channel Kir1.1 can also associate 
with SUR2B and has a conductance of 39.0 pS in rats; this channel is a very weak 
inward rectifier: it gives rise to outward currents, while strong inward rectifiers only 
give rise to inward currents. Kir1.1/SUR2B is regulated by ATP (Ho et al., 1993; 
Alexander Stephen PH et al., 2017).  
Finally, several currents with two conductances were recorded in this study. 7F2 cells 
cultured with basal medium alone and with adipogenic medium + ghrelin possessed an 
outward current that had a conductance of 6.3 pS from – 70 to + 60 mV, and a 
conductance of 65.9 pS from + 60 to + 150 mV. Another channel that gave rise to 
outward currents with two conductances was recorded in 7F2 cells cultured with 
adipogenic medium + ghrelin; it had a conductance of 14.6 pS from + 20 to + 100 mV, 
and a conductance of 233.3 pS from + 100 mV to + 140 mV. These channels may 
correspond to ion channels other than potassium channels, such as calcium or chloride 
channels.  
7F2 cells cultured with adipogenic medium possessed a current displaying outward 
rectification, with a conductance of 1.3 pS from – 150 to – 40 mV, and a conductance of 
28.7 pS from – 40 to + 80 mV. The current-voltage plots were similar to that of the two 
P domain potassium channel K2P4.1 in the presence of 150 nM Na+; however, in the 
present study, this current was recorded in the presence of symmetric 140 mM K+ 
(Leonoudakis et al., 1998; Alexander Stephen PH et al., 2017). Alternatively, this 
channel may correspond to various chloride (Cl-) channels, such as the volume-
regulated anion channel (VRAC) or ClC-3. VRAC has a conductance of 10-20 pS at 
negative potentials, and 50-90 pS at positive potentials (Alexander Stephen PH et al., 
2017), although here the conductance at positive potentials was much lower (28.7 pS). 
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This channel displays outward rectification and has been reported to play a role in 
regulating membrane excitability, cell proliferation (Hoffmann et al., 2014) and insulin 
release from pancreatic β cells (Best et al., 2010). The ClC-3 channel has an inward 
conductance of 12.8 ± 1.8 pS and an outward conductance of 39.7 ± 0.6 pS (Duan et al., 
1997), which is closer to the current recorded in this study.  
6.4.3. Chapter conclusions 
Due to a lack of consistent evidence, it is difficult to make any firm conclusions about 
the identity of the ion channels recorded in this study; further work with 
pharmacological agents (specific channel blockers or openers) and RT-PCR analysis 
would be useful to confirm the identity of these channels. Subunits corresponding to BK 
channels and KATP channels were detected by RT-PCR analysis (Chapter 5), and 
currents that may correspond to these channels were recorded, suggesting that they 
are expressed at the protein level and functional; but the identity of the other ion 
channels detected in this study remains to be elucidated. Hence, it is difficult to accept 
or reject the hypothesis that adipogenic differentiation modified the 
electrophysiological properties of 7F2 osteoblast-like cells. 
However, the hypothesis that ghrelin had an impact on the electrophysiogical 
properties of 7F2 cells was accepted. Overall, ghrelin seemed to have two effects on 7F2 
cell electrophysiological properties: some currents were only detected in 7F2 cells 
cultured with ghrelin, and ghrelin modified the open probabilities of some currents that 
were detected in 7F2 cells both in presence and in absence of ghrelin. Future work may 
investigate whether the currents detected in 7F2 cells treated with ghrelin are carried 
by ion channels whose expression is induced by ghrelin. 
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Figure 6.2: Patch configurations for electrophysiological recording. 
In the perforated-patch clamping technique, the recording microelectrode contains an antibiotic 
in addition to intracellular solution; here it contained High K+ solution and amphotericin B. 
Adapted from (Ogden and Stanfield, 1994) 
  
Chapter 6 – A comparison of the electrophysiological characteristics of osteoblasts and 
adipocytes, and the effects of ghrelin on these 
175 
 
 
Figure 6.3: Current 1 in 7F2 cells cultured with adipogenic medium + 20 nM ghrelin 
(part 1) 
A: Typical recordings of current 1 in cell-attached patch configuration. Bath solution was Na+ 
Locke and pipette solution was high-K+ medium. Downward deflections represent ion channel 
opening. 
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Figure 6.3: Current 1 in 7F2 cells cultured with adipogenic medium + 20 nM ghrelin 
(part 2) 
B: Corresponding current-voltage data plot. Data points were derived from fitting amplitude 
histograms at each membrane potential. Lines of best fit yielded a conductance of 8.3 pS. C: 
Corresponding open probability plot. NPo (Po/3) was used as a measure of open probability, as 
there were at least 3 currents of the same type in this patch; NPo decreased with increasing 
pipette voltage, indicating that this channel is voltage-sensitive. D: Current-voltage relationship 
for current 1 in cell-attached patches from 7F2 cells cultured with adipogenic medium + 20 nM 
ghrelin; each data point represents the average channel current calculated from amplitude 
histograms (mean ± SD of 5 patches from different cells).  
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Figure 6.4: Current 1 in 7F2 cells cultured with basal medium + 20 nM ghrelin (part 1) 
A: Typical recordings of current 1 in cell-attached patch configuration. Bath solution was Na+ 
Locke and pipette solution was high-K+ medium. Downward deflections represent ion channel 
opening. 
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Figure 6.4: Current 1 in 7F2 cells cultured with basal medium + 20 nM ghrelin (part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 6.5 pS. 
Data points were derived from fitting amplitude histograms at each membrane potential. 
Probability of opening could not be analysed as all these patches exhibited several types of 
currents. C:  Current-voltage relationship for current 1 in cell-attached patches from 7F2 cells 
cultured with basal medium; each data point represents the average channel current calculated 
from amplitude histograms (mean ± SD of 3 patches from different cells). 
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Figure 6.5: Current 2 in 7F2 cells cultured with adipogenic medium + 20 nM ghrelin 
(part 1) 
A: Typical recordings of the current 2 in excised inside-out patch configuration. Bath solution 
was Na+ Locke and pipette solution was high-K+ medium. Downward deflections represent ion 
channel opening. 
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Figure 6.5: Current 2 in 7F2 cells cultured with adipogenic medium + 20 nM ghrelin 
(part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 8.0 pS. 
Data points were derived from fitting amplitude histograms at each membrane potential. C: 
Current-voltage relationship for current 2 in cell-attached patches from 7F2 cells cultured with 
adipogenic medium + 20 nM ghrelin; each data point represents the average channel current 
calculated from amplitude histograms (mean ± SD of 2 patches from different cells). Probability 
of opening could not be analysed as all these patches exhibited several types of currents. 
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Figure 6.6: Current 2 in 7F2 cells cultured with basal medium + 20 nM ghrelin 
A: Typical recordings of the 6.5 pS conductance channel current. Bath solution was Na+ Locke 
and pipette solution was high-K+ medium. Upward deflections represent ion channel opening. B: 
Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 13.9 pS. Data 
points were derived from fitting amplitude histograms at each membrane potential. Probability 
of opening could not be analysed as this patch exhibited several types of currents.  
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Figure 6.7: Current 3 in 7F2 cells cultured with basal medium (part 1) 
A: Typical recordings of the current 3 in cell-attached patch configuration. Bath solution was Na+ 
Locke and pipette solution was high-K+ medium. Upward deflections represent ion channel 
open-state currents. 
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Figure 6.7: Current 3 in 7F2 cells cultured with basal medium (part 2) 
B: Corresponding current-voltage data plot (n = 1). Line of best fit yielded a conductance of 30.7 
pS. Data points were derived from fitting amplitude histograms at each membrane potential. C: 
Corresponding Popen plot. Po decreased slightly with increasing pipette voltage. D: Current-
voltage relationship for the current 3 in cell-attached patches from 7F2 cells cultured with basal 
medium; each data point represents the average channel current calculated from amplitude 
histograms (mean ± SD of 5 patches from different cells). Reversal potential was -69.2 ± 10.5 
mV. 
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Figure 6.8: Current 3 in 7F2 cells cultured with adipogenic medium + ghrelin (cell-
attached) (part 1) 
A: Typical recordings of the current 3 in cell-attached patch configuration. Bath solution was Na+ 
Locke and pipette solution was high-K+ medium. Upward deflections represent ion channel 
opening. 
 
Chapter 6 – A comparison of the electrophysiological characteristics of osteoblasts and 
adipocytes, and the effects of ghrelin on these 
185 
 
 
Figure 6.8: Current 3 in 7F2 cells cultured with adipogenic medium + ghrelin (cell-
attached) (part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 18.8 pS. 
Data points were derived from fitting amplitude histograms at each membrane potential. C: 
Corresponding open probability plot. NPo (Po/5) was used as a measure of open probability, as 
there were at least 5 currents of the same type in this patch; NPo increased with increasing 
pipette voltages from 0 mV to +60 mV, then plateaued at ~0.2. Reversal potential was -109 mV. 
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Figure 6.9: Current 3 in 7F2 cells cultured with adipogenic medium + ghrelin (excised 
inside-out) (part 1) 
A: Typical recordings of the current 3 in excised inside-out patch configuration. Bath solution 
was Na+ Locke and pipette solution was high-K+ medium. Downward deflections represent ion 
channel opening. 
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Figure 6.9: Current 3 in 7F2 cells cultured with adipogenic medium + ghrelin (excised 
inside-out) (part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 27.4 pS. 
Data points were derived from fitting amplitude histograms at each membrane potential. C: 
Corresponding open probability plot. NPo (Po/5) was used as a measure of open probability, as 
there were at least 5 currents of the same type in this patch; NPo did not seem to vary with 
increasing pipette voltages. D: Current-voltage relationship for the current 3 in excised inside-
out patches from 7F2 cells cultured with adipogenic medium + 20 nM ghrelin; each data point 
represents the average channel current calculated from amplitude histograms (mean ± SD of 3 
patches from different cells). Reversal potential was -55 ± 3.6 mV. 
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Figure 6.10: Current 3 in 7F2 cells cultured with basal medium + ghrelin (excised 
inside-out) (part 1) 
A: Typical recordings of the current 3 in excised inside-out patch configuration. Bath solution 
was Na+ Locke and pipette solution was high-K+ medium. Downward deflections represent ion 
channel opening. 
Chapter 6 – A comparison of the electrophysiological characteristics of osteoblasts and 
adipocytes, and the effects of ghrelin on these 
189 
 
 
Figure 6.10: Current 3 in 7F2 cells cultured with basal medium + ghrelin (excised 
inside-out) (part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 33.4 pS. 
Data points were derived from fitting amplitude histograms at each membrane potential. C: 
Corresponding open probability plot. NPo (Po/3) was used as a measure of open probability; 
NPo decreased with increasing pipette voltage. D: Current-voltage relationship for the current 3 
in excised inside-out patches from 7F2 cells cultured with adipogenic medium + 20 nM ghrelin; 
each data point represents the average channel current calculated from amplitude histograms 
(mean ± SD of 3 patches from different cells). Reversal potential was -81 ± 6.1 mV. 
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Figure 6.11: Current 4 in 7F2 cells cultured with basal medium (part 1) 
A: Typical recordings of the current 4 in a cell-attached patch from a 7F2 cell cultured with basal 
medium. Bath solution was Na+ Locke and pipette solution was high-K+ medium. Downward 
deflections correspond to inward currents and upward deflections correspond to outward 
currents. 
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Figure 6.11: Current 4 in 7F2 cells cultured with basal medium (part 2) 
B: Corresponding current-voltage plot. Data points were derived from fitting amplitude 
histograms at each membrane potential. C: Corresponding open probability; NPo (Po/3) was 
used as there were at least three channels of same family in this patch; NPo decreased from -120 
mV to 0 mV, increased from 0 mV to +100 mV, then decreased again, suggesting that this 
channel was voltage-sensitive. D: Current-voltage relationship for the current 4 in cell-attached 
patches from 7F2 cells cultured with basal medium; each data point represents the average 
channel current calculated from amplitude histograms (mean ± SD of 2 patches from different 
cells). Reversal potential was -22.5 ± 0.7 mV. 
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Figure 6.12: Current 5 in 7F2 cells cultured with basal medium (part 1) 
A: Typical recordings of the current 5 in cell-attached patch configuration. Bath solution was Na+ 
Locke and pipette solution was high-K+ medium. Upward deflections represent ion channel 
opening. 
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Figure 6.12: Current 5 in 7F2 cells cultured with basal medium (part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 49.2 pS. 
Data points were derived from fitting amplitude histograms at each membrane potential. C: 
Corresponding Popen plot. Po tended to decrease with increasing pipette voltage, indicating that 
this channel was voltage-dependent. D: Pooled current-voltage relationship for the current 5 in 
cell-attached patches from 7F2 cells cultured with basal medium; each data point represents the 
average channel current calculated from amplitude histograms (mean ± SD of 5 patches from 
different cells). Reversal potential was -2.4 ± 9.1 mV. 
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Figure 6.13: Current 5 in 7F2 cells cultured with adipogenic medium (part 1) 
A: Typical recordings of the current 5 in excised inside-out patch configuration. Bath solution 
was Na+ Locke and pipette solution was high-K+ medium. Downward deflections represent ion 
channel opening. 
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Figure 6.13: Current 5 in 7F2 cells cultured with adipogenic medium (part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 40.9 pS. 
Data points were derived from fitting amplitude histograms at each membrane potential. C: 
Corresponding Popen plot. Po decreased with increasing pipette voltage, indicating that this 
channel was voltage-dependent. D: Pooled current-voltage relationship for the current 5 in cell-
attached patches from 7F2 cells cultured with adipogenic medium (n=3); data are mean current 
(pA) ± SD. Reversal potential was +24 ± 8.5 mV. 
  
Chapter 6 – A comparison of the electrophysiological characteristics of osteoblasts and 
adipocytes, and the effects of ghrelin on these 
196 
 
 
Figure 6.14: Current 5 in 7F2 cells cultured with adipogenic medium + ghrelin (part 1) 
A: Typical recordings of the current 5. Bath solution was Na+ Locke and pipette solution was 
high-K+ medium. Inward and upward deflections from the dotted line represent ion channel 
opening. 
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Figure 6.14: Current 5 in 7F2 cells cultured with adipogenic medium + ghrelin (part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 42.9 pS. 
Data points were derived from fitting amplitude histograms at each membrane potential. C: 
Corresponding open probability plot. NPo (Po/4) was used as a measure of open probability; 
NPo decreased then increased again with increasing pipette voltages. D: Current-voltage 
relationship for the current 5 in cell-attached patches from 7F2 cells cultured with adipogenic 
medium + 20 nM ghrelin; each data point represents the average channel current calculated 
from amplitude histograms (mean ± SD of 2 patches from different cells). Reversal potential was 
-21.5 ± 3.5 mV.  
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Figure 6.15: Current 6 in 7F2 cells cultured with adipogenic medium + ghrelin (part 1) 
A: Typical recordings of the current 6 in excised inside-out configuration. Bath solution was Na+ 
Locke and pipette solution was high-K+ medium. Inward and upward deflections from the 
dotted line represent ion channel opening. 
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Figure 6.15: Current 6 in 7F2 cells cultured with adipogenic medium + ghrelin (part 2) 
B: Corresponding current-voltage data plot. Lines of best fit yielded a conductance of 66 pS. Data 
points were derived from fitting amplitude histograms at each membrane potential. C: 
Corresponding open probability plot; Popen did not change with increasing pipette voltages.. D: 
Current-voltage relationship for the current 6 in excised inside-out patches from 7F2 cells 
cultured with adipogenic medium + 20 nM ghrelin; each data point represents the average 
channel current calculated from amplitude histograms (mean ± SD of 2 patches from different 
cells). Reversal potential was -36 ± 1.4 mV. 
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Figure 6.16: Current 7 in 7F2 cells cultured with basal medium + ghrelin (part 1) 
A: Recordings of the current 7 in excised inside-out configuration. Bath solution was Na+ Locke 
and pipette solution was high-K+ medium. Upward deflections from the dotted line represent 
ion channel opening. Reversal potential was -60 mV.  
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Figure 6.16: Current 7 in 7F2 cells cultured with basal medium + ghrelin (part 2) 
B: Corresponding current-voltage data plot. Data points were derived from fitting amplitude 
histograms at each membrane potential. Open probability could not be analysed as there were 
several types of current in this patch. 
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Figure 6.17: Current 8 in 7F2 cells cultured with basal medium (cell-attached) (part 1) 
A: Current 8 in cell-attached patch from a 7F2 cell cultured with basal medium (n = 1). Bath 
solution was Na+ Locke and pipette solution was high K+ medium containing Amphotericin B 
(375 ug/ml). Upward deflections represent ion channel openings 
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Figure 6.17: Current 8 in 7F2 cells cultured with basal medium (cell-attached) (part 2) 
B: Corresponding current-voltage data plot. Data points were derived from fitting amplitude 
histograms at each membrane potential. Lines of best fit yielded a conductance of 158.4 pS. C: 
Corresponding open probability, which decreased with increasing pipette voltage, indicating 
that the current was voltage-sensitive. 
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Figure 6.18: Current 8 in 7F2 cells cultured with basal medium (excised inside-out) 
(part 1) 
A: Current 8 in excised inside-out patch from a 7F2 cell cultured with basal medium (n = 1). Bath 
solution was Na+ Locke and pipette solution was high K+ medium. Upward deflections represent 
ion channel openings. 
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Figure 6.18: Current 8 in 7F2 cells cultured with basal medium (excised inside-out) 
(part 2) 
B: Current-voltage data for the current 8. Data points were derived from fitting amplitude 
histograms at each membrane potential. Lines of best fit yielded a conductance of 244.1 pS. 
Open probability could not be obtained for this channel, as the patch where it was recorded 
exhibited three families of ion channels. 
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Figure 6.19: Current 9 in 7F2 cells cultured with basal medium + ghrelin (part 1) 
A: Recordings of the large conductance channel current in excised inside-out configuration. Bath 
solution was Na+ Locke and pipette solution was high-K+ medium. Inward and upward 
deflections from the dotted line represent ion channel opening. 
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Figure 6.19: Current 9 in 7F2 cells cultured with basal medium + ghrelin (part 2) 
B: Corresponding current-voltage data plot. Data points were derived from fitting amplitude 
histograms at each membrane potential. Open probability could not be analysed as there were 
several types of current in this patch. Reversal potential was +23 mV.  
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Figure 6.20: Current 10 in 7F2 cells cultured with basal medium (part 1) 
A: Current 10 in a cell-attached patch from 7F2 cells (n=1). Bath solution was Na+ Locke and 
pipette solution was high-K+ medium. Upward deflections represent ion channel opening. 
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Figure 6.20: Current 10 in 7F2 cells cultured with basal medium (part 2) 
B: Corresponding current-voltage plot. Data points were derived from fitting amplitude 
histograms at each membrane potential. C: Corresponding open probability; NPo (Po/2) was 
used as there were two channels of same family in this patch. NPo increased with increasing 
pipette voltage, and several channels were active when pipette voltage was higher than 40 mV, 
indicating that this channel was voltage-sensitive. 
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Figure 6.21: Current 10 in 7F2 cells cultured with adipogenic medium + ghrelin (part 1) 
A: Recordings of the two conductance channel current in excised inside-out configuration. Bath 
solution was Na+ Locke and pipette solution was high-K+ medium. Upward deflections from the 
dotted line represent ion channel opening. 
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Figure 6.21: Current 10 in 7F2 cells cultured with adipogenic medium + ghrelin (part 2) 
B: Corresponding current-voltage data plot. Data points were derived from fitting amplitude 
histograms at each membrane potential. C: Corresponding open probability plot. NPo (Po/5) 
was used as a measure of open probability. NPo increased from 0.02-0.06 to 0.15 with 
increasing pipette voltage. 
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Figure 6.22: Current 11 in 7F2 cells cultured with adipogenic medium (part 1) 
A: Typical recordings of the two conductance channel in a cell-attached patch from 7F2-cell 
derived adipocytes (n=1). Bath solution was Na+ Locke and pipette solution was high-K+ 
medium. Upward deflections represent ion channel opening. 
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Figure 6.22: Current 11 in 7F2 cells cultured with adipogenic medium (part 2) 
B: Corresponding current-voltage plot. Data points were derived from fitting amplitude 
histograms at each membrane potential. C: Corresponding open probability; NPo (Po/3) was 
used as there were two channels of same family in this patch. D: Current-voltage relationship for 
the two conductance channel in cell-attached patches from 7F2 cells cultured with adipogenic 
medium; each data point represents the average channel current calculated from amplitude 
histograms (mean ± SD of 2 patches from different cells). Reversal potential was -16.5 ± 0.7 mV.  
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Figure 6.23: Current 12 in 7F2 cells cultured with adipogenic medium + ghrelin (part 1) 
A: Recordings of the two conductance channel current (configuration unkown). Bath solution 
was Na+ Locke and pipette solution was high-K+ medium. Upward deflections from the dotted 
line represent ion channel opening.  
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Figure 6.23: Current 12 in 7F2 cells cultured with adipogenic medium + ghrelin (part 2) 
B: Corresponding current-voltage data plot. Each data point represents the average channel 
current calculated from amplitude histograms (mean ± SD). C: Corresponding open probability 
plot. NPo (Po/4) was used as a measure of open probability (mean ± SD). NPo increased from 
0.1 to 0.25 over the voltage range of 20 mV to 110 mV and then dropped to <0.05.  
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7.1. Summary of Key Findings 
The main aim of this thesis was to investigate the roles of ghrelin and ion channels, 
particularly K+ channels, in the adipogenic differentiation of 7F2 preosteoblastic cells. 
The key findings can be summarised as follows: 
- Treatment with adipogenic medium increased the lipid content of the cells, 
significantly upregulated the mRNA expression of the adipocytic markers 
PPARγ, C/EBPα and Glut4, and downregulated the expression of the 
osteoblastic markers osteocalcin and Runx2. ALP mRNA expression was not 
affected by adipogenic treatment.  
- 7F2 osteoblastic cells and 7F2 cell-derived adipocytes expressed the three key 
genes from ghrelin signalling (Ghsr, Ghrl and Mboat4), including previously un-
reported variants isoforms of Ghrl, one of which contained exon 1, intron 1, 
exon 2, intron 2, exon 3, and may also contain exons 4, intron 4 and 5. mRNA of 
the variant isoform retaining intron 2 was much more abundant than that of 
native ghrelin, and was upregulated by treatment with 20 nM and 200 nM 
ghrelin.  
- Ghrelin treatment did not seem to promote 7F2 cell proliferation, as there was 
no effect on cell numbers. 
- Ghrelin treatment did not seem to inhibit the adipogenic differentiation of 7F2 
cells; ghrelin treatment had no effect on the number and size of lipid droplets 
inside the cells, and it upregulated the mRNA expression of both osteoblastic 
and adipocytic markers, although the difference was not significant. This effect 
may be mediated by GHSR1a.  
- 7F2 cells and 7F2 cell-derived adipocytes expressed several K+ channel 
subunits, including KATP channel subunits (Kir6.1/SUR2B) and BK channel 
subunits (KCNMA1/KCNMB2) at the mRNA level.  
- Treatment with TEA, but not diazoxide, decreased 7F2 cell proliferation and 
adipogenic differentiation.  
- 12 types of functional ion channels were detected in electrophysiology 
experiments, some of which may correspond to BK channels and KATP channels 
composed of Kir6.1/SUR2B. Several currents were only detected in 7F2 cells 
treated with ghrelin, and ghrelin treatment seemed to modify the open 
probabilities of some currents that were detected both in presence and in 
absence of ghrelin. 
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7.2. Discussion of findings 
Ghrelin and ghrelin receptor agonists are emerging as promising therapeutic targets in 
the treatment of pathological conditions associated with aging, including the alterations 
in food intake, energy metabolism, cardiovascular function, neuronal activity, adaptive 
immunity and inflammation (Yin and Zhang, 2016). In particular, a decline in ghrelin 
activity may contribute to the aging-associated increase in adiposity, which is a 
common feature in several pathologies, including some forms of osteoporosis. 
Similarly, ion channels, and particularly potassium channels, have been shown to play 
an important role in regulating many cell processes such as proliferation, 
differentiation and apoptosis, but they are also involved in a number of pathologies, 
particularly in bone (Zhao et al., 2009; Schulz et al., 2010; O’Conor et al., 2013; Loukin 
et al., 2015). Hence, understanding the roles of ghrelin signalling and ion channels in 
pathological adipogenesis may provide new therapeutic targets to treat bone disorders 
such as osteoporosis. 
In this study, adipogenic differentiation of 7F2 cells was induced by treatment with 
dexamethasone and indomethacin. 7F2 cells are already committed to the osteogenic 
lineage but were still able to differentiate into adipocytes, illustrating the degree of 
plasticity between these two lineages. Others have shown that osteoblasts can trans-
differentiate into adipocytes and vice-versa (Song and Tuan, 2004; Kassem et al., 2008; 
Berendsen and Olsen, 2014; Greco et al., 2015). This may be relevant to humans, as 
some bone disorders such as osteoporosis are associated with increased bone marrow 
adipogenesis and decreased osteoblastogenesis and osteoblast function. BMSCs from 
elderly and osteoporotic patients tend to differentiate preferentially into adipocytes at 
the expense of osteoblasts (Rosen and Bouxsein, 2006; Sui et al., 2016; Wang et al., 
2016). Although several studies have shown that BMSCs derived from dexamethasone-
induced osteoporotic mice are more likely to differentiate into adipocytes (Li et al., 
2013a; Zhang et al., 2015), others have shown that BMSCs retain their differentiation 
potential, as these cells are still able to differentiate into osteoblasts, to levels that are 
comparable to that of BMSCs from younger and non-osteoporotic patients (Justesen et 
al., 2002; Stenderup et al., 2003). The age-related increased adipogenic differentiation 
of BMSCs may result from changes in the bone marrow microenvironment (Justesen et 
al., 2002; Stenderup et al., 2003; Abdallah et al., 2006; Kassem et al., 2008), including 
changes in hormone and cytokines levels. In addition to altered BMSC differentiation, 
osteoporosis may also result from the trans-differentiation of osteoblasts and 
osteoblast-committed progenitor cells into adipocytes. Both dexamethasone and 
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indomethacin are known to increase the risk of osteoporosis and promote the 
adipogenic differentiation of MSCs (Styner et al., 2010; Li et al., 2013a; Zhang et al., 
2015); they may also downregulate preosteoblast differentiation by inducing them to 
undergo adipogenic differentiation.  
7F2 cells expressed the three key genes from ghrelin signalling (Ghrl, Ghsr and Mboat4), 
suggesting that ghrelin plays a physiological role in these cells via autocrine/paracrine 
mechanisms, which is consistent with the literature (Fukushima et al., 2005; Kim et al., 
2005; Maccarinelli et al., 2005; Delhanty et al., 2006). 7F2 cells expressed variant 
isoforms of ghrelin, which had never been reported in bone cells before; at least one of 
these variant isoforms was much more abundant than native ghrelin, and may encode a 
peptide that retains the first 12 amino acids of native ghrelin, suggesting that this 
variant, if expressed at the protein level, may be acylated by GOAT and activate 
GHSR1a.  A number of variants of ghrelin have been identified in other tissues, 
including breast, ovary, testis, stomach, thymus, kidney, prostate, uterus, and brain 
(Hosoda et al., 2000b; Jeffery et al., 2005a; Yeh et al., 2005; Seim et al., 2007; Gahete et 
al., 2010; Seim et al., 2010; Gahete et al., 2011; Seim et al., 2013, 2016). Some of these 
variants have biological functions, such as In1-ghrelin which stimulates cancer cell 
proliferation and migration when overexpressed (Gahete et al., 2011; Ibáñez-Costa et 
al., 2015; Luque et al., 2015; Hormaechea-Agulla et al., 2017). Ghrelin variants may 
arise from tissue-specific alternative splicing. Ghrelin is known to have biological 
functions in a wide range of tissues; these effects may be mediated by these tissue-
specific ghrelin variants. Identifying the ghrelin variants present in bone, particularly in 
MSCs and osteoblasts, may provide new therapeutic targets for bone disorders. 
Despite the fact that 7F2 cells expressed genes from ghrelin signalling, the hypothesis 
that ghrelin could inhibit the adipogenic differentiation of 7F2 cells could not be 
verified, as ghrelin did not seem to have any effect on the number or size of lipid 
droplets inside 7F2 cell-derived adipocytes. The effects of ghrelin on 7F2 cells cultured 
with osteogenic medium was not tested in this study, as the subject was the role of 
ghrelin on the adipogenic differentiation of 7F2 cells. However, it would be interesting 
to test whether ghrelin favours a phenotype (osteoblastic or adipocytic) when 7F2 cells 
are cultured in the presence of both osteogenic and adipogenic media (Peng et al., 
2012; Cai et al., 2014; Ghali et al., 2015).  
Although ghrelin did not inhibit the adipogenic differentiation of 7F2 cells, it 
upregulated the mRNA expression of both osteoblastic and adipocytic markers, in 7F2 
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cells cultured with basal medium or adipogenic medium, which seemed to be 
consistent with published data about the effects of ghrelin in bone and adipose tissues. 
On one hand, ghrelin stimulates the osteoblastic differentiation of preosteoblasts and 
primary osteoblasts, increasing the expression of osteoblastic markers such as Runx2, 
collagen α1 type 1, ALP, and osteocalcin (Fukushima et al., 2005; Kim et al., 2005; 
Maccarinelli et al., 2005). On the other hand, ghrelin promotes adipogenesis, including 
bone marrow adipogenesis, with increased expression of adipogenic markers such as 
PPARγ and fatty acid synthase (Choi et al., 2003; Thompson et al., 2004; Rodríguez et 
al., 2009; Brown et al., 2014). In these studies, it is unclear whether ghrelin may 
promote both osteogenic and adipogenic differentiation in vivo, as only one type of 
tissue (bone or adipose) is investigated individually. In vivo experiments have shown 
that Ghsr or Ghrl deficiency causes alterations of bone microarchitecture; Ghsr-/- and 
Ghrl-/- mice have lower trabecular and cortical bone mass, respectively (Delhanty et al., 
2014b), but it is not known whether bone marrow adipogenesis is affected. Here, 
treatment with 20 nM ghrelin increased the mRNA expression of both adipogenic and 
osteoblastic markers, suggesting that ghrelin may promote both lineages. 
Contrary to ghrelin, treatment of 7F2 cells potassium channel ligands had an effect on 
cell proliferation and differentiation; in particular, treatment with TEA decreased cell 
number and limited the size of lipid droplets inside 7F2 cell-derived adipocytes, 
suggesting that voltage-gated potassium channels were involved in regulating cell 
proliferation and adipogenic differentiation. This is consistent with previous studies: in 
human BMSCs, blocking KV currents with TEA significantly reduces lipid droplet 
formation and the expression of the adipogenic marker aP2 (You et al., 2013). However, 
there are a large number of KV channels, and it is not known which ones were involved 
in regulating lipid content in 7F2 cells. 
To help answering this question, the ionic mechanisms in 7F2 cells were investigated in 
electrophysiological experiments. A variety of currents corresponding to several types 
of ion channels were detected in 7F2 cells cultured for a few days with basal or 
adipogenic medium, in the presence or absence of ghrelin. Some currents were 
detected only in 7F2 osteoblastic cells, while others were detected only when 7F2 
osteoblastic and adipocytic cells were treated with ghrelin. In addition, ghrelin 
treatment seemed to modify the open probabilities of some currents that were detected 
both in presence and in absence of ghrelin treatment. Ghrelin may exert effects in 7F2 
cells by promoting the surface expression and activity of some ion channels. Other 
hormones have been shown to increase ion channel expression, such as insulin, which 
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may regulate adipogenesis by increasing potassium channel density in white 
adipocytes (Ramirez-Ponce et al., 2002). Similarly, leptin may inhibit insulin secretion 
by causing a transient increase KATP and Kv2.1 channel density in rodent and human β-
cells (Wu et al., 2015). Interestingly, ghrelin also inhibits insulin secretion by activating 
Kv2.1 channels (Dezaki et al., 2004, 2007), and these channels are expressed in rat 
MSCs and are implicated in regulating MSC proliferation (Li et al., 2006; Deng et al., 
2007). As one of the currents detected in 7F2 cells may correspond to Kv2.1, this 
channel and its role in regulating 7F2 cell proliferation and adipogenic differentiation 
may be the focus of future investigations. 
7.3. Limitations and assumptions 
7.3.1. Cell culture assays 
Firstly, as mentioned in the result chapters, there was a great variability between the 
repeats of Oil Red O staining assays; this variability may be explained by the effect of 
cell density, as adipogenesis was increased in areas of higher cell densities; but also by 
the Oil Red O crystals that artificially increased the amount of stain measured by 
absorbance, blunting the differences between cells cultured with basal medium and 
cells cultured with adipogenic medium, in the presence or absence of ghrelin.  
Secondly, only short-term cultures were performed; 7 days of culture may not be a long 
enough period to reveal an effect of ghrelin on adipogenesis, and long-term cultures 
may be more sensitive. The decision to perform short-term cultures was made because 
of the proliferation rate in 7F2 cells cultured with basal medium; even with low seeding 
densities, after 7 days of culture the wells and flasks were confluent. Increasing the 
duration of culture resulted in the detachment and loss of these cells when replacing 
culture medium. In addition, it was not possible to passage 7F2 cells cultured with 
adipogenic medium, as this resulted in the loss of adipocytes.  
Thirdly, only two concentrations of ghrelin were tested, 20 nM and 200 nM; it would 
have been helpful to use a larger range of concentrations, similarly to what was done in 
other studies (Kim and Chen, 2004; Liu et al., 2009). In particular, lower concentrations 
of ghrelin (in the pM range) may have had stronger effects on adipogenic 
differentiation than 20 nM or 200 nM ghrelin. Also, the ghrelin used in this study was 
human, whereas 7F2 cells are murine. 
Chapter 7 – General discussion and conclusions  
 
222 
 
7.3.2. Molecular biology 
There was a great variability between qRT-PCR repeats; increasing the number of 
repeats would have been necessary to increase the statistical power of these 
experiments. Here, only 2 repeats were performed, with 3 replicate samples per 
condition in each repeat, and each of these samples were run in duplicate. Three house-
keeping genes were chosen: GAPDH, HPRT1 – which are commonly used in qRT-PCR – 
and EEF2. GAPDH and HPRT1 tend to be differentially expressed depending on the 
experimental conditions and the type of tissue the cells originate from (Jonge et al., 
2007; Kouadjo et al., 2007). Here, 7F2 osteoblastic cells and adipocytic cells originated 
from the same tissue – bone – but since they were differentiated into adipocytes in 
vitro, this may have had an influence on GAPDH and HPRT1 expression levels. EEF2 on 
the contrary was shown to have very stable expression levels (Jonge et al., 2007; 
Kouadjo et al., 2007); this gene is involved in translation and was evenly expressed 
between all tissues tested, particularly in mouse tissues (Kouadjo et al., 2007). 
However, in some qRT-PCR repeats, the EEF2 expression levels varied significantly 
between the various samples, whereas HPRT1 expression levels seemed relatively 
even, which is why expression levels of the tested genes were normalised with both 
EEF2 and HPRT1 in the result sections. 
Glut4 expression level was not measured by qRT-PCR analysis, because when its 
expression first tested by RT-PCR, it was not detected in 7F2 cells cultured with basal 
or adipogenic medium, despite running RT-PCR several times with various 
temperatures for the annealing step (56°C and 58°C), and increasing the number of 
cycles from 35 to 40. However, when tested again several months later, Glut4 mRNA 
was detected in 7F2 cells cultured with adipogenic medium. Similarly, osteocalcin 
expression was not measured by qRT-PCR, because the first set of primers that was 
used showed a low expression in RT-PCR experiments.  
7.3.3. Electrophysiology 
The main limitation of this study regarding electrophysiology data was the 
impossibility to obtain whole-cell patches, which caused several problems. Firstly, it 
prevented the pharmacological characterisation of the ion channels that were detected 
using single-channel patch clamping. Secondly, it prevented other types of experiments 
that would have provided useful data. In particular, it was not possible to test whether 
some ion channels opened in response to ghrelin binding to its receptor when adding 
ghrelin to the bathing solution, and to identify these ion channels using 
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pharmacological modulators. Thirdly, whole-cell patch may have allowed verifying that 
GHSR1a was the receptor ghrelin bound to, by using an antagonist of this receptor; if 
ghrelin bound to GHSR1a and triggered ion channel opening, then the corresponding 
currents may have been abolished by the addition of a GHSR1a antagonist. 
The protocol used here favoured the detection of voltage-dependent and voltage-
activated ion channels, by trying to detect currents when changing membrane voltage, 
but other types of ion channels exist that are activated by other stimuli, such as ligand-
activated ion channels. In particular, some inwardly-rectifying K+ channels are coupled 
to GPCRs (Hibino et al., 2010), which may have been relevant to this study, as GHSR1a 
is a GCPR (Camiña, 2006). These other types of ion channels may have been 
investigated using whole-cell patch clamping or perforated patch clamping, had those 
techniques been efficient with 7F2 cells.  
This study focussed on the roles of K+ channels in this study, even though other families 
of ion channels such as Ca2+, Na+ or Cl- channels are present and have biological 
functions in osteoblasts. PCR tools were used to detect expression of subunits of 
various K+ channels, but not other types of ion channels. However, in electrophysiology 
experiments, the recording solutions that were used also allowed detecting other 
families of ion channels, as they contained a non-negligible amount of other ions (Na+, 
Ca2+ and Cl- in particular). The role of K+ channels in regulating 7F2 cell proliferation 
and adipogenic differentiation was investigated using TEA and diazoxide in cell culture 
assays, but using pharmacological modulators for other families of ion channels may 
have provided interesting data on the ionic mechanisms underlying 7F2 cell adipogenic 
differentiation. 
7.4. Recommendations for future work 
The findings presented in this study raise a number of questions that were not 
approached in this study due to lack of time or funding; these questions may be 
investigated in future work.  
The transdifferentiation of 7F2 cells into adipocytes 
Given the high degree of plasticity between the osteoblastic and adipocytic lineages, the 
work done on 7F2 cells in this study may be extended to other osteoblastic cells, 
especially primary osteoblasts and osteoblast cell lines from other species, including 
humans. Other differentiation markers may be tested, especially adipogenic markers 
such as secretion of leptin or adiponectin; it would be interesting to study whether 7F2 
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cell-derived adipocytes can secrete adipokines, which are known to regulate bone 
homeostasis.  
The expression of differentiation markers was only tested at the mRNA level; future 
work may extend these results by analysing expression at the protein level, using 
western blotting. 
Ghrelin signalling in 7F2 cells 
7F2 cells express genes from ghrelin signalling, including several variant isoforms of 
ghrelin at the mRNA level, which raises several questions. Are these genes and the 
variant isoforms of ghrelin expressed at the protein level? Are ghrelin variants 
upregulated by ghrelin treatment, similarly to Ghrl mRNA? Other studies have shown 
that the ghrelin gene gives rise to a large number of isoforms whose expression pattern 
may be tissue-specific. Are the ghrelin variants detected in 7F2 cells expressed in other 
osteoblastic cells, such as primary osteoblasts? Are they expressed in osteoblasts from 
other species, especially humans?  
The exact structure of the ghrelin variants in 7F2 cells could not be established due to 
the fact that PCR reaction with primers located on exons 1 and 5, or exons 1 and 4, did 
not work. These may be due to the fact that the PCR reaction needs to be optimised; or 
maybe there are several isoforms, one that contains exon 1 but not exons 4 and 5, and 
one that contains exons 4 and 5, but not exon 1. Further work is needed to establish the 
exact snumber and structure of the ghrelin variants detected in 7F2 cells.  
Effect of ghrelin treatment on 7F2 cell adipogenic differentiation 
Ghrelin treatment did not seem to inhibit 7F2 cell adipogenic differentiation, but 
upregulated both osteogenic and adipogenic marker mRNA expression. However, 
repeating qRT-PCR assays would be useful; here the effects of ghrelin on differentiation 
marker mRNA expression was only tested twice (with two different concentrations of 
ghrelin), and a great variability was observed between the two repeats.  
If the ghrelin variants are expressed at the protein level, it would be interesting to 
study their effects on adipogenic differentiation of 7F2 cells, other osteoblastic cell lines 
or BMSCs. Overexpressing these variants may be used as an approach to test their 
effects on osteoblast formation and function. 
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Electrophysiological properties of 7F2 cells 
Several functional ion channels were detected in 7F2 cells that could not be identified 
by pharmacological modulation during electrophysiological recording. To identify 
these ion channels, it may be helpful to investigate the mRNA expression the candidates 
that were proposed for the currents detected in 7F2 cells, including intermediate-
conductance Ca2+-activated K+ channels (KCa3.1), which are expressed in mouse 
BMSCs; TRPV1 and the inward rectifier K+ channel Kir2.1, which have been reported to 
regulate cell proliferation and differentiation in bone; and Kv2.1 which mediates 
ghrelin signalling in pancreatic β-cells. Analysing the kinetics of the currents, with less 
background noise in single-patch clamping experiments, will also help identify the 
corresponding ion channels. 
The roles of K+ channels in 7F2 cell proliferation and differentiation 
The data in this study indicate that K+ channels are involved in regulating 7F2 cell 
proliferation and adipogenic differentiation. Testing the effects of specific channel 
blockers or activators in cell culture assays should help identify the ion channels that 
are involved in regulating adipogenic differentiation. The channel blockers/openers 
may be selected based on RT-PCR and electrophysiological data. 
KATP channels are involved in regulating the secretion of various hormones such as 
insulin and osteocalcin (Moreau et al., 1997; Ashcroft, 2005). Here, diazoxide did not 
seem to affect cell proliferation and differentiation as measured by cell counting and Oil 
Red O staining, but it may affect other processes such as osteocalcin secretion by 7F2 
cells. 
Due to lack of time, the role of ion channels in mediating ghrelin signalling could not be 
tested. With electrophysiology techniques, since whole-cell and perforated-patch 
configurations could not be obtained, it was not possible to test whether adding ghrelin 
to the bathing solution could trigger ion channel activity or modify their kinetics. It may 
be interesting to test whether channel blockers/openers can attenuate the effects of 
ghrelin on the mRNA expression of differentiation markers and Ghrl. 
7.5. Concluding statement 
Understanding the mechanisms underlying pathological adipogenesis in bone is of 
importance to identify new therapeutic approaches to treat some forms of 
osteoporosis. The findings in this thesis provide data on the role of ghrelin signalling 
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and ionic mechanisms in osteoblast proliferation and adipogenic differentiation, but 
also raise many questions that will need to be answered in future studies. 
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8.1. Oligonucleotide primers 
8.1.1. Oligonucleotide primers for house-keeping genes 
Oligonucleotide primers (see table 8.1 and figure 8.1) for three house-keeping genes: 
Hypoxanthine-guanine Phosphoribosyltransferase 1 (Hprt1), Glyceraldehyde 3-
phosphate dehydrogenase (Gapdh) and Eukaryotic elongation factor 2 (Eef2), were 
designed from mouse gene sequences using FasterDB (Cancer Research Center of Lyon, 
CRCL) and Primer3 as follows: the FasterDB database was searched for genetic 
sequences in the mouse genome; part of mRNA sequences were selected so that they 
covered as many splicing isoforms as possible and copied into the ‘source sequence 
box’ of the web-based Primer3 primer design software. The software selected left and 
right primers for the given sequence without modification of the default software 
settings. Primer3-suggested primers were checked against the complete genetic 
sequence using the FasterDB ‘in silico PCR’ tool, to determine predicted amplicon sizes, 
especially when primer sequences were in different exons. Primers were obtained from 
Eurogentec. 
 
Gene Sequences Product Size 
Hprt1 
F: ATTAGCGATGATGAACCAGGT 
155 bp 
R: GCCTCCCATCTCCTTCATGA 
Gapdh 
F: AAAGGGTCATCATCTCCGCC 
170 bp 
R: CCCTTCCACAATGCCAAAGT 
Eef2 
F: GGAGCTCTACCAGACCTTCC 
186 bp 
R: GCCACATACATCTCCGCAAA 
Table 8.1: Oligonucleotide primer details for differentiation markers 
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Hprt1 
> NM_013556 Mus musculus hypoxanthine guanine phosphoribosyl transferase (Hprt), 
mRNA 
 
Gapdh 
> NM_008084 Mus musculus glyceraldehyde-3-phosphate dehydrogenase (Gapdh), 
transcript variant 2, mRNA 
 
Eef2 
> NM_007907 Mus musculus eukaryotic translation elongation factor 2 (Eef2), mRNA 
 
Figure 8.1: Primers and amplification sequences for house-keeping genes.  
Target primer sequences are shown in red. 
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8.1.2. Oligonucleotide primers for differentiation markers 
Oligonuclotide primers (see table 8.2 and figure 8.2) for various adipocytic markers: 
peroxisome proliferator-activated receptor gamma (Pparg), Glucose transporter type 4 
(Glut4) and CCAAT-enhancer-binding protein alpha (Cebpa); and osteoblastic markers: 
osteocalcin, Runt-related transcription factor 2 (Runx2), and alkaline phosphatase 
(Alpl), were designed as previously described (see above, section 8.1.1) and obtained 
from Eurogentec. 
 
Gene Sequences Product Size 
Pparg 
F: AGAACCTGCATCTCCACCTT 
155 bp 
R: TGCATCCTTCACAAGCATGA 
Glut4 
F: CTTGGCTCCCTTCAGTTTG 
130 bp 
R: TGCCTTGTGGGATGGAAT 
Cebpa 
F: TACAACAGGCCAGGTTTCCT 
206 bp 
R: AAGTTCCTTCAGCAACAGCG 
Osteocalcin 
F: AGGTAGTGAACAGACTCCGG 
162 bp 
R: ACTGTACAAGAGGCTCCAGG 
Runx2 
F: TTCAACGATCTGAGATTTGTGGG 
221 bp 
R: GGATGAGGAATGCGCCCTA 
Alpl 
F: TCAGGGCAATGAGGTCACAT 
161 bp 
R: CCTCTGGTGGCATCTCGTTA 
Table 8.2: Oligonucleotide primer details for differentiation markers 
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Pparg 
> NM_001127330.2 Mus musculus peroxisome proliferator activated receptor gamma 
(Pparg), transcript variant 1, mRNA: 155 bp 
 
Also detects transcript variant 3 (NM_001308352.1) and 4 (NM_001308354.1), 155 bp  
Glut4 
> NM_009204 Mus musculus solute carrier family 2 (facilitated glucose transporter), 
member 4 (Slc2a4), mRNA: 130 bp 
 
Cebpa 
> NM_007678 Mus musculus CCAAT/enhancer binding protein (C/EBP), alpha (Cebpa), 
transcript variant 1, mRNA: 206 bp 
 
Figure 8.2: Primers and amplification sequences for differentiation markers (part 1) 
Target primer sequences are underlined. 
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Osteocalcin (1st set of primers) 
> BC069910 Mus musculus bone gamma-carboxyglutamate protein, related sequence 1, 
mRNA: 162 bp 
 
Osteocalcin (2nd set of primers) 
> NM_007541 Mus musculus bone gamma carboxyglutamate protein (Bglap), mRNA 
(longer PolyA) 
 
> NM_001032298 Mus musculus bone gamma-carboxyglutamate protein 2 (Bglap2), 
mRNA 
 
Figure 8.2: Primers and amplification sequences for differentiation markers (part 2) 
Target primer sequences are underlined. 
 
  
Chapter 8 - Appendix 
 
233 
 
> BC069910 Mus musculus bone gamma-carboxyglutamate protein, related sequence 1, 
mRNA (cDNA clone IMAGE:5250978), with apparent retained intron : 384/385 bp, 
intron retention between exon 3 and 4 
 
Runx2 
> NM_001146038 Mus musculus runt related transcription factor 2 (Runx2), transcript 
variant 1, mRNA: 221 bp 
 
Also detects transcript variants 2 (NM_001145920) and 3 (NM_009820), 221 bp 
Alpl  
> NM_007431 Mus musculus alkaline phosphatase, liver/bone/kidney (Alpl), 
transcript variant 1, mRNA: 161 bp 
 
Figure 8.2: Primers and amplification sequences for differentiation markers (part 3) 
Target primer sequences are underlined. 
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8.1.3. Oligonucleotide primers for ghrelin signalling genes 
Oligonuclotide primers (see table 8.3 and figure 8.3) for Growth-Hormone 
Secretagogue Receptor (Ghsr), Ghrelin (Ghrl) and Ghrelin-O-Acyltransferase (Mboat4) 
were designed as previously described (section 8.1.1) and obtained from Eurogentec. 
 
Gene Sequences Product Size 
Ghsr 
F: GGCAACGACTCACTCTCTGA 
215 bp 
R: GGCATGCACAGGAAGATGAG 
Ghrl 
F: GTCATCTGTCCTCACCACCA 
220 bp 
R: TGCTTGTCCTCTGTCCTCTG 
Mboat4 
F: TGCCCTTCATCTCACCTAGC 
240 bp 
R: GCCACACCTCCTAGTCCTTT 
Table 8.3: Oligonucleotide primer details for ghrelin signalling components 
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Ghsr 
> NM_177330 Mus musculus growth hormone secretagogue receptor (Ghsr), mRNA: 
215 bp 
 
Ghrl 
> NM_021488 Mus musculus ghrelin (Ghrl), transcript variant 1, mRNA: 220 bp 
 
Mboat4 
> NM_001126314 Mus musculus membrane bound O-acyltransferase domain 
containing 4 (Mboat4), mRNA: 240 bp 
 
Figure 8.3: Primers and amplification sequences for ghrelin signalling components.  
Target primer sequences are underlined. 
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8.1.4. Oligonucleotide primers for ghrelin signalling genes 
Oligonuclotide primers (see tables 8.4 and 8.5; and figure 8.4) spanning the various 
exons and intron 2 of the mouse ghrelin gene were obtained from Eurogentec. The 
primers were designed by (Kineman et al., 2007), except for Ghrl458_E2f (Exon 2, 
forward) and Ghrl753_E3r (Exon 3, reverse), which were designed as previously 
described (section 8.1.1). All primers were obtained from Eurogentec.  
 
Name Sequence Location Direction 
Ghrl30_E1f ACATCCCCAGGCATTCCAG Exon 1 Forward 
Ghrl458_E2f GTCATCTGTCCTCACCACCA Exon 2 Forward 
Ghrl698_E3f TCCAAGAAGCCACCAGCTAA Exon 3 Forward 
Ghrl798_E3-4f TCAGGTTCAATGCTCCCTTC Exon 3/4 Forward 
Ghrl2751_E4f CAATGCTCCCTTCGATGTTG Exon 4 Forward 
Ghrl607_In2r GTAGATGTGGGGGCTTAGGG Intron 2 Reverse 
Ghrl637_In2r TTCTCTCTCTCTCACACACACACAC Intron 2 Reverse 
Ghrl753_E3r TGCTTGTCCTCTGTCCTCTG Exon 3 Reverse 
Ghrl2752_E4r AACATCGAAGGGAGCATTGA Exon 4 Reverse 
Ghrl3657_E5r AGGCCTGTCCGTGGTTACTT Exon 5 Reverse 
Table 8.4: Names, sequences and location of primers 
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Primer sets 
Primer 
locations 
Sequences 
Product  
Size* 
Ghrl30_E1f - Ghrl753_E3r Ex1-Ex3 
F: ACATCCCCAGGCATTCCAG 
239 bp 
R: TGCTTGTCCTCTGTCCTCTG 
Ghrl458_E2f - Ghrl607_In2r Ex2-In2 
F: GTCATCTGTCCTCACCACCA 
169 bp 
R: GTAGATGTGGGGGCTTAGGG 
Ghrl458_E2f - Ghrl637_In2r Ex2-In2 
F: GTCATCTGTCCTCACCACCA 
204 bp 
R: TTCTCTCTCTCTCACACACACACAC 
Ghrl458_E2f - Ghrl753_E3r Ex2-Ex3 
F: GTCATCTGTCCTCACCACCA 
220 bp 
R: TGCTTGTCCTCTGTCCTCTG 
Ghrl698_E3f - Ghrl2752_E4r Ex3-Ex4 
F: TCCAAGAAGCCACCAGCTAA 
126 bp 
R: AACATCGAAGGGAGCATTGA 
Ghrl2751_E4f - Ghrl3657_E5r Ex4-Ex5 
F: CAATGCTCCCTTCGATGTTG 
141 bp 
R: AGGCCTGTCCGTGGTTACTT 
Table 8.5: Expected product size for each tested sets of primers 
* sizes indicated are without any intron, except for when reverse primers are located within 
intron 2. 
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Ghrl (Exon 1 - Exon 3) 
> NM_021488 Mus musculus ghrelin (Ghrl), transcript variant 1, mRNA: 239 bp – Exon 
1, Exon 2, Exon 3 
 
Ghrl (Exon 2 - Intron 2, first primer set)  
> DQ993169 Mus musculus ghrelin variant mRNA sequence: 169 bp - Exon 2, Intron 2 
 
Ghrl (Exon 2 - Intron 2, second primer set)  
> DQ993169 Mus musculus ghrelin variant mRNA sequence: 204 bp - Exon 2, Intron 2 
 
Figure 8.4: Primers and amplification sequences for the various regions of the ghrelin 
gene (part 1) 
 Target primer sequences are underlined. No intron included except for when reverse primer is 
located on intron 2.  
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Ghrl (Exon 2 - Exon 3)  
> NM_021488 Mus musculus ghrelin (Ghrl), transcript variant 1, mRNA: 220 bp - Exon 
2, Exon 3 (no Intron 2) 
 
Ghrl (Exon 3 - Exon 4)  
> NM_021488 Mus musculus ghrelin (Ghrl), transcript variant 1, mRNA: 126 bp - Exon 
3, Exon 4 
 
Ghrl (Exon 4 - Exon 5)  
> NM_021488 Mus musculus ghrelin (Ghrl), transcript variant 1, mRNA: 141 bp - Exon 
4, Exon 5 
 
Figure 8.4: Primers and amplification sequences for the various regions of the ghrelin 
gene (part 2) 
 Target primer sequences are underlined. No intron included except for when reverse primer is 
located on intron 2.  
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8.1.5. Oligonucleotide primers for ion channels 
Oligonuclotide primers (see table 8.6 and figure 8.5) for Kir6.1 (Kcnj8), Kir6.2 (Kcnj11), 
SUR1 (Abcc8), SUR2 (Abcc9), KCa1.1 (Kcnma1), KCa1.1 regulatory β subunits (Kcnmb1-
4) and Kv4.2 (Kcnd2) were designed as previously described (section 8.1.1) and 
obtained from Eurogentec. 
 
Gene Sequences Product Size 
Kcnj8 
F: CATGATCATTAGCGCCTCGG 
155 bp 
R: CGTGGCAGATGATCAATGGG 
Kcnj11 
F: CACCTCCTACCTAGCTGACG 
249 bp 
R: ATGCTAAACTTGGGCTTGGC 
Abcc8 
F: CCATTGATTACTGGCTGGCC 
175 bp 
R: TCCACAGTGACAGAGGTGAC 
Abcc9 
F: CCATCATCAGTGTTCAAAAGC 
148 bp 
R: GGCTGCTTCCTGTTTATTGG 
Abcc9 
F: ATCATGGATGAAGCCACTGC SUR2A: 397 bp 
SUR2B: 221 bp R: AACGAGGCAAACACTCCATC 
Kcnma1 
F: TGGTGGAGAATTCAGGGGAC 
167 bp 
R: CCCGAGGATGAAGAAGACCA 
Kcnmb1 
F: GGACAACTACCAGACAGCCT 
164 bp 
R: TGGGCCAGAAGAAGGAGAAG 
Kcnmb2 
F: TCGTGAGTGTCGTCATGGAA 
155 bp 
R: CCCAGCCATCATACAAGTTGG 
Kcnmb3 
F: AAACTTCTAGAGGACCCCGC 
217 bp 
R: ACCCTGTAGCGTGATTTGGA 
Kcnmb4 
F: CTGTCGGTGCAGCAGATC 
167 bp 
R: TTGGGGTTGGTCAGGAGC 
Kcnd2 
F: GAACCGGCCTTCATAAGCAA 
162 bp 
R: ACTGTGACTTGATGGGCGAT 
Table 8.6: Oligonucleotide primer details for ion channels 
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Kcnj8 
> NM_008428 Mus musculus potassium inwardly-rectifying channel, subfamily J, 
member 8 (Kcnj8), transcript variant 1, mRNA: 155 bp 
 
Also detects transcript variants 2 (NM_001330363.1) and 3 (NM_001330366.1), 155 bp 
Kcnj11 
> NM_010602.3 Mus musculus potassium inwardly rectifying channel, subfamily J, 
member 11 (Kcnj11), transcript variant 1, mRNA: 249 bp 
 
Also detects transcript variant 2 (NM_001204411.1), 249 bp 
Abcc8 
> NM_011510.3 Mus musculus ATP-binding cassette, sub-family C (CFTR/MRP), 
member 8 (Abcc8), transcript variant 1, mRNA: 175 bp 
 
Also detects transcript variant 2 (NM_001357538.1), 175 bp 
Figure 8.5: Primers and amplification sequences for ion channels (part 1) 
Target primer sequences are underlined. 
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Abcc9 (first set of primers) 
> NM_011511.2 Mus musculus ATP-binding cassette, sub-family C (CFTR/MRP), 
member 9 (Abcc9), transcript variant 1, mRNA: 148 bp 
 
Also detects transcript variants 2 (NM_021041.2), 5 (NM_001044720.1) and 6 
(NM_001310143.1), 148 bp 
Abcc9 (second set of primers) 
> NM_011511.2 Mus musculus ATP-binding cassette, sub-family C (CFTR/MRP), 
member 9 (Abcc9), transcript variant 1, mRNA: 221 bp (isoform a, SUR2B) 
 
> NM_021041.2 Mus musculus ATP-binding cassette, sub-family C (CFTR/MRP), 
member 9 (Abcc9), transcript variant 2, mRNA: 397 bp (isoform b, SUR2A) 
 
Also detects transcript variants 4 (NM_021042.2) and 5 (NM_001044720.1), 397 bp; 
and transcript variant 6 (NM_001310143.1), 221 bp  
Figure 8.5: Primers and amplification sequences for ion channels (part 2) 
Target primer sequences are underlined. 
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Kcnma1 
> NM_001253358.1 Mus musculus potassium large conductance calcium-activated 
channel, subfamily M, alpha member 1 (Kcnma1), transcript variant 1, mRNA: 167 bp 
 
Also detects all the other isoforms (transcript variants 2 to 21, same expected size for 
the PCR products) but not the transcript variant 18 (NM_001253374.1). 
Kcnmb1 
> NM_031169.4 Mus musculus potassium large conductance calcium-activated channel, 
subfamily M, beta member 1 (Kcnmb1), mRNA: 164 bp 
 
Kcnmb2 
> NM_028231.2 Mus musculus potassium large conductance calcium-activated channel, 
subfamily M, beta member 2 (Kcnmb2), mRNA: 155 bp 
 
Figure 8.5: Primers and amplification sequences for ion channels (part 3) 
Target primer sequences are underlined. 
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Kcnmb3 
> NM_001195074.1 Mus musculus potassium large conductance calcium-activated 
channel, subfamily M, beta member 3 (Kcnmb3), mRNA: 217 bp 
 
Kcnmb4 
> NM_021452.1 Mus musculus potassium large conductance calcium-activated channel, 
subfamily M, beta member 4 (Kcnmb4), mRNA: 167 bp 
 
Kcnd2 
> NM_019697.3 Mus musculus potassium voltage-gated channel, Shal-related family, 
member 2 (Kcnd2), mRNA: 162 bp 
 
Figure 8.5: Primers and amplification sequences for ion channels (part 4) 
Target primer sequences are underlined. 
 
 
  
Chapter 8 - Appendix 
 
245 
 
8.2. Sequencing of Ghrl PCR products 
The following figures show the raw data supplied by GATC Biotech (chromatographs), 
the sequence of the PCR product in FASTA format, and the alignment of that sequence 
with that of the mouse ghrelin gene, for each Ghrl PCR product that could be sequenced. 
These PCR products are presented in Chapter 4 (section 4.3.3.). 
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Figure 8.6: Sequencing of the 741 bp band from PCR with primers located on exons 1 
and 3 (part 1) 
A: chromatograph supplied by GATC Biotech; N indicates unidentified bases (Phred quality 
score < 10).  
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Figure 8.6: Sequencing of the 741 bp band from PCR with primers located on exons 1 
and 3 (part 2) 
B: sequence of the PCR product, extracted from the chromatograph. 
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Figure 8.6: Sequencing of the 741 bp band from PCR with primers located on exons 1 
and 3 (part 3) 
C: sequence alignment between the ghrelin gene (mouse) and the PCR product sequence 
extracted from the chromatograph, using the Clustal Omega program (EBI-EMBL). Underlined= 
exons; dotted line= intronic sequence that has been found to be included in some ghrelin 
variants; perforated line= 8 repetitions of TG (Kineman et al., 2007); highlighted = location of 
primers; * = matching bases; - = base missing in the PCR product. 
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Figure 8.7: Sequencing of the 315 bp band from PCR with primers located on exons 2 
and 3 (part 1) 
A: chromatograph supplied by GATC Biotech; N indicates unidentified bases (Phred quality 
score < 10). B: sequence of the PCR product, extracted from the chromatograph. 
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Figure 8.7: Sequencing of the 315 bp band from PCR with primers located on exons 2 
and 3 (part 2) 
C: sequence alignment between the ghrelin gene (mouse) and the PCR product sequence 
extracted from the chromatograph, using the Clustal Omega program (EBI-EMBL). Underlined= 
exons; perforated line= 8 repetitions of TG (Kineman et al., 2007); highlighted = location of 
primers; * = matching bases; - = base missing in the PCR product 
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Figure 8.8: Sequencing of the 924 bp band from PCR with primers located on exons 4 
and 5 (part 1) 
A: chromatograph supplied by GATC Biotech; N indicates unidentified bases (Phred quality 
score < 10).  
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Figure 8.8: Sequencing of the 924 bp band from PCR with primers located on exons 4 
and 5 (part 2) 
B: sequence of the PCR product, extracted from the chromatograph. 
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Figure 8.8: Sequencing of the 924 bp band from PCR with primers located on exons 4 and 5 (part 3) 
C: sequence alignment between the ghrelin gene (mouse) and the PCR product sequence extracted from the chromatograph, using the Clustal Omega 
program (EBI-EMBL). Underlined= exons; highlighted = location of primers; * = matching bases; - = base missing in the PCR product. 
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Figure 8.9: Sequencing of the 2088 bp band from PCR with primers located on exons 
3/4 and 5 (part 1) 
A: chromatograph supplied by GATC Biotech; N indicates unidentified bases (Phred quality 
score < 10).  
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Figure 8.9: Sequencing of the 2088 bp band from PCR with primers located on exons 
3/4 and 5 (part 2) 
B: sequence of the PCR product, extracted from the chromatograph. 
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Figure 8.9: Sequencing of the 2088 bp band from PCR with primers located on exons 3/4 and 5 (part 3) 
C: sequence alignment between the ghrelin gene (mouse) and the PCR product sequence extracted from the chromatograph, using the Clustal Omega 
program (EBI-EMBL). Underlined= exons; |: junction between exon 3 and exon 4; * = matching bases; - = base missing in the PCR product. 
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